Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40759040	s-c-pep-a	nmol/l (nmol/l)	2138	2713	0.00%
40759040	p-c-pepta	nmol/l (nmol/l)	1466	1962	0.92%
40759040	s-c-pep-a	— (—)	392	509	100.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	nmol/l (nmol/l)	245	274	0.00%
40759040	p-c-pepta	— (—)	146	165	100.00%	Distribution not available
40759040	s-c-pep-a	nmol/l____ (nmol/l)	111	126	0.00%
40759040	s-c-peptidi,proinsuliinin,aterianjälkeen	nmol/l (nmol/l)	57	63	0.00%
40759040	s-c-pepaj	nmol/l (nmol/l)	54	64	0.00%
40759040	s-c-peptidi1haterianjäkeen	nmol/l (nmol/l)	47	57	0.00%
40759040	c-peptidi,proinsuliinin,aterianjälkeinen	nmol/l____ (nmol/l)	42	43	0.00%
40759040	c-pepta	nmol/l (nmol/l)	10	13	0.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	— (—)	9	9	100.00%	Distribution not available	Distribution not available
40759040	c-peptidi,proinsuliinin,aterianjälkeinen	nmol/l (nmol/l)	8	8	0.00%	Distribution not available
40759040	s-c-pepaj	— (—)	5	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic pancreatitis

428

554

8.29

312.77

1.5

1.3

0.94

1.58

nmol/l

20.41

388

496

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3002

185

101.23

307.65

1.3

2.0

1.45

nmol/l

0.01

2696

167

Statin medication

872

710

7.03

307.65

1.4

1.5

1.52

1.33

nmol/l

2.94

773

655

Diabetes, insulin treatment (Kela reimbursement)

3135

369

53.08

307.65

1.3

1.8

1.44

1.58

nmol/l

1.45

2818

338

Type 1 diabetes

779

110.01

307.65

1.5

2.1

0.81

1.47

nmol/l

4.75

653

Diabetes medication

2983

286

63.64

307.65

1.3

1.9

1.44

1.52

nmol/l

0.51

2687

261

Type 2 diabetes

2650

200

79.97

307.65

1.3

2.0

1.50

1.45

nmol/l

0.27

2393

180

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2069

347

50.16

307.65

1.3

1.5

1.52

1.18

nmol/l

7.19

1899

299

Insulin medication

3118

215

131.79

307.65

1.4

1.7

1.28

1.56

nmol/l

3.10

2806

196

Insulin, fast-acting

1861

540

38.06

307.65

1.4

1.05

1.81

nmol/l

34.22

1644

492

Diabetes mellitus

2762

211

78.77

307.65

1.3

2.0

1.46

1.48

nmol/l

0.09

2496

190

Insulin, combination of fast acting with intermediate-acting or long-acting

3119

911

33.92

307.65

1.4

1.3

1.28

1.84

nmol/l

35.79

2807

836

Diabetes, varying definitions

2729

241

68.39

307.65

1.3

2.0

1.46

1.41

nmol/l

0.29

2469

215

Other blood glucose lowering drugs, excl. Insulins

576

100

62.50

307.65

1.4

1.6

1.40

1.27

nmol/l

0.49

510

Any reimbursement code in KELA

591

180

16.68

307.65

1.4

1.7

1.40

1.54

nmol/l

0.81

529

169

Insulin, intermediate and long-acting

2926

856

36.37

307.65

1.4

1.3

1.26

1.83

nmol/l

35.60

2622

788

Type 2 diabetes, strict (exclude DM1)

2305

244

57.07

307.65

1.3

1.9

1.62

1.35

nmol/l

3.26

2116

222

Insulin, fast-acting or short human

1866

1036

19.79

307.65

1.4

1.3

1.05

1.72

nmol/l

52.05

1649

943

Glucagon-like peptide-1 (GLP-1) analogues

1451

291

54.83

307.65

1.3

1.6

1.69

1.20

nmol/l

10.15

1351

252

Type 2 diabetes, wide definition

2333

299

51.67

307.65

1.3

1.7

1.51

1.01

nmol/l

14.28

2117

260

Other (not insulin) diabetes medications

2771

276

61.59

307.65

1.3

1.9

1.52

1.49

nmol/l

0.12

2519

253

Type 1 diabetes, wide definition

641

99.60

307.65

1.5

2.0

0.75

1.53

nmol/l

5.37

531

Endocrine, nutritional and metabolic diseases

1075

104

53.18

307.65

1.4

1.2

1.43

1.51

nmol/l

0.24

974

Biguanides

2708

575

29.70

307.65

1.3

1.6

1.52

1.19

nmol/l

9.34

2469

499

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1451

291

54.83

307.65

1.3

1.6

1.69

1.20

nmol/l

10.15

1351

252

Type 2 diabetes, definitions combined

2301

186

74.75

307.65

1.3

2.1

1.62

1.43

nmol/l

1.48

2113

168

Cardiac arrhythmias

439

115

24.73

307.65

1.5

2.0

1.63

1.56

nmol/l

0.21

405

100

Sulfonylureas

971

161

50.64

307.65

1.3

1.18

1.22

nmol/l

0.16

888

132

Type 1 diabetes, wide definition, subgroup 1

626

110.53

307.65

1.5

2.0

0.74

1.60

nmol/l

5.39

516

Sub-endpoint used in defining T1D endpoints

808

1049

7.93

307.65

1.5

1.3

0.80

1.59

nmol/l

60.93

682

956

Type 2 diabetes, definitions combined, including avohilmo

2249

219

61.58

307.65

1.3

2.0

1.63

1.32

nmol/l

3.90

2060

200

Thiazolidinediones

421

56.16

307.65

1.4

1.5

1.38

1.21

nmol/l

0.58

386

Combinations of oral blood glucose lowering drugs

997

234

45.92

307.65

1.3

1.5

1.42

1.21

nmol/l

2.00

913

202

Special screening examination for other diseases and disorders

384

398

10.19

307.65

1.3

1.78

1.46

nmol/l

3.81

348

369

Obesity

990

2600

3.65

293.79

1.5

1.3

1.68

1.39

nmol/l

11.03

910

2342

Obesity and other hyperalimentation

993

2610

3.64

293.56

1.5

1.3

1.68

1.39

nmol/l

10.76

913

2349

Hypertension, essential

993

1396

4.08

289.06

1.4

1.61

1.34

nmol/l

7.74

880

1261

Hypertensive diseases

998

1420

4.02

285.13

1.4

1.61

1.35

nmol/l

7.46

890

1282

Hypertension

998

1420

4.02

285.05

1.4

1.61

1.35

nmol/l

7.46

890

1282

Other nutritional deficiencies

1008

2716

3.45

272.36

1.5

1.3

1.68

1.39

nmol/l

10.70

926

2444

Hypertensive diseases (excluding secondary)

729

871

4.96

267.83

1.4

1.60

1.31

nmol/l

6.44

652

791

Obesity due to excess calories

742

1998

3.79

236.31

1.5

1.3

1.75

1.40

nmol/l

10.92

681

1786

Metabolic disorders

1187

2445

2.95

220.75

1.3

1.4

1.43

1.46

nmol/l

0.28

1071

2201

Obesity, other/unspecified

571

1338

4.37

220.52

1.6

1.3

1.66

1.45

nmol/l

3.51

528

1196

Acute pancreatitis

420

792

5.50

211.41

1.4

1.3

1.15

1.53

nmol/l

8.04

386

711

Disorders of gallbladder, biliary tract and pancreas

1231

2822

2.75

204.37

1.4

1.34

1.50

nmol/l

4.58

1126

2542

Disorders of lipoprotein metabolism and other lipidaemias

1041

2213

2.90

188.65

1.3

1.46

nmol/l

0.05

939

1987

Acute pancreatitis (for exclusion)

420

892

4.88

184.33

1.4

1.3

1.15

1.52

nmol/l

8.08

386

799

Neurological diseases, wide definition

215

21.80

173.88

1.4

1.2

1.47

1.71

nmol/l

0.55

197

Alcohol-induced chronic pancreatitis

232

295

8.54

172.77

1.5

1.3

0.91

1.57

nmol/l

11.31

212

268

Heart failure and antihypertensive medication

297

270

7.28

163.92

1.3

1.4

1.79

1.19

nmol/l

8.13

263

245

Autoimmune diseases excluding thyroid diseases

1155

2461

2.57

162.25

1.4

1.3

1.21

1.54

nmol/l

16.31

1021

2278

Autoimmune diseases excluding thyroid diseases, strict definition

1111

2399

2.54

153.31

1.4

1.3

1.18

1.54

nmol/l

18.61

980

2218

Cardiovascular diseases (excluding rheumatic etc)

637

1062

3.47

150.85

1.4

1.51

1.30

nmol/l

3.82

567

972

Heart failure, not strict

918

2332

2.68

148.92

1.3

1.63

1.39

nmol/l

5.76

812

2125

Antihypertensive medication - note that there are other indications

543

722

3.97

148.70

1.4

1.5

1.49

1.26

nmol/l

3.41

486

669

All chronic kidney diseases

707

1897

3.01

148.62

1.3

1.55

1.41

nmol/l

2.33

642

1706

Continuous positive airway pressure

109

32.77

147.47

1.2

1.8

1.49

nmol/l

0.01

Tramadol

916

2068

2.69

145.42

1.4

1.3

1.50

1.43

nmol/l

0.81

831

1877

Diseases of arteries, arterioles and capillaries (FINNGEN)

333

433

5.42

144.66

1.4

1.43

1.25

nmol/l

1.58

300

396

Other disorders of glucose regulation and pancreatic internal secretion

218

319

7.19

142.52

2.3

1.3

1.04

1.46

nmol/l

4.37

190

288

Insulin, fast-acting (human)

167

176

9.70

142.40

1.4

0.87

1.84

nmol/l

11.48

111

160

All kidney diseases

1081

3068

2.38

138.25

1.4

1.53

1.43

nmol/l

1.67

976

2778

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1194

2739

2.34

137.26

1.4

1.3

1.49

1.44

nmol/l

0.72

1080

2483

Diabetes mellitus in pregnancy

366

491

4.81

135.99

1.6

1.4

1.51

1.45

nmol/l

0.40

333

444

Gestational diabetes (for exclusion)

403

662

4.25

133.78

1.6

1.4

1.47

1.49

nmol/l

0.11

370

595

Pure hypercholesterolaemia

863

2109

2.63

132.92

1.3

1.42

1.46

nmol/l

0.37

781

1895

Autoimmune diseases

1132

2472

2.34

129.30

1.4

1.3

1.30

1.54

nmol/l

8.50

996

2289

Elevated blood glucose level

215

347

6.51

128.05

1.5

1.4

1.16

1.52

nmol/l

3.67

190

313

Hypoglycaemia, other or unspecified

181

253

7.55

123.50

2.5

1.3

1.08

1.43

nmol/l

2.62

158

230

Renal tubulo-interstitial diseases

955

2985

2.37

123.15

1.3

1.4

1.54

1.43

nmol/l

1.74

869

2691

Percutaneous Coronary Intervention

890

2195

2.49

122.00

1.3

1.4

1.60

1.38

nmol/l

5.86

803

1986

Other bacterial diseases, including avohilmo

1077

3005

2.26

119.82

1.4

1.46

1.45

nmol/l

0.06

965

2726

Ischemic heart diseases

917

2260

2.44

119.65

1.3

1.4

1.60

1.38

nmol/l

5.79

822

2043

Coronary revascularization (ANGIO or CABG)

885

2195

2.48

119.58

1.3

1.4

1.60

1.38

nmol/l

5.84

799

1986

Hard cardiovascular diseases

901

2223

2.42

115.19

1.3

1.4

1.59

1.38

nmol/l

5.00

817

2000

Coronary atherosclerosis

748

1834

2.60

113.02

1.3

1.4

1.57

1.37

nmol/l

3.83

667

1655

Emergency coronary revascularization (for ACS)

920

2398

2.34

110.04

1.3

1.4

1.60

1.38

nmol/l

5.77

829

2162

Persons encountering health services in other circumstances, wide

1143

2739

2.16

109.01

1.4

1.3

1.47

1.44

nmol/l

0.47

1026

2483

Used for control exclusion in common control thyroid runs

1026

2313

2.25

107.44

1.4

1.3

1.32

1.53

nmol/l

6.18

901

2141

Major coronary heart disease event

905

2348

2.33

106.92

1.3

1.4

1.59

1.38

nmol/l

5.66

814

2118

Other diseases of pancreas

196

346

5.93

106.53

1.4

1.3

1.08

1.60

nmol/l

6.77

177

309

General examination and investigation of persons without complaint and reported diagnosis

689

1331

2.71

106.35

1.4

1.3

1.64

1.43

nmol/l

3.71

636

1210

STROKE

466

984

3.22

104.68

1.4

1.3

1.49

1.51

nmol/l

0.09

413

892

Peripheral artery disease

547

1537

2.85

104.28

1.3

1.36

1.45

nmol/l

0.98

491

1386

Other bacterial diseases

995

3050

2.18

103.48

1.4

1.3

1.46

1.45

nmol/l

0.06

895

2766

Alcohol use disorder, Swedish definition

669

2469

2.49

101.32

1.4

1.3

1.34

1.46

nmol/l

1.66

609

2227

Ischaemic heart disease, wide definition

843

2246

2.33

100.93

1.3

1.4

1.55

1.42

nmol/l

2.18

755

2024

Renal failure

575

1868

2.66

97.75

1.3

1.59

1.41

nmol/l

2.23

524

1686

Glomerular disorders in diseases classified elsewhere

230

513

4.65

95.41

1.5

1.3

1.39

1.54

nmol/l

0.85

201

456

Diseases of liver

463

1640

2.87

94.38

1.4

1.3

1.55

1.44

nmol/l

1.05

421

1465

704

2622

2.36

93.94

1.4

1.34

1.47

nmol/l

2.08

642

2370

Other retinal disorders

715

2313

2.37

93.73

1.4

1.3

1.19

1.48

nmol/l

10.52

607

2107

Hypertensive heart and/or renal disease

276

489

4.18

92.04

1.4

1.3

1.63

1.23

nmol/l

4.52

250

439

675

2577

2.37

90.93

1.4

1.33

1.46

nmol/l

2.27

615

2328

Hypertensive Heart Disease

253

448

4.35

89.76

1.3

1.66

1.24

nmol/l

4.65

229

402

Cardiovascular diseases

507

964

2.81

84.41

1.4

1.50

1.30

nmol/l

3.33

454

885

Viral hepatitis, IBD co-morbidity

44.38

80.60

1.3

1.2

1.33

1.97

nmol/l

0.46

Other heart diseases

403

879

3.01

80.37

1.4

1.5

1.59

1.28

nmol/l

4.85

368

803

Explicit Sepsis, including avohilmo

507

1830

2.54

80.12

1.3

1.49

1.44

nmol/l

0.32

451

1655

Chronic kidney disease

387

1308

2.89

79.41

1.3

1.61

1.42

nmol/l

1.91

350

1174

Erysipelas, including avohilmo

751

2622

2.14

76.92

1.3

1.51

1.45

nmol/l

0.76

683

2372

Obesity related asthma

428

1624

2.67

76.48

1.4

1.3

1.74

1.43

nmol/l

5.28

392

1458

Explicit Sepsis

490

1801

2.51

75.40

1.3

1.49

1.45

nmol/l

0.33

437

1627

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

950

3289

1.96

75.35

1.4

1.3

1.45

1.46

nmol/l

0.15

857

2980

Ulcer of lower limb, not elsewhere classified

233

636

3.76

73.43

1.4

1.3

1.34

1.50

nmol/l

1.20

201

568

Nerve, nerve root and plexus disorders

1021

3228

1.91

73.42

1.4

1.3

1.49

1.45

nmol/l

0.42

928

2916

Glomerular diseases

267

799

3.42

73.08

1.4

1.3

1.41

1.50

nmol/l

0.54

234

715

Septicaemia

465

1714

2.50

71.34

1.3

1.47

1.45

nmol/l

0.13

416

1553

Other septicaemia, including avohilmo

429

1581

2.58

70.45

1.3

1.46

1.45

nmol/l

0.04

390

1432

Other disorders of fluid, electrolyte and acid-base balance

343

1136

2.88

69.91

1.4

1.3

1.36

1.46

nmol/l

0.78

312

1018

Sleep apnoea

918

3004

1.94

69.66

1.3

1.4

1.69

1.39

nmol/l

10.51

833

2714

Mood disorders, excluding more controls

878

2645

1.96

67.93

1.4

1.3

1.51

1.44

nmol/l

0.92

800

2386

Atherosclerosis, excluding cerebral and coronary sclerosis

451

1424

2.52

67.82

1.3

1.37

1.45

nmol/l

0.76

409

1280

Disorders of choroid and retina

804

2842

2.00

67.69

1.3

1.26

1.50

nmol/l

7.15

691

2593

Other septicaemia

414

1545

2.56

66.98

1.3

1.46

1.45

nmol/l

0.08

377

1397

Substance abuse, excluding more controls

580

2208

2.21

66.48

1.4

1.3

1.38

1.43

nmol/l

0.55

523

1991

Codeine

807

2170

2.02

66.34

1.4

1.3

1.46

1.44

nmol/l

0.25

722

1975

Cholelithiasis, broad definition with cholecystitis

777

2600

2.00

65.42

1.3

1.50

nmol/l

0.03

706

2343

Fever of other and unknown origin

565

2229

2.21

65.26

1.4

1.3

1.51

1.44

nmol/l

0.84

524

2001

Cerebrovascular diseases (FINNGEN)

276

596

3.28

64.94

1.4

1.51

1.27

nmol/l

2.36

250

537

Influenza and pneumonia

972

3249

1.86

64.52

1.4

1.50

1.44

nmol/l

0.77

879

2945

Infections of the skin and subcutaneous tissue

612

2875

2.11

64.28

1.4

1.3

1.44

nmol/l

0.01

557

2597

Atrial fibrillation and flutter with reimbursement

242

423

3.65

64.21

1.4

1.61

1.25

nmol/l

3.49

223

386

Charcot foot

17.83

63.98

1.4

1.1

0.99

1.56

nmol/l

1.11

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

838

2949

1.93

63.79

1.4

1.48

1.45

nmol/l

0.30

753

2678

Angina pectoris

558

1653

2.26

63.74

1.3

1.59

1.36

nmol/l

3.71

509

1502

Sleep apnoea, including avohilmo

931

3016

1.88

63.72

1.3

1.4

1.71

1.38

nmol/l

12.16

842

2723

Cholelithiasis

743

2542

2.01

63.47

1.3

1.51

1.49

nmol/l

0.19

676

2291

Alcohol-induced acute pancreatitis

108

179

6.45

63.13

1.4

1.3

0.83

1.59

nmol/l

7.76

100

163

Other diseases of liver

249

788

3.22

62.25

1.4

1.3

1.68

1.48

nmol/l

1.67

220

710

Malignant neoplasm of pancreas, including Hilmo

160

376

4.40

62.24

1.4

1.3

1.19

1.45

nmol/l

2.11

144

338

Major coronary heart disease event excluding revascularizations

591

1802

2.18

62.10

1.3

1.56

1.36

nmol/l

3.30

532

1624

Diseases of arteries, arterioles and capillaries

667

2403

2.05

61.33

1.3

1.41

1.45

nmol/l

0.36

603

2171

Persons encountering health services for specific procedures and health care

973

3162

1.83

60.77

1.3

1.4

1.47

1.44

nmol/l

0.33

870

2883

Dental caries

285

931

2.93

59.91

1.4

1.3

1.44

1.42

nmol/l

0.11

256

836

Mood [affective] disorders

934

3298

1.82

59.24

1.4

1.3

1.50

1.44

nmol/l

0.92

854

2977

Mood disorders

935

3298

1.82

59.15

1.4

1.3

1.50

1.44

nmol/l

0.92

854

2978

Implicit Sepsis

720

2720

1.96

58.73

1.4

1.3

1.46

1.45

nmol/l

0.14

646

2466

Pain in throat and chest

773

2365

1.95

58.63

1.4

1.3

1.55

1.38

nmol/l

2.97

700

2146

Implicit Sepsis, including avohilmo

768

2878

1.92

58.22

1.4

1.3

1.49

1.45

nmol/l

0.38

686

2610

Implicit bacterial Sepsis, including avohilmo

478

1768

2.27

58.18

1.4

1.3

1.45

1.44

nmol/l

0.08

433

1601

All pneumoniae

925

3325

1.82

58.15

1.4

1.49

1.45

nmol/l

0.51

838

3013

Dialysis, with operation codes

197

563

3.59

58.14

1.4

1.3

1.44

1.46

nmol/l

0.08

172

500

Caries of dentine

262

853

3.00

57.94

1.4

1.3

1.42

nmol/l

0.02

235

765

Opioids

813

2191

1.93

57.87

1.4

1.3

1.50

1.43

nmol/l

0.83

724

1995

Pneumonia, organism unspecified

844

3132

1.86

57.64

1.4

1.50

1.44

nmol/l

0.72

761

2833

811

2505

1.90

57.47

1.4

1.3

1.49

1.42

nmol/l

0.97

732

2273

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

811

2505

1.90

57.47

1.4

1.3

1.49

1.42

nmol/l

0.97

732

2273

Pneumonias (Asthma/COPD co-morbidities)

918

3325

1.81

57.35

1.4

1.49

1.45

nmol/l

0.49

831

3014

Cutaneous abscess, furuncle and carbuncle

310

1162

2.71

56.93

1.4

1.3

1.45

1.46

nmol/l

0.05

280

1042

Kidney transplant status

109

201

5.66

56.72

1.5

1.4

1.30

1.52

nmol/l

0.93

185

Amputation

158

395

4.11

56.49

1.4

1.3

1.31

1.52

nmol/l

1.45

141

346

Codeine or tramadol medication

984

3004

1.79

56.42

1.4

1.3

1.49

1.44

nmol/l

0.63

885

2720

Parasetamol

608

1452

2.13

56.23

1.4

1.3

1.46

1.35

nmol/l

1.24

541

1325

L04AD Calcineurin inhibitors

173

464

3.83

56.13

1.5

1.3

1.39

1.51

nmol/l

0.58

153

421

Examination and observation for other reasons

523

1330

2.23

55.97

1.4

1.3

1.38

1.43

nmol/l

0.50

464

1209

Transplanted organ and tissue status

164

425

3.97

55.90

1.4

1.3

1.42

1.50

nmol/l

0.36

145

379

Depression

866

3187

1.83

55.77

1.4

1.3

1.51

1.44

nmol/l

0.92

788

2875

Chronic apical periodontitis

975

3084

1.78

55.67

1.4

1.45

1.46

nmol/l

0.04

871

2802

Acute tubulo-interstitial nephritis

577

2383

2.06

55.21

1.3

1.50

1.45

nmol/l

0.55

523

2148

Peripheral artery operations in Hilmo

177

488

3.70

54.98

1.4

1.3

1.24

1.48

nmol/l

2.13

156

426

Bacterial Sepsis

481

1822

2.20

54.42

1.3

1.45

1.43

nmol/l

0.18

429

1651

Condition for Implicit Sepsis (Organ dysfunction codes)

781

2915

1.87

54.26

1.4

1.3

1.47

1.45

nmol/l

0.19

697

2645

Nausea and vomiting

282

1003

2.77

54.23

1.5

1.3

1.39

1.45

nmol/l

0.33

255

885

Certain infectious and parasitic diseases

816

2189

1.88

53.44

1.4

1.3

1.50

1.44

nmol/l

0.72

728

2010

Other maternal disorders predominantly related to pregnancy

424

1129

2.37

53.23

1.5

1.4

1.47

1.51

nmol/l

0.28

392

1014

Other antidepressants

899

2543

1.81

53.22

1.4

1.3

1.50

1.41

nmol/l

1.49

818

2315

Nonalcoholic fatty liver disease

165

445

3.81

53.14

1.4

1.3

1.79

1.47

nmol/l

2.55

144

406

Atrial fibrillation and flutter

260

557

3.04

52.96

1.4

1.63

1.26

nmol/l

3.81

235

503

Erysipelas

555

2349

2.05

52.93

1.4

1.3

1.53

1.44

nmol/l

0.91

506

2127

Personality disorders, excluding more controls

264

944

2.82

52.79

1.4

1.63

1.45

nmol/l

1.57

245

850

Asthma, excluding more controls

677

1757

1.99

52.77

1.4

1.3

1.56

1.37

nmol/l

3.57

616

1599

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

890

3353

1.78

52.32

1.4

1.48

1.45

nmol/l

0.40

805

3040

Hyperlipidaemia, other/unspecified

384

1474

2.37

52.27

1.3

1.54

1.44

nmol/l

0.95

349

1322

Implicit viral Sepsis, including avohilmo

317

1254

2.55

51.91

1.3

1.52

1.46

nmol/l

0.40

293

1134

Poisoning by drugs, medicaments and biological substances

264

958

2.79

51.68

1.4

1.44

1.46

nmol/l

0.11

235

862

Diseases of pulp and periapical tissues, including avohilmo

852

2426

1.83

51.65

1.4

1.3

1.50

1.42

nmol/l

1.08

766

2199

Abnormalities of breathing

776

2397

1.86

51.29

1.4

1.3

1.58

1.39

nmol/l

4.01

702

2175

Implicit bacterial Sepsis

425

1634

2.25

51.12

1.4

1.3

1.43

1.45

nmol/l

0.14

383

1481

Cholecystectomy

646

2872

1.92

51.11

1.4

1.3

1.51

1.46

nmol/l

0.55

594

2589

Poisoning by medicine

245

860

2.89

51.07

1.4

1.42

1.46

nmol/l

0.20

217

781

Malaise and fatigue

499

1878

2.11

50.17

1.3

1.44

1.45

nmol/l

0.08

452

1685

Asthma

700

1887

1.92

49.75

1.4

1.3

1.57

1.40

nmol/l

3.15

638

1713

General symptoms and signs

908

2583

1.77

49.41

1.4

1.3

1.49

1.44

nmol/l

0.63

828

2328

Mental and behavioural disorders due to psychoactive substance use

593

2814

1.95

49.13

1.4

1.37

1.45

nmol/l

1.01

536

2548

Diseases of the digestive system

445

2074

2.15

49.10

1.5

1.3

1.38

1.46

nmol/l

0.72

403

1866

Substance abuse

580

2775

1.96

49.04

1.4

1.38

1.45

nmol/l

0.77

523

2512

Myocardial infarction

465

1516

2.16

48.56

1.2

1.3

1.52

1.35

nmol/l

2.28

414

1375

Disorders of lens

648

2099

1.93

48.46

1.3

1.46

1.48

nmol/l

0.17

572

1910

Lower back pain or/and sciatica

944

3441

1.71

48.31

1.4

1.3

1.58

1.42

nmol/l

3.91

867

3103

Nephropathy related operations

184

569

3.31

48.06

1.4

1.3

1.44

1.52

nmol/l

0.38

161

509

Intestinal malabsorption

173

5.59

47.95

1.6

1.3

0.91

1.46

nmol/l

4.23

156

Periodontitis

891

3292

1.73

47.81

1.3

1.4

1.47

1.46

nmol/l

0.12

804

2982

Asthma (mode)

690

1919

1.90

47.49

1.4

1.3

1.60

1.40

nmol/l

3.80

630

1741

Other and unspecified iron deficiency

340

1448

2.37

47.44

1.4

1.3

1.45

1.49

nmol/l

0.24

308

1297

Abnormal findings on examination of blood, without diagnosis

491

2183

2.05

47.32

1.4

1.3

1.36

1.45

nmol/l

1.01

438

1980

Episodal and paroxysmal disorders

899

2623

1.75

47.00

1.3

1.4

1.56

1.36

nmol/l

5.18

811

2370

Heart failure and coronary heart disease

397

1234

2.27

46.84

1.3

1.72

1.35

nmol/l

6.26

358

1115

Other special examinations and investigations of persons without complaint or reported diagnosis

541

1331

2.07

46.83

1.3

1.50

1.43

nmol/l

0.56

483

1210

Maternal care for other conditions predominantly related to pregnancy

167

481

3.42

46.29

1.6

1.5

1.39

1.50

nmol/l

0.54

149

431

GASTRO-related operations

617

1586

1.96

46.07

1.4

1.3

1.50

1.42

nmol/l

0.86

559

1451

Any gastric operation

617

1586

1.96

46.07

1.4

1.3

1.50

1.42

nmol/l

0.86

559

1451

Iron deficiency anaemia

407

1857

2.17

45.96

1.4

1.3

1.44

1.47

nmol/l

0.24

371

1668

Chronic periodontitis, including avohilmo

883

3299

1.72

45.77

1.3

1.4

1.47

1.46

nmol/l

0.10

797

2988

Complications of procedures, not elsewhere classified

731

3313

1.79

45.60

1.5

1.3

1.49

1.45

nmol/l

0.36

658

3000

Myocardial infarction, strict

430

1422

2.16

44.94

1.2

1.3

1.50

1.34

nmol/l

1.97

385

1290

Malignant neoplasm of pancreas

126

317

4.10

44.89

1.4

1.3

1.23

1.40

nmol/l

0.89

113

282

Nutritional anaemias

458

2145

2.05

44.54

1.4

1.3

1.42

1.47

nmol/l

0.36

418

1930

Diseases of oesophagus, stomach and duodenum

919

3223

1.69

44.46

1.4

1.3

1.52

1.44

nmol/l

1.29

833

2916

Complications of surgical and medical care, not elsewhere classified

868

3413

1.71

44.35

1.5

1.3

1.50

1.45

nmol/l

0.66

784

3093

Acute renal failure

253

974

2.64

44.23

1.2

1.3

1.53

1.43

nmol/l

0.55

227

867

Abdominal and pelvic pain

833

2401

1.75

43.83

1.4

1.3

1.43

1.45

nmol/l

0.27

755

2169

Any mental disorder

908

2675

1.71

43.82

1.4

1.3

1.44

nmol/l

0.03

817

2414

Asthma (only as main-diagnosis), excluding more controls

604

1757

1.91

42.99

1.4

1.3

1.65

1.37

nmol/l

6.03

551

1599

Heart failure,strict

483

1674

2.03

42.90

1.3

1.70

1.37

nmol/l

5.80

431

1530

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

311

800

2.47

42.90

1.5

1.49

1.29

nmol/l

2.21

277

726

Mixed hyperlipidaemia

144

5.78

42.77

1.4

1.2

1.69

1.49

nmol/l

0.65

131

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

847

3158

1.70

42.64

1.4

1.53

1.43

nmol/l

1.40

756

2876

Low back pain

685

2579

1.80

42.55

1.4

1.3

1.61

1.41

nmol/l

4.38

632

2319

Alcohol use disorder, ICD-based

429

2103

2.06

42.48

1.4

1.3

1.39

1.44

nmol/l

0.45

384

1899

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

208

745

2.85

42.05

1.4

1.3

1.52

1.51

nmol/l

0.04

196

671

Mental and behavioural disorders due to alcohol, excluding acute intoxication

454

2261

2.01

41.87

1.4

1.3

1.38

1.45

nmol/l

0.65

408

2040

Dyspnoea

784

3319

1.71

41.47

1.4

1.3

1.63

1.42

nmol/l

5.14

718

2995

Asthma, hospital admission 2, infections

526

2713

1.90

41.44

1.4

1.3

1.65

1.41

nmol/l

4.51

484

2442

Asthma-related infections

526

2713

1.90

41.44

1.4

1.3

1.65

1.41

nmol/l

4.51

484

2442

Secondary hypertension

159

5.30

41.33

1.5

1.4

1.73

1.18

nmol/l

2.17

145

Symptoms and signs involving the digestive system and abdomen

823

2401

1.73

41.26

1.4

1.3

1.41

1.45

nmol/l

0.51

751

2169

Mental and behavioural disorders due to alcohol

502

2494

1.93

41.19

1.4

1.34

1.45

nmol/l

1.38

453

2253

Neurological diseases

669

1839

1.84

41.16

1.4

1.3

1.53

1.38

nmol/l

2.45

605

1664

Implicit viral Sepsis

223

837

2.70

41.02

1.3

1.61

1.47

nmol/l

0.92

207

751

Viral Sepsis

223

839

2.69

40.83

1.3

1.61

1.46

nmol/l

0.94

207

753

Hypothyroidism, strict autoimmune

568

1982

1.89

40.81

1.4

1.3

1.50

1.54

nmol/l

0.36

500

1824

Bleeding

731

2960

1.74

40.69

1.4

1.3

1.51

1.44

nmol/l

0.75

648

2681

Chronic periodontitis, complicated

546

2870

1.87

40.60

1.3

1.35

1.48

nmol/l

1.77

495

2585

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

351

1390

2.21

40.57

1.5

1.4

1.61

1.47

nmol/l

1.42

317

1258

Care involving dialysis

127

346

3.77

40.45

1.4

1.58

1.52

nmol/l

0.19

110

301

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

254

1009

2.51

40.34

1.4

1.40

1.45

nmol/l

0.29

227

906

Unstable angina pectoris

339

1193

2.25

40.30

1.3

1.62

1.34

nmol/l

3.46

312

1077

Asthma (only as main-diagnosis)

621

1887

1.85

40.20

1.4

1.3

1.64

1.40

nmol/l

4.86

565

1713

Diarrhoea and gastroenteritis of presumed infectious origin

622

3111

1.79

40.17

1.4

1.3

1.54

1.43

nmol/l

1.35

553

2822

Anxiety disorders, excluding more controls

684

2478

1.77

39.78

1.5

1.3

1.56

1.45

nmol/l

1.42

619

2233

Asthma, unspecified (mode), excluding more controls

463

1670

2.00

39.67

1.4

1.3

1.63

1.37

nmol/l

4.27

424

1521

410

2010

2.04

39.60

1.4

1.3

1.68

1.42

nmol/l

4.22

383

1804

Other soft tissue disorders, not elsewhere classified

776

2582

1.72

39.45

1.4

1.3

1.51

1.43

nmol/l

0.97

701

2343

Other diseases of biliary tract

121

324

3.82

39.45

1.3

1.26

1.59

nmol/l

1.83

110

292

Dorsalgia

830

2615

1.69

39.13

1.4

1.3

1.54

1.41

nmol/l

2.57

760

2353

Disorder of lipoprotein metabolism, unspecified

158

507

3.17

38.80

1.3

1.51

1.49

nmol/l

0.09

142

450

Myocardial infarction, without ST-elevation

381

1663

2.09

38.41

1.2

1.3

1.46

1.45

nmol/l

0.03

349

1495

Senile cataract

566

1856

1.87

38.41

1.3

1.45

1.48

nmol/l

0.23

513

1690

Non-invasive ventilation

9.66

38.35

1.3

1.7

1.49

1.45

nmol/l

0.06

Pregnancy hypertension

317

1276

2.24

38.19

1.5

1.4

1.60

1.47

nmol/l

1.26

287

1158

Diseases of the skin and subcutaneous tissue

806

2397

1.69

37.97

1.4

1.3

1.50

1.43

nmol/l

0.76

719

2192

Bacterial infection, other or unspecified, including avohilmo

513

2249

1.88

37.94

1.3

1.41

1.45

nmol/l

0.32

460

2034

Volume depletion

118

320

3.76

37.72

1.4

1.3

1.54

1.50

nmol/l

0.13

107

284

Other CVD (FINNGEN)

106

190

4.31

37.69

1.5

1.3

1.45

1.10

nmol/l

2.45

178

Personality disorders

264

1118

2.39

37.67

1.4

1.63

1.45

nmol/l

1.59

245

1011

Dental pulpitis, including avohilmo

793

3051

1.67

37.57

1.4

1.51

1.45

nmol/l

0.70

719

2762

Pain in limb

689

2544

1.73

36.83

1.4

1.3

1.51

1.43

nmol/l

0.89

629

2311

Hyperkalaemia

200

4.57

36.77

1.3

1.2

1.68

1.49

nmol/l

0.56

178

Diabetic nephropathy, excluding more controls

377

1515

2.09

36.17

1.4

1.3

1.44

1.50

nmol/l

0.40

333

1374

Bipolar affective disorders

190

702

2.74

36.11

1.3

1.4

1.71

1.44

nmol/l

1.92

175

634

Certain infectious and parasitic diseases, including avohilmo

568

1545

1.85

35.96

1.3

1.51

1.42

nmol/l

0.91

507

1422

Other heart diseases, wide

764

2776

1.67

35.87

1.4

1.59

1.40

nmol/l

3.83

692

2512

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

178

639

2.83

35.79

1.5

1.4

1.33

1.45

nmol/l

0.67

158

572

Asthma, unspecified (mode)

470

1790

1.91

35.40

1.4

1.3

1.63

1.40

nmol/l

3.43

431

1626

L04AA Selective immunosuppressants

234

967

2.45

35.36

1.5

1.3

1.55

1.48

nmol/l

0.41

207

871

Sleep disorders (combined)

877

2838

1.62

35.27

1.3

1.58

1.37

nmol/l

5.83

801

2556

Oxycodone

354

1467

2.08

35.16

1.4

1.3

1.62

1.43

nmol/l

1.96

322

1337

Bacterial infection, other or unspecified

466

2096

1.89

35.10

1.3

1.40

1.44

nmol/l

0.31

415

1897

Acidosis

7.58

35.09

1.4

1.2

1.07

1.61

nmol/l

1.87

Disorders of adult personality and behaviour

270

1191

2.29

35.09

1.4

1.64

1.45

nmol/l

1.77

249

1075

ILD medications: prednisolone, methylprednisolone, prednisone

888

3084

1.61

35.00

1.4

1.3

1.58

1.39

nmol/l

4.50

802

2798

Other cataract

398

1487

2.00

34.80

1.3

1.42

1.48

nmol/l

0.42

345

1357

Sciatica+with lumbago

474

2268

1.86

34.54

1.4

1.3

1.59

1.41

nmol/l

2.78

441

2026

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

839

3355

1.61

34.38

1.4

1.3

1.52

1.43

nmol/l

1.38

748

3053

Intestinal infectious diseases, including avohilmo, including avohilmo

940

3332

1.58

34.31

1.4

1.3

1.53

1.43

nmol/l

1.82

837

3034

Alcohol dependence

285

1299

2.22

34.29

1.4

1.3

1.44

nmol/l

0.02

255

1163

Amputation of toe

111

310

3.68

34.17

1.4

1.2

1.18

1.49

nmol/l

2.11

274

Covid-19 confirmed case

344

1684

2.06

34.16

1.3

1.56

1.44

nmol/l

1.05

319

1511

Dental caries, including avohilmo

553

1556

1.83

33.93

1.3

1.51

1.45

nmol/l

0.45

493

1407

Caries of dentine, including avohilmo

589

1690

1.79

33.75

1.3

1.52

1.44

nmol/l

0.77

525

1531

Persons encountering health services for examination and investigation

499

1331

1.89

33.70

1.4

1.3

1.49

1.43

nmol/l

0.41

446

1210

Asthma-related pneumonia

323

1556

2.09

33.30

1.4

1.3

1.58

1.41

nmol/l

1.64

292

1396

Asthma, hospital admissions 3, pneumonia

323

1557

2.08

33.24

1.4

1.3

1.58

1.41

nmol/l

1.65

292

1397

Asthma-related pneumonia or sepsis

323

1557

2.08

33.24

1.4

1.3

1.58

1.41

nmol/l

1.65

292

1397

Intestinal infectious diseases

780

3612

1.61

33.04

1.4

1.3

1.54

1.44

nmol/l

1.51

693

3287

Other disorders of skin and subcutaneous tissue

619

3086

1.70

33.01

1.4

1.3

1.44

1.46

nmol/l

0.14

548

2801

Non-selective monoamine reuptake inhibitors

323

1500

2.08

32.96

1.3

1.60

1.41

nmol/l

2.06

291

1354

Specific personality disorders

225

943

2.41

32.95

1.4

1.62

1.44

nmol/l

1.41

205

851

Other reaction to severe stress, and adjustment disorders

322

1566

2.07

32.61

1.5

1.4

1.52

1.45

nmol/l

0.44

296

1411

First line medication for Crohn's disease

888

3032

1.58

32.60

1.4

1.3

1.56

1.39

nmol/l

4.01

798

2749

Other and unspecified polyneuropathies, also in other diseases

212

871

2.47

32.53

1.5

1.3

1.17

1.51

nmol/l

4.71

187

782

Asthma (diagnoses ohter than nonallergic)

717

3561

1.63

32.48

1.4

1.3

1.61

1.42

nmol/l

4.00

659

3220

Anxiety (asthma-related co-morbidities)

497

2098

1.81

32.27

1.4

1.54

1.43

nmol/l

1.09

449

1889

ILD medications

904

3114

1.57

32.23

1.4

1.3

1.53

1.39

nmol/l

3.04

810

2827

Symptoms and signs involving the circulatory and respiratory systems

778

2399

1.63

31.91

1.4

1.3

1.56

1.39

nmol/l

3.62

701

2177

Polyneuropathies and other disorders of the peripheral nervous system

233

1008

2.34

31.84

1.5

1.3

1.16

1.49

nmol/l

4.97

203

905

Redundant prepuce, phimosis and paraphimosis

242

1046

2.31

31.80

1.4

1.3

1.28

1.41

nmol/l

1.16

215

945

Candidiasis, including avohilmo

278

1294

2.17

31.72

1.3

1.4

1.67

1.48

nmol/l

1.64

244

1166

Arthropathies in other diseases classified elsewhere

139

5.08

31.64

1.3

1.2

1.08

1.45

nmol/l

1.71

129

Hernia of abdominal wall, postoperative

194

768

2.54

31.64

1.6

1.3

1.48

1.40

nmol/l

0.37

174

697

Emotionally unstable personality disorder

127

408

3.16

31.19

1.4

1.5

1.67

1.43

nmol/l

1.35

118

374

Peripheral arterial reconstruction

184

722

2.59

31.14

1.4

1.2

1.29

1.47

nmol/l

1.35

164

650

Intracranial trauma

434

1566

1.88

31.12

1.5

1.3

1.54

1.38

nmol/l

1.76

389

1425

Psychiatric diseases

764

2363

1.63

30.94

1.4

1.3

1.44

nmol/l

0.01

690

2127

Alcoholic liver disease

140

481

2.97

30.73

1.4

1.3

1.43

1.48

nmol/l

0.15

129

434

Selective serotonin reuptake inhibitors

785

2548

1.61

30.68

1.4

1.3

1.52

1.40

nmol/l

1.68

695

2319

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

195

4.23

30.61

1.6

1.4

1.61

1.36

nmol/l

1.34

179

Diseases of pulp and periapical tissues and dental caries

483

1349

1.85

30.59

1.3

1.53

1.44

nmol/l

0.79

432

1223

Asthma, including avohilmo

944

3403

1.53

30.45

1.4

1.56

1.42

nmol/l

3.29

857

3081

Medical observation and evaluation for suspected diseases and conditions

478

1331

1.84

30.21

1.5

1.3

1.52

1.43

nmol/l

0.77

433

1210

Paroxysmal tachycardia

156

465

2.81

30.03

1.5

1.4

1.71

1.25

nmol/l

3.26

137

420

Mycoses, including avohilmo

758

3659

1.58

29.99

1.3

1.4

1.53

1.44

nmol/l

1.30

688

3315

Diseases of the eye and adnexa

627

1858

1.70

29.95

1.4

1.42

1.51

nmol/l

1.05

549

1721

Depression or dysthymia

539

1678

1.76

29.93

1.4

1.3

1.39

1.40

nmol/l

0.09

486

1523

Concussion

383

1559

1.91

29.82

1.5

1.3

1.58

1.38

nmol/l

2.41

343

1418

Chronic lower respiratory diseases

957

3319

1.52

29.77

1.4

1.55

1.42

nmol/l

2.89

865

3010

Heart failure, strict

509

2022

1.76

29.59

1.3

1.68

1.40

nmol/l

4.89

457

1841

Amputation of foot

5.82

29.54

1.5

1.2

1.23

1.69

nmol/l

1.51

Neurotic, stress-related and somatoform disorders

722

3116

1.60

29.53

1.4

1.54

1.44

nmol/l

1.29

655

2816

Other and unspecified anaemias

371

1848

1.90

29.04

1.3

1.38

1.46

nmol/l

0.63

336

1669

Anxiety disorders

726

3137

1.59

29.03

1.4

1.55

1.44

nmol/l

1.57

660

2836

All-cause Heart Failure

498

1985

1.76

28.72

1.3

1.67

1.40

nmol/l

4.48

446

1808

Dialysis

144

4.74

28.43

1.5

1.3

1.42

1.49

nmol/l

0.14

129

Codes for special purposes

446

2509

1.77

28.31

1.3

1.52

1.45

nmol/l

0.57

415

2249

GI-bleeding

285

1402

2.05

28.15

1.3

1.53

1.46

nmol/l

0.38

259

1262

Pain, not elsewhere classified

249

1165

2.16

28.10

1.4

1.3

1.59

1.45

nmol/l

1.07

228

1033

Provisional assignment of new diseases of uncertain etiology

445

2508

1.77

28.09

1.3

1.52

1.45

nmol/l

0.58

415

2248

Other anaemias

371

1865

1.87

27.98

1.3

1.38

1.46

nmol/l

0.65

336

1686

Osteomyelitis

284

3.50

27.88

1.4

1.2

1.35

1.46

nmol/l

0.34

251

Spondylopathies

644

2343

1.63

27.57

1.4

1.3

1.57

1.41

nmol/l

2.56

595

2101

Suicide or other Intentional self-harm

225

1021

2.23

27.47

1.4

1.39

1.48

nmol/l

0.50

203

912

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

254

1214

2.11

27.15

1.4

1.40

1.51

nmol/l

0.78

227

1084

Coronary artery bypass grafting

230

765

2.25

27.14

1.2

1.3

1.56

1.31

nmol/l

2.31

208

693

Benzodiazepine use

807

3569

1.53

27.09

1.4

1.56

1.43

nmol/l

2.27

719

3243

Urinary track infection

395

1051

1.89

26.91

1.5

1.4

1.53

1.48

nmol/l

0.40

354

956

Preparatory care for dialysis

176

4.23

26.87

1.3

1.2

1.68

1.43

nmol/l

0.75

160

Other disorders of urethra and urinary system

543

2259

1.68

26.84

1.4

1.3

1.48

1.46

nmol/l

0.15

489

2051

Polyarthropathies

567

2198

1.66

26.66

1.3

1.65

1.39

nmol/l

5.01

510

1989

ILD medications: immunosuppressive drugs

532

2909

1.66

26.56

1.4

1.3

1.54

1.40

nmol/l

2.32

476

2635

Fibrosis and cirrhosis of liver

106

338

3.21

26.56

1.3

1.78

1.48

nmol/l

1.33

305

Gestational [pregnancy-induced] hypertension

185

783

2.38

26.45

1.5

1.4

1.63

1.50

nmol/l

0.81

169

702

Other gastritis (incl. Duodenitis)

211

948

2.25

26.43

1.3

1.61

1.48

nmol/l

0.80

194

850

Oral corticosteroids

839

3257

1.52

26.13

1.4

1.3

1.68

1.39

nmol/l

9.18

761

2950

Shoulder lesions

623

2313

1.62

26.06

1.4

1.3

1.55

1.44

nmol/l

1.28

554

2092

Aplastic and other anaemias

388

1979

1.81

25.91

1.3

1.38

1.45

nmol/l

0.63

351

1786

Other diseases of the digestive system

280

1415

1.99

25.72

1.4

1.3

1.55

1.46

nmol/l

0.49

255

1274

Inflammatory bowel disease treatment related agents

889

3309

1.50

25.69

1.4

1.3

1.62

1.39

nmol/l

6.59

807

2998

Gastrointestinal diseases

417

1148

1.83

25.67

1.4

1.3

1.49

1.43

nmol/l

0.34

379

1033

Problems related to lifestyle

111

371

3.04

25.57

1.5

1.3

1.43

1.45

nmol/l

0.03

336

Gout

275

1178

2.02

25.49

1.2

1.3

1.89

1.37

nmol/l

7.54

258

1074

Other anxiety disorders

378

1781

1.82

25.47

1.4

1.53

1.45

nmol/l

0.65

341

1611

All anxiety disorders

504

2340

1.68

25.42

1.4

1.54

1.42

nmol/l

1.47

456

2107

Hypo-osmolality and hyponatraemia

157

628

2.51

25.12

1.4

1.3

1.23

1.49

nmol/l

1.98

147

560

Asthma, hospital admissions , main diagnosis only

641

3566

1.57

25.09

1.4

1.3

1.65

1.42

nmol/l

4.88

584

3236

Persons encountering health services for specific procedures, not carried out

105

344

3.11

25.09

1.4

1.32

1.51

nmol/l

0.91

306

Oedema, not elsewhere classified

275

1366

1.98

24.70

1.4

1.3

1.49

1.46

nmol/l

0.18

246

1220

Cellulitis

212

984

2.18

24.55

1.3

1.50

1.47

nmol/l

0.10

193

884

Symptoms and signs involving cognition, perception, emotional state and behaviour

773

3426

1.51

24.54

1.4

1.47

1.45

nmol/l

0.18

703

3095

Unspecified mental disorder

342

1876

1.84

24.47

1.3

1.4

1.69

1.45

nmol/l

2.92

305

1691

Gout, FINNGEN

275

1398

1.97

24.40

1.2

1.3

1.89

1.41

nmol/l

6.51

258

1256

Diseases of oral cavity, salivary glands and jaws

429

1248

1.78

24.39

1.3

1.52

1.42

nmol/l

0.76

386

1119

Amputation of ankle bones

5.96

24.35

1.4

1.2

1.56

1.80

nmol/l

0.53

COPD/asthma/ILD related infections

764

2505

1.53

24.32

1.5

1.3

1.47

1.42

nmol/l

0.60

686

2273

COPD/asthma related infections

764

2505

1.53

24.32

1.5

1.3

1.47

1.42

nmol/l

0.60

686

2273

Disorders of other endocrine glands

357

1958

1.81

24.19

1.4

1.61

1.47

nmol/l

1.51

328

1756

Carpal tunnel syndrome

488

2559

1.66

24.05

1.4

1.3

1.64

1.46

nmol/l

2.53

436

2312

Kela-code for severe mental illness

313

1682

1.87

23.97

1.3

1.4

1.73

1.45

nmol/l

3.45

281

1510

Cystitis

632

2398

1.57

23.43

1.4

1.3

1.51

1.45

nmol/l

0.62

567

2173

Other headache syndromes

314

1696

1.86

23.36

1.5

1.4

1.51

1.38

nmol/l

1.42

291

1514

Mycoses

254

1286

1.99

23.30

1.2

1.3

1.52

1.48

nmol/l

0.17

228

1160

Other and unspecified dermatitis

425

2518

1.70

23.28

1.4

1.3

1.52

1.45

nmol/l

0.70

386

2269

Vitreous haemorrhage

122

453

2.74

23.27

1.4

1.3

1.24

1.53

nmol/l

1.74

408

Recurrent or chronic depression

317

1174

1.88

23.13

1.5

1.3

1.30

1.40

nmol/l

1.05

284

1062

Benign neoplasm: Pancreas

100

5.09

22.93

1.3

1.2

1.53

1.49

nmol/l

0.07

Substance use, excluding alcohol

185

837

2.23

22.87

1.4

1.38

1.47

nmol/l

0.45

168

755

Implicit fungal Sepsis, including avohilmo

265

3.31

22.82

1.3

1.71

1.56

nmol/l

0.40

240

Benign neoplasm of other and ill-defined parts of digestive system

173

764

2.29

22.71

1.4

1.3

1.52

1.48

nmol/l

0.18

159

684

Complications of medical and surgical care

582

3356

1.56

22.66

1.5

1.3

1.52

1.45

nmol/l

0.79

528

3035

Adenocarcinoma and ductal carcinoma of pancreas

155

4.13

22.51

1.2

1.3

1.10

1.41

nmol/l

1.38

138

Diabetic retinopathy, excluding more controls

563

1989

1.61

22.11

1.4

1.3

1.20

1.52

nmol/l

9.02

478

1810

Other diseases of urinary system

758

2855

1.50

22.10

1.4

1.3

1.49

1.44

nmol/l

0.58

680

2588

Schizophrenia or delusion, excluding more controls

240

1199

1.99

22.00

1.3

1.72

1.44

nmol/l

2.76

216

1071

Hypothyreosis and Thyroxine purchase for inclusion criteria

685

2970

1.52

21.96

1.4

1.3

1.52

1.44

nmol/l

1.07

607

2700

Gingivitis and periodontal diseases

739

2542

1.51

21.93

1.3

1.45

nmol/l

0.01

660

2308

Genitourinary diseases

456

1356

1.69

21.81

1.3

1.46

1.37

nmol/l

0.80

414

1235

Hypothyroidism, strict autoimmune, 3 medication purchases required

618

2695

1.55

21.81

1.4

1.3

1.50

1.44

nmol/l

0.61

547

2448

Hypothyroidism, other/unspecified

665

2882

1.52

21.76

1.4

1.3

1.52

1.44

nmol/l

1.01

589

2621

Periapical abscess

402

2394

1.69

21.69

1.4

1.3

1.43

1.46

nmol/l

0.15

364

2157

Dermatitis

499

3070

1.60

21.49

1.4

1.3

1.56

1.45

nmol/l

1.36

453

2777

Other dialysis

129

4.34

20.88

1.4

1.2

1.22

1.49

nmol/l

0.90

116

Allergic asthma (mode), excluding more controls

181

821

2.17

20.82

1.4

1.3

1.54

1.40

nmol/l

0.95

166

743

Headache

493

2387

1.60

20.79

1.4

1.3

1.62

1.43

nmol/l

2.79

451

2150

Alcohol abuse, main dg, excluding more controls

146

623

2.37

20.79

1.4

1.3

1.17

1.46

nmol/l

2.53

137

553

Gout, idiopatic and unspecified

236

1217

1.96

20.63

1.2

1.3

1.97

1.40

nmol/l

7.20

221

1092

Symptoms and signs concerning food and fluid intake

108

401

2.72

20.51

1.5

1.4

1.31

1.49

nmol/l

1.02

361

Disorders of the thyroid gland

710

3119

1.48

20.39

1.4

1.3

1.51

1.44

nmol/l

0.98

626

2839

Bronchitis

821

3427

1.44

20.18

1.4

1.3

1.54

1.43

nmol/l

1.83

744

3106

Other functional intestinal disorders

363

1944

1.70

20.04

1.4

1.3

1.59

1.43

nmol/l

1.67

328

1751

Diabetic nephropathy

379

2258

1.70

19.98

1.4

1.3

1.44

nmol/l

0.01

335

2045

Other dorsopathies, not elsewhere classified

740

2617

1.47

19.81

1.4

1.3

1.56

1.40

nmol/l

3.18

678

2355

Allergic asthma (mode)

181

840

2.12

19.67

1.4

1.3

1.54

1.45

nmol/l

0.54

166

760

Other diseases of intestines

791

3055

1.45

19.58

1.4

1.3

1.54

1.42

nmol/l

1.92

717

2769

837

2962

1.44

19.57

1.5

1.3

1.52

1.42

nmol/l

1.59

756

2684

All influenza

223

1149

1.96

19.52

1.4

1.3

1.55

1.42

nmol/l

1.04

205

1031

Other acute lower respiratory infections

418

2463

1.62

19.29

1.5

1.3

1.52

1.44

nmol/l

0.68

384

2214

Late syphilis

6.34

19.27

1.4

1.2

0.85

1.59

nmol/l

3.49

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

256

662

1.95

19.24

1.4

1.3

1.55

1.44

nmol/l

0.61

229

586

Disease of hard tissues of teeth, NOS

396

1229

1.69

19.23

1.4

1.3

1.51

1.42

nmol/l

0.62

362

1101

Excluding asthma or asthma-COPD overlap

584

1910

1.54

19.00

1.4

1.3

1.49

1.40

nmol/l

1.09

520

1734

Use of hypnotics and sedatives

823

3310

1.43

18.92

1.4

1.48

1.45

nmol/l

0.33

733

3007

Oesophageal varices

176

3.62

18.84

1.3

1.2

1.81

1.60

nmol/l

0.48

156

Other pulmonary diagnosis

583

1910

1.53

18.83

1.4

1.3

1.51

1.40

nmol/l

1.33

519

1734

Other intervertebral disc disorders

624

2489

1.50

18.80

1.5

1.3

1.57

1.41

nmol/l

2.62

580

2233

Spondylosis

437

2134

1.61

18.79

1.4

1.3

1.50

1.42

nmol/l

0.84

400

1912

Constipation

687

3190

1.46

18.79

1.3

1.61

1.42

nmol/l

3.59

621

2887

Gout, strict definition

184

902

2.06

18.65

1.2

1.3

1.97

1.41

nmol/l

6.43

172

809

Pruritus

106

412

2.60

18.51

1.4

1.57

1.46

nmol/l

0.41

374

Lumbar disc prolapse

503

2410

1.55

18.47

1.4

1.3

1.59

1.41

nmol/l

2.54

459

2159

Asthma/COPD (KELA code 203)

715

3315

1.45

18.30

1.4

1.60

1.41

nmol/l

3.64

649

3006

Pain (limb, back, neck, head abdominally)

516

1657

1.57

18.24

1.4

1.3

1.52

1.41

nmol/l

1.18

464

1491

Extracorporeal dialysis

266

3.04

18.19

1.4

1.3

1.51

1.47

nmol/l

0.09

238

Other follicular disorders

293

2.91

18.11

1.3

1.4

1.84

1.49

nmol/l

1.68

268

Factors influencing health status and contact with health services

214

531

2.03

18.09

1.4

1.3

1.45

1.50

nmol/l

0.20

194

485

Dermatitis and eczema

840

3550

1.40

17.96

1.4

1.3

1.54

1.44

nmol/l

1.90

760

3218

Symptoms and signs involving the nervous and musculoskeletal systems

449

2880

1.57

17.95

1.4

1.3

1.60

1.43

nmol/l

2.38

403

2601

113

460

2.48

17.90

1.8

1.3

1.37

1.45

nmol/l

0.28

105

414

Adenocarcinoma of pancreas

114

4.25

17.82

1.1

1.2

1.09

1.36

nmol/l

0.87

100

Diabetic neuropathy

269

1525

1.80

17.61

1.4

1.3

1.19

1.46

nmol/l

4.74

245

1362

Chronic ulcer of skin, not elsewhere classified

260

3.01

17.61

1.4

1.2

1.57

1.46

nmol/l

0.34

232

Exclusions for E4_PCOS_BROAD

155

728

2.15

17.55

1.3

1.4

1.70

1.47

nmol/l

1.52

140

657

Missing teeth due to accident, extraction or parodontitis

494

2896

1.53

17.54

1.3

1.44

1.46

nmol/l

0.14

440

2623

Polycystic ovarian syndrome, consortium definition

443

1598

1.60

17.51

1.4

1.60

1.47

nmol/l

1.42

403

1447

Explicit bacterial Sepsis, including avohilmo

105

419

2.54

17.40

1.2

1.3

1.49

1.51

nmol/l

0.05

377

Rotator cuff syndrome

483

2157

1.55

17.35

1.5

1.3

1.51

1.44

nmol/l

0.60

429

1955

Autoimmune diseases related-to ILD

638

3684

1.45

17.28

1.4

1.58

1.43

nmol/l

2.32

571

3345

Status post-ami

201

778

1.97

17.28

1.2

1.3

1.79

1.33

nmol/l

4.84

178

702

Late syphilis, including avohilmo

5.31

17.13

1.5

1.3

0.89

1.54

nmol/l

2.73

Irregular menses

310

1365

1.71

17.00

1.5

1.4

1.63

1.46

nmol/l

1.89

286

1239

Other medical care

376

1956

1.62

16.98

1.2

1.3

1.55

1.44

nmol/l

0.99

339

1775

Diabetic maculopathy

313

1781

1.70

16.65

1.4

1.3

1.05

1.52

nmol/l

13.84

258

1619

Gastroduodenal ulcer

209

1110

1.89

16.64

1.4

1.3

1.59

1.45

nmol/l

0.86

191

1005

Explicit bacterial Sepsis

102

411

2.51

16.58

1.2

1.3

1.49

1.52

nmol/l

0.07

370

Fungal Sepsis

157

3.58

16.58

1.3

1.59

1.46

nmol/l

0.24

139

Other metabolic disorders

104

423

2.48

16.55

1.4

1.45

1.50

nmol/l

0.14

383

Benign neoplasm of colon, rectum, anus and anal canal

497

2792

1.51

16.55

1.4

1.3

1.50

1.45

nmol/l

0.43

454

2523

Acute upper respiratory infections of multiple and unspecified sites

565

2803

1.47

16.37

1.4

1.3

1.53

1.44

nmol/l

1.02

504

2532

Panic disorder

119

518

2.32

16.28

1.4

1.53

1.41

nmol/l

0.52

107

465

COPD differential diagnosis

569

1919

1.49

16.15

1.4

1.3

1.50

1.40

nmol/l

1.17

507

1741

Persons encountering health services in other circumstances

283

1646

1.71

16.13

1.5

1.3

1.58

1.44

nmol/l

1.24

268

1483

Pre-eclampsia or eclampsia

148

708

2.11

16.04

1.5

1.4

1.61

1.47

nmol/l

0.79

137

637

ILD differential diagnosis

568

1919

1.49

15.99

1.4

1.3

1.50

1.40

nmol/l

1.20

506

1741

Disorders of skin appendages

377

2378

1.58

15.94

1.4

1.60

1.45

nmol/l

1.79

328

2147

Acute bronchitis

310

1839

1.66

15.86

1.4

1.3

1.49

1.44

nmol/l

0.35

286

1652

Soft tissue disorders

715

2589

1.42

15.78

1.4

1.3

1.54

1.43

nmol/l

1.59

642

2350

Other diseases of hard tissues of teeth

387

1246

1.61

15.76

1.4

1.3

1.46

1.42

nmol/l

0.27

350

1118

Acute upper respiratory infections

755

3249

1.40

15.73

1.5

1.3

1.53

1.44

nmol/l

1.21

678

2943

Care involving use of rehabilitation procedures

473

2834

1.51

15.71

1.3

1.4

1.52

1.43

nmol/l

0.82

415

2581

Hernia of abdominal wall

374

2384

1.58

15.53

1.4

1.3

1.54

1.44

nmol/l

0.96

342

2145

Dorsopathies

727

2621

1.41

15.41

1.4

1.3

1.55

1.40

nmol/l

2.65

666

2359

Injuries to the knee and lower leg

867

3445

1.36

15.37

1.4

1.47

1.45

nmol/l

0.13

786

3119

Persistent mood disorders

149

727

2.07

15.35

1.3

1.52

1.49

nmol/l

0.13

132

653

Spinal stenosis

392

1846

1.57

15.32

1.4

1.3

1.67

1.41

nmol/l

3.39

364

1659

Other and unspecified local infections of skin and subcutaneous tissue

395

2.46

14.99

1.4

1.3

1.30

1.46

nmol/l

0.71

356

Presence of other functional implants

448

2025

1.52

14.93

1.5

1.3

1.41

1.42

nmol/l

0.10

395

1835

Candidiasis

122

558

2.21

14.89

1.2

1.4

1.60

1.49

nmol/l

0.37

107

506

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

236

2.92

14.87

1.3

1.4

1.52

1.42

nmol/l

0.27

214

Maternal care for other known or suspected fetal problems

148

441

2.12

14.83

1.6

1.4

1.74

1.47

nmol/l

1.56

133

397

Pre-eclampsia

135

644

2.11

14.79

1.5

1.4

1.64

1.49

nmol/l

0.84

125

581

Presence of cardiac and vascular implants and grafts

346

1594

1.60

14.74

1.3

1.63

1.41

nmol/l

2.57

319

1451

Pre-eclampsia or poor fetal growth

193

1042

1.85

14.58

1.5

1.4

1.59

1.50

nmol/l

0.55

178

932

Alcohol abuse, main dg

146

722

2.04

14.57

1.4

1.3

1.17

1.48

nmol/l

2.82

137

651

Necrosis of pulp, including avohilmo

453

3014

1.49

14.55

1.5

1.4

1.49

1.45

nmol/l

0.31

416

2721

Gout, unspecified

185

993

1.88

14.52

1.2

1.3

2.01

1.39

nmol/l

6.48

172

892

Acute sinusitis

388

2299

1.54

14.38

1.5

1.3

1.53

1.45

nmol/l

0.69

352

2063

Streptococcal septicaemia, including avohilmo

369

2.47

14.19

1.2

1.51

1.56

nmol/l

0.13

331

Postprocedural endocrine and metabolic disorders, not elsewhere classified

388

2.42

14.08

1.4

1.50

1.52

nmol/l

0.05

350

Fracture of lower leg, including ankle

412

2690

1.51

14.06

1.4

1.3

1.44

1.45

nmol/l

0.10

367

2430

Heart failure and bmi 25plus

284

1138

1.67

14.06

1.3

1.67

1.45

nmol/l

1.82

254

1031

Open wound of ankle and foot

100

433

2.34

13.97

1.5

1.3

1.34

1.47

nmol/l

0.54

389

Cholecystitis

112

510

2.22

13.85

1.3

1.51

nmol/l

0.01

455

Cholangitis (primary sclerosing, PSC)

224

2.90

13.82

1.6

1.3

1.21

1.54

nmol/l

1.30

200

Injuries to the head

810

3566

1.35

13.82

1.4

1.3

1.45

nmol/l

0.00

739

3229

Streptococcal septicaemia

357

2.47

13.71

1.2

1.51

1.57

nmol/l

0.14

320

Hidradenitis suppurativa

128

3.59

13.68

1.3

1.5

1.92

1.44

nmol/l

1.66

117

Mixed and other personality disorders

299

2.61

13.62

1.4

1.65

1.45

nmol/l

0.79

277

Schizophrenia or delusion

240

1418

1.70

13.59

1.3

1.4

1.72

1.47

nmol/l

2.31

216

1273

Benign neoplasm: Colon

414

2604

1.50

13.56

1.4

1.3

1.50

1.44

nmol/l

0.51

379

2352

Other/unspecified dorsalgia

275

1666

1.64

13.43

1.4

1.3

1.54

1.41

nmol/l

1.15

248

1473

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

447

2993

1.47

13.40

1.5

1.3

1.52

1.45

nmol/l

0.72

411

2689

Schizophrenia, schizotypal and delusional disorders

240

1426

1.69

13.32

1.3

1.4

1.72

1.47

nmol/l

2.32

216

1280

Dental operations

427

1454

1.52

13.32

1.3

1.55

1.44

nmol/l

0.92

385

1317

Osteopathies and chondropathies

410

2516

1.49

13.27

1.5

1.3

1.53

1.44

nmol/l

0.76

370

2257

Dermatophytosis, including avohilmo

493

3367

1.44

13.26

1.3

1.4

1.50

1.45

nmol/l

0.46

454

3034

Finngen Rheumatological endpoints

689

2845

1.38

13.26

1.4

1.62

1.37

nmol/l

6.43

617

2576

Other local infections of skin and subcutaneous tissue

433

2.29

13.09

1.4

1.3

1.29

1.47

nmol/l

0.92

389

Sequelae of external causes of morbidity and mortality

206

1185

1.75

12.90

1.6

1.3

1.54

1.50

nmol/l

0.22

189

1061

Acute peritonitis

251

2.71

12.78

1.4

1.3

1.40

1.48

nmol/l

0.25

223

Hypokalaemia

433

2.26

12.64

1.4

1.3

1.69

1.53

nmol/l

0.44

388

Fall on same level

823

3305

1.33

12.51

1.4

1.3

1.47

1.45

nmol/l

0.16

746

2992

Phobic anxiety disorders

447

2.23

12.46

1.3

1.4

1.67

1.36

nmol/l

1.53

408

Benign neoplasms

703

2820

1.36

12.41

1.4

1.3

1.49

1.42

nmol/l

0.81

630

2555

Dizziness and giddiness

536

2972

1.41

12.33

1.4

1.3

1.50

1.46

nmol/l

0.41

499

2684

Malignant neoplasm of digestive organs, including Hilmo

348

1678

1.53

12.25

1.3

1.35

1.44

nmol/l

0.64

310

1533

Acute alcohol intoxication

204

1189

1.73

12.21

1.4

1.3

1.21

1.45

nmol/l

2.70

193

1059

Other and unspecified effects of external causes

204

1193

1.72

12.06

1.6

1.4

1.59

1.46

nmol/l

0.88

181

1065

Early onset COPD, excluding more controls

167

928

1.81

11.77

1.5

1.3

1.44

1.43

nmol/l

0.06

152

847

Fibromyalgia

291

2.50

11.76

1.7

1.3

1.97

1.45

nmol/l

2.24

262

Trigger finger

124

627

1.99

11.73

1.3

1.43

1.51

nmol/l

0.34

109

556

Syphilis

108

3.62

11.65

1.4

1.3

0.94

1.46

nmol/l

2.69

Syphilis, including avohilmo

108

3.62

11.65

1.4

1.3

0.94

1.46

nmol/l

2.69

Other neurological diseases

515

2858

1.40

11.63

1.3

1.44

1.46

nmol/l

0.09

454

2591

Adverse effects, not elsewhere classified

144

768

1.89

11.62

1.6

1.4

1.67

1.49

nmol/l

1.01

128

692

Other symptoms and signs involving the nervous and musculoskeletal systems

301

1958

1.54

11.56

1.4

1.3

1.69

1.43

nmol/l

3.11

264

1765

Other diseases of stomach and duodenum

253

2.61

11.52

1.3

1.37

1.51

nmol/l

0.35

227

Superficial injury of head

180

1029

1.76

11.51

1.4

1.3

1.33

1.43

nmol/l

0.63

163

925

Convulsions, not elsewhere classified

171

952

1.78

11.50

1.5

1.3

1.33

1.40

nmol/l

0.36

157

849

Schizoaffective disorder

289

2.49

11.47

1.2

1.4

1.51

1.40

nmol/l

0.38

264

Pain in joint

390

1628

1.48

11.23

1.4

1.3

1.55

1.41

nmol/l

1.47

355

1462

Ascites

305

2.42

11.16

1.3

1.57

1.53

nmol/l

0.09

274

Papulosquamous disorders

297

1944

1.54

11.13

1.3

1.67

1.44

nmol/l

2.46

267

1746

Psoriasis

225

1382

1.64

11.10

1.3

1.73

1.47

nmol/l

2.22

205

1237

Familial hypercholesterolemia

113

566

2.01

11.00

1.3

1.2

1.54

1.49

nmol/l

0.18

501

Sequelae with surgical and medical care as external cause

163

921

1.78

10.96

1.5

1.3

1.54

1.53

nmol/l

0.03

151

831

Injuries to the ankle and foot

519

3218

1.38

10.94

1.4

1.54

1.44

nmol/l

1.17

473

2909

Nonorganic sleeping disorders, excluding more controls

137

735

1.87

10.87

1.4

1.3

1.36

1.46

nmol/l

0.49

128

658

Chronic gastritis

190

1126

1.70

10.76

1.3

1.48

1.46

nmol/l

0.05

172

1014

Oligomenorrhoea

3.64

10.66

1.8

1.3

1.60

1.37

nmol/l

0.41

Disorders of sclera, cornea, iris and ciliary body

398

2788

1.43

10.62

1.4

1.3

1.42

1.45

nmol/l

0.23

352

2514

Injury, poisoning and certain other consequences of external causes

361

1216

1.49

10.57

1.4

1.3

1.56

1.44

nmol/l

0.99

327

1108

Abnormalities of heart beat

239

1460

1.59

10.56

1.5

1.3

1.48

1.38

nmol/l

0.68

212

1317

Other noninfective gastroenteritis and colitis

178

1042

1.72

10.53

1.3

1.56

1.49

nmol/l

0.31

165

932

Retention of urine

269

1403

1.56

10.47

1.3

1.51

1.44

nmol/l

0.39

237

1275

Visual disturbances and blindness

365

2525

1.45

10.37

1.4

1.3

1.51

1.45

nmol/l

0.38

321

2277

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

407

2868

1.42

10.35

1.5

1.3

1.54

1.45

nmol/l

0.84

371

2585

Diseases of peritoneum

412

2.16

10.31

1.5

1.3

1.46

1.54

nmol/l

0.33

373

Acute alcohol intoxication, ICD10

168

976

1.73

10.28

1.4

1.3

1.14

1.48

nmol/l

4.09

161

872

Falls/tendency to fall

755

2894

1.31

10.28

1.4

1.3

1.48

1.45

nmol/l

0.24

684

2623

Anosmia

+∞

10.25

1.0

0.0

1.36

—

nmol/l

—

Primary biliary cholangitis, wide definition

4.54

10.06

1.3

1.5

1.43

1.50

nmol/l

0.09

Psoriasis vulgaris

153

873

1.77

10.00

1.3

1.79

1.49

nmol/l

2.03

138

786

Hernia

659

3328

1.32

9.94

1.4

1.3

1.46

nmol/l

0.03

594

3008

Haemorrhage from respiratory passages

243

1381

1.56

9.81

1.3

1.69

1.35

nmol/l

3.65

217

1255

AV-block

134

626

1.84

9.81

1.4

1.3

1.30

1.38

nmol/l

0.34

121

562

Pacemaker

248

1490

1.55

9.79

1.5

1.3

1.70

1.44

nmol/l

2.03

219

1350

Urolithiasis

241

1554

1.56

9.75

1.3

1.59

1.44

nmol/l

1.25

219

1403

Speech and linguistic disorders, excluding more controls

173

2.73

9.73

1.5

1.3

1.56

1.36

nmol/l

0.54

160

Calculus of kidney and ureter

226

1437

1.58

9.73

1.4

1.3

1.60

1.45

nmol/l

1.19

205

1290

Diverticular disease of intestine

516

2361

1.36

9.67

1.3

1.55

1.42

nmol/l

1.71

466

2128

Otitis externa

170

1013

1.69

9.51

1.4

1.3

1.47

1.50

nmol/l

0.12

146

910

Non-allergic asthma (mode), excluding more controls

129

704

1.83

9.47

1.4

1.3

1.61

1.36

nmol/l

1.55

119

640

Asthma and allergy, excluding more controls

409

2.09

9.34

1.4

1.3

1.46

1.33

nmol/l

0.49

373

Acute pharyngitis

111

580

1.91

9.33

1.4

1.3

1.37

1.41

nmol/l

0.12

524

Malignant neoplasm of digestive organs

304

1578

1.48

9.28

1.3

1.36

1.44

nmol/l

0.63

274

1440

Other and unspecified nonorganic psychotic disorders

139

789

1.77

9.27

1.3

1.4

1.74

1.43

nmol/l

1.74

122

716

Erythema intertrigo

3.52

9.25

1.4

1.2

1.90

1.36

nmol/l

1.47

Unspecified acute lower respiratory infection

124

681

1.83

9.24

1.4

1.3

1.51

nmol/l

0.03

116

614

Mental and behavioural disorders due to sedatives or hypnotics

276

2.35

9.19

1.4

1.11

1.46

nmol/l

1.88

251

Injuries to the thorax

335

2337

1.44

9.18

1.4

1.3

1.32

1.44

nmol/l

1.31

306

2103

Familial hypercholesterolemia, with ischemic heart disease

308

2.26

9.14

1.2

1.3

1.61

1.45

nmol/l

0.63

276

Follow-up examination after treatment for conditions other than malignant neoplasms

259

1130

1.53

9.13

1.4

1.3

1.32

1.43

nmol/l

0.82

225

1026

Migraine

302

1603

1.47

9.01

1.5

1.4

1.56

1.37

nmol/l

2.35

281

1445

Tobacco use

230

2.47

8.98

1.4

1.56

1.45

nmol/l

0.19

210

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

242

2.42

8.96

1.6

1.4

1.57

1.36

nmol/l

0.75

219

Amenorrhoea

183

2.65

8.93

1.6

1.4

1.64

1.48

nmol/l

0.45

161

Symptoms and signs involving the urinary system

535

3036

1.33

8.91

1.3

1.57

1.44

nmol/l

1.74

475

2747

Diseases of the respiratory system

420

1508

1.40

8.86

1.4

1.3

1.50

1.40

nmol/l

0.79

374

1373

Asthma and allergy

418

2.04

8.83

1.4

1.3

1.46

1.38

nmol/l

0.25

380

Non-allergic asthma (mode)

129

720

1.78

8.83

1.4

1.3

1.61

1.43

nmol/l

0.97

119

652

Social phobias

256

2.36

8.81

1.3

1.5

1.61

1.37

nmol/l

0.80

237

Myalgia

167

1014

1.66

8.73

1.3

1.55

1.47

nmol/l

0.38

145

914

Other infective otitis externa

234

2.42

8.66

1.4

1.3

1.49

1.47

nmol/l

0.03

214

Diseases of external ear

251

1679

1.50

8.62

1.4

1.3

1.41

1.46

nmol/l

0.26

221

1507

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

355

2.13

8.62

1.6

1.3

1.57

1.54

nmol/l

0.07

322

Duodenal ulcer

449

2.00

8.61

1.3

1.2

1.51

1.48

nmol/l

0.07

396

Cerebrovascular diseases

520

2713

1.33

8.58

1.3

1.44

1.46

nmol/l

0.11

469

2460

Dysphagia

170

1044

1.64

8.51

1.6

1.3

1.38

1.46

nmol/l

0.49

152

927

Diseases of the musculoskeletal system and connective tissue

350

1228

1.43

8.47

1.3

1.48

1.40

nmol/l

0.60

309

1117

Intracranial injury

408

2781

1.37

8.46

1.4

1.3

1.54

1.44

nmol/l

0.96

368

2513

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

571

1.87

8.45

1.4

1.3

1.50

1.54

nmol/l

0.10

509

Syncope and collapse

298

1724

1.45

8.33

1.4

1.3

1.42

1.45

nmol/l

0.16

274

1549

Bell's palsy

483

1.94

8.30

1.4

1.3

1.43

1.52

nmol/l

0.41

436

Trochanteric bursitis

104

561

1.87

8.26

1.3

1.62

1.47

nmol/l

0.66

505

Other postsurgical states

258

2.31

8.25

2.2

1.3

1.51

1.52

nmol/l

0.02

228

Migraine with aura

145

862

1.69

8.22

1.6

1.4

1.53

1.43

nmol/l

0.53

133

768

Visual disturbances

331

2359

1.41

8.16

1.4

1.3

1.54

1.45

nmol/l

0.72

293

2128

Decubitus ulcer and pressure area

235

2.37

8.11

1.3

1.2

1.57

1.52

nmol/l

0.11

206

Cardiomyopathy

131

761

1.73

8.11

1.3

1.76

1.36

nmol/l

2.96

119

690

Viral and other specified intestinal infections, including avohilmo

173

1039

1.61

8.08

1.4

1.55

1.42

nmol/l

0.67

155

947

Injuries to the abdomen, lower back, lumbar spine and pelvis

276

1880

1.45

8.04

1.5

1.3

1.28

1.46

nmol/l

1.93

251

1684

External causes of morbidity and mortality

432

1587

1.37

8.01

1.4

1.3

1.52

1.44

nmol/l

0.68

390

1449

Alcohol withdrawal state with delirium

333

2.13

8.00

1.4

1.3

1.28

1.49

nmol/l

0.99

304

Umbilical hernia

217

1433

1.52

7.99

1.4

1.3

1.52

1.46

nmol/l

0.32

198

1302

Dermatophytosis

115

648

1.79

7.96

1.3

1.49

1.52

nmol/l

0.09

105

582

Cardiomyopathies, Primary/intrinsic

100

541

1.86

7.91

1.2

1.3

1.87

1.35

nmol/l

3.37

485

Radiculopathy

116

657

1.78

7.88

1.4

1.3

1.63

1.45

nmol/l

0.70

104

581

Prurigo nodularis

3.29

7.85

1.2

1.4

1.51

1.47

nmol/l

0.07

Excessive earwax

444

3017

1.34

7.84

1.4

1.3

1.53

1.43

nmol/l

1.08

398

2738

Tubulo-interstitial nephritis, not specified as acute or chronic

214

2.41

7.83

1.2

1.4

1.85

1.44

nmol/l

1.13

188

Viral pneumonia

100

544

1.85

7.77

1.5

1.3

1.67

1.50

nmol/l

0.71

487

Cervicobrachial syndrome

157

969

1.63

7.76

1.4

1.3

1.65

1.45

nmol/l

1.16

151

860

Allergic rhinitis

198

1274

1.54

7.72

1.3

1.4

1.74

1.45

nmol/l

2.12

178

1151

Disorders of vitreous body and globe

358

2468

1.38

7.66

1.4

1.3

1.55

1.45

nmol/l

0.85

315

2234

Vasomotor and allergic rhinitis

255

1716

1.46

7.59

1.3

1.4

1.71

1.46

nmol/l

2.12

227

1549

Superficial injury of ankle and foot

463

1.91

7.58

1.3

1.4

1.54

1.44

nmol/l

0.33

417

Diseases of male genital organs

402

1482

1.37

7.57

1.3

1.46

1.40

nmol/l

0.47

361

1348

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

120

603

1.74

7.50

1.5

1.4

1.66

1.36

nmol/l

1.84

104

552

Noninfectious colitis NAS

544

1.83

7.46

1.5

1.3

1.55

1.50

nmol/l

0.17

492

Cardiomyopathy (excluding other)

101

559

1.82

7.45

1.2

1.3

1.86

1.38

nmol/l

3.00

502

Disorders of vitreous body

349

2423

1.37

7.44

1.4

1.3

1.55

1.45

nmol/l

0.75

306

2190

Bacterial pneumoniae

269

1645

1.44

7.44

1.3

1.43

1.42

nmol/l

0.02

248

1482

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

264

2.22

7.41

1.4

1.37

1.38

nmol/l

0.03

239

Bacterial pneumonia (organism specified)

292

1872

1.42

7.41

1.3

1.43

nmol/l

0.00

270

1684

Rheumatism, unspecified

467

1.90

7.40

1.5

1.3

1.99

1.47

nmol/l

2.65

418

Open wound of lower leg

116

670

1.74

7.40

1.3

1.44

1.45

nmol/l

0.05

107

607

Noninfective enteritis and colitis

314

2256

1.39

7.37

1.4

1.3

1.52

1.45

nmol/l

0.47

286

2026

Other abnormal findings of blood chemistry

184

2.48

7.35

1.3

1.2

1.81

1.48

nmol/l

1.00

168

Fracture of rib(s), sternum and thoracic spine

222

1500

1.49

7.35

1.4

1.3

1.27

1.45

nmol/l

1.62

202

1350

Other bacterial intestinal infections, including avohilmo

158

991

1.60

7.34

1.5

1.3

1.64

1.47

nmol/l

0.97

145

897

Injuries to the shoulder and upper arm

590

3572

1.28

7.30

1.4

1.3

1.50

1.45

nmol/l

0.52

545

3225

Ventral hernia

174

1119

1.56

7.27

1.4

1.3

1.55

1.46

nmol/l

0.44

160

1006

Generalized anxiety disorder

101

562

1.80

7.27

1.4

1.69

1.40

nmol/l

1.32

505

Lesion of ulnar nerve

107

608

1.77

7.24

1.5

1.3

1.55

1.47

nmol/l

0.25

554

Personal history of other diseases and conditions

332

2.05

7.16

1.2

1.4

1.46

1.43

nmol/l

0.09

299

Diseases of the ear and mastoid process

783

3166

1.24

7.12

1.4

1.3

1.46

1.45

nmol/l

0.12

704

2879

Post-traumatic stress disorder

237

2.25

7.07

1.5

1.50

1.38

nmol/l

0.34

220

Other diseases of lip and oral mucosa

287

2050

1.41

7.06

1.5

1.3

1.52

1.45

nmol/l

0.45

261

1839

Abnormalities of gait and mobility

518

1.83

7.06

1.3

1.46

1.52

nmol/l

0.20

466

Other complications of surgical and medical care, not elsewhere classified

384

1.97

7.05

1.5

1.3

1.39

1.47

nmol/l

0.23

350

Corns and callosities

270

2.17

7.04

1.3

1.43

1.54

nmol/l

0.29

240

Visual impairment including blindness (binocular or monocular)

257

2.20

7.04

1.4

1.30

1.48

nmol/l

0.52

233

Stroke, including SAH

427

2315

1.33

7.00

1.3

1.48

1.45

nmol/l

0.28

383

2108

Gastro-oesophageal reflux disease

453

2922

1.31

6.96

1.4

1.3

1.51

1.44

nmol/l

0.62

418

2638

Undetermined asthma, excluding more controls

484

1.85

6.94

1.4

1.3

1.60

1.42

nmol/l

0.63

438

Early onset COPD

167

1077

1.56

6.93

1.5

1.3

1.44

1.48

nmol/l

0.16

152

969

Conjunctivitis (acute, non atopic), including avohilmo

694

3360

1.25

6.92

1.4

1.3

1.53

1.44

nmol/l

1.34

634

3040

Mental disorders, not otherwise specified

272

2.15

6.91

1.7

1.4

1.49

1.39

nmol/l

0.28

248

Vascular disorders of the intestines

259

2.18

6.90

1.5

1.3

1.49

1.50

nmol/l

0.02

227

Cough

257

1684

1.43

6.90

1.3

1.43

1.38

nmol/l

0.33

234

1526

Idiopathic gout

451

1.88

6.88

1.1

1.3

1.81

1.42

nmol/l

2.01

394

Delirium, not induced by alcohol and other psychoactive substances

478

1.85

6.87

1.3

1.39

1.54

nmol/l

0.42

421

Viral infections characterized by skin and mucous membrane lesions

290

2084

1.40

6.86

1.3

1.57

1.44

nmol/l

1.30

264

1864

Other diseases of arteries and capillaries

347

2.01

6.83

1.4

1.3

1.63

1.51

nmol/l

0.29

307

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

287

2.11

6.81

1.2

1.84

1.42

nmol/l

1.26

257

Inflammatory diseases of female pelvic organs

341

1710

1.37

6.79

1.4

1.59

1.48

nmol/l

0.98

305

1553

Other obstetric conditions, not elsewhere classified

159

631

1.59

6.77

1.6

1.5

1.54

1.52

nmol/l

0.04

146

570

Other external causes of accidental injury

541

2107

1.29

6.76

1.4

1.3

1.52

1.46

nmol/l

0.50

486

1913

Psychotic depression

161

2.51

6.76

1.2

1.3

1.30

1.40

nmol/l

0.24

148

Excessive, frequent and irregular menstruation

210

746

1.51

6.75

1.5

1.4

1.64

1.43

nmol/l

1.73

183

673

Exposure to unspecified factor

686

3755

1.24

6.75

1.4

1.3

1.40

1.46

nmol/l

0.78

618

3409

Behavioural syndromes associated with physiological disturbances and physical factors

633

3416

1.26

6.75

1.5

1.3

1.51

1.45

nmol/l

0.62

588

3078

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

138

2.65

6.74

1.6

1.4

0.98

1.54

nmol/l

2.81

129

Other symptoms and signs involving cognitive functions and awareness

312

2014

1.38

6.74

1.4

1.3

1.37

1.46

nmol/l

0.72

276

1817

Hyperkinetic disorders, excluding more controls

286

2.06

6.72

1.7

1.5

1.73

1.27

nmol/l

2.15

262

Misadventures to patients during surgical and medical care

107

623

1.73

6.68

1.4

1.3

1.57

1.49

nmol/l

0.28

559

Other disorders of kidney and ureter

102

587

1.75

6.65

1.5

1.3

1.69

1.51

nmol/l

0.65

526

Superficial injury of lower leg

172

1127

1.53

6.64

1.3

1.4

1.58

1.45

nmol/l

0.93

167

1014

Other and unspecified drugs and medicaments

351

1.98

6.64

1.6

1.4

1.61

1.55

nmol/l

0.15

316

Keratitis

244

1715

1.43

6.62

1.4

1.3

1.46

1.48

nmol/l

0.09

212

1532

Migraine without aura

108

632

1.72

6.60

1.4

1.55

1.40

nmol/l

0.74

101

557

Certain disorders involving the immune mechanism

137

854

1.61

6.59

1.3

1.62

1.48

nmol/l

0.62

122

767

Benign neoplasm: Ascending colon

111

657

1.70

6.55

1.4

1.3

1.60

1.51

nmol/l

0.33

102

587

Schizophrenia

117

702

1.68

6.55

1.2

1.3

1.71

1.45

nmol/l

1.32

106

630

Corneal ulcer

131

809

1.63

6.55

1.5

1.3

1.32

1.49

nmol/l

0.95

112

723

Conduction disorders

196

1054

1.50

6.54

1.4

1.3

1.34

1.38

nmol/l

0.19

177

961

Cervical disc disorders

247

1745

1.42

6.52

1.4

1.3

1.62

1.42

nmol/l

1.61

220

1554

Disorders of mineral metabolism

300

2.05

6.45

1.3

1.67

1.53

nmol/l

0.39

268

Other enthesopathies

197

1337

1.48

6.43

1.6

1.3

1.44

1.45

nmol/l

0.08

180

1203

Accidents

537

2107

1.28

6.37

1.4

1.3

1.51

1.46

nmol/l

0.39

482

1913

Undetermined asthma

498

1.80

6.37

1.4

1.3

1.60

1.47

nmol/l

0.41

450

Disorders of tooth development and eruption

456

1.76

6.31

1.4

1.3

1.48

1.44

nmol/l

0.13

410

Stroke, excluding SAH

401

2203

1.32

6.30

1.3

1.51

1.44

nmol/l

0.54

358

2006

Vulvovaginal ulceration/inflammation in other diseases

199

2.28

6.21

1.4

1.5

1.42

1.44

nmol/l

0.04

183

Abscess of anal and rectal regions

388

1.90

6.20

1.3

1.55

1.46

nmol/l

0.25

346

Other diseases of upper respiratory tract

735

3122

1.23

6.19

1.4

1.3

1.42

1.44

nmol/l

0.17

654

2831

Gastric ulcer

119

729

1.64

6.17

1.4

1.3

1.64

1.50

nmol/l

0.58

107

650

Viral and other specified intestinal infections

123

741

1.63

6.15

1.5

1.4

1.49

1.40

nmol/l

0.32

108

682

Hepatic failure, not elsewhere classified

133

2.59

6.14

1.2

1.3

1.15

1.39

nmol/l

0.58

116

Conjunctivitis (acute, non atopic)

188

1272

1.48

6.13

1.4

1.47

1.46

nmol/l

0.06

172

1144

Glaucoma suspect

236

1675

1.41

6.08

1.4

1.3

1.39

1.47

nmol/l

0.50

214

1512

Fracture of foot, except ankle

161

1062

1.52

6.08

1.4

1.46

1.45

nmol/l

0.05

146

958

Use of pramipexole

147

951

1.55

6.07

1.4

1.3

1.59

1.51

nmol/l

0.35

131

851

Sleep disorders

602

3333

1.25

6.06

1.5

1.3

1.50

1.45

nmol/l

0.56

559

3002

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

151

608

1.57

6.06

1.6

1.5

1.55

1.53

nmol/l

0.09

138

547

Use of disulfiram, acamprosate or naltrexone

449

1.82

6.05

1.3

1.44

1.49

nmol/l

0.14

409

Urticaria and erythema

232

1644

1.42

6.05

1.5

1.3

1.59

1.47

nmol/l

0.80

209

1474

Other specific joint derangements/joint disorders

481

2346

1.28

5.99

1.4

1.3

1.54

1.40

nmol/l

1.99

435

2130

Unspecified privation

443

1.82

5.98

1.4

1.3

1.41

1.50

nmol/l

0.31

397

Paracetamol or NSAID medication

272

1.79

5.95

1.3

1.63

1.37

nmol/l

0.87

248

Other keratitis

473

1.79

5.94

1.5

1.3

1.43

1.47

nmol/l

0.13

429

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

603

3801

1.24

5.81

1.4

1.51

1.45

nmol/l

0.77

545

3448

Primary biliary cholangitis (PBC)

3.66

5.78

1.3

1.5

1.68

1.57

nmol/l

0.09

Haemorrhage in early pregnancy

123

751

1.60

5.73

1.4

1.56

1.50

nmol/l

0.25

115

673

Other degenerative diseases of the nervous system

165

801

1.51

5.70

1.3

1.17

1.46

nmol/l

3.72

143

727

Arthropathies

585

2376

1.25

5.65

1.4

1.3

1.52

1.39

nmol/l

1.77

519

2160

Other bacterial intestinal infections

118

739

1.60

5.64

1.6

1.3

1.66

1.49

nmol/l

0.74

108

666

Exclusions for E4_PCOS_CONSORTIUM

418

2024

1.29

5.62

1.5

1.4

1.61

1.46

nmol/l

1.58

367

1837

Other and unspecified tonsillitis

218

1283

1.42

5.60

1.4

1.53

1.41

nmol/l

0.91

204

1153

Cardiomyopathy, other and unspecified

310

1.95

5.59

1.3

1.86

1.39

nmol/l

1.70

278

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

217

1548

1.41

5.50

1.3

1.4

1.63

1.47

nmol/l

1.10

195

1393

Calcific aortic valvular stenosis, diagnosis (helper)

185

1233

1.45

5.50

1.2

1.58

1.47

nmol/l

0.65

175

1105

Operations 2 for CAVS

185

1233

1.45

5.50

1.2

1.58

1.47

nmol/l

0.65

175

1105

Ischaemic Stroke, excluding all haemorrhages

369

2087

1.30

5.50

1.3

1.51

1.44

nmol/l

0.57

334

1896

COPD related to multimorbidity

264

1638

1.37

5.49

1.3

1.53

1.44

nmol/l

0.50

235

1490

Speech and linguistic disorders

239

2.06

5.48

1.5

1.3

1.58

1.39

nmol/l

0.49

211

Calcific aortic valvular stenosis, operated

185

1234

1.45

5.48

1.2

1.58

1.47

nmol/l

0.65

175

1106

Calcific aortic valvular stenosis

185

1234

1.45

5.48

1.2

1.58

1.47

nmol/l

0.65

175

1106

Disorders of psychological development

327

1.88

5.47

1.4

1.68

1.35

nmol/l

1.39

293

Thyroiditis, ILD-related definition

398

1.82

5.45

1.3

1.4

1.39

1.50

nmol/l

0.34

354

Type1 diabetes, definitions combined, early onset

178

2.25

5.43

1.2

1.5

0.62

1.37

nmol/l

4.31

160

Iron deficiency anaemia secondary to blood loss (chronic)

107

661

1.63

5.43

1.3

1.54

1.52

nmol/l

0.05

100

592

Calcific aortic valvular stenosis, including rheumatic fever

185

1236

1.44

5.40

1.2

1.58

1.47

nmol/l

0.66

175

1107

Invasive ventilation

300

1.95

5.40

1.7

1.3

1.10

1.48

nmol/l

2.35

274

Venous thromboembolism

350

2592

1.30

5.39

1.3

1.55

1.45

nmol/l

0.84

318

2339

Other disorders of ear

621

3279

1.23

5.38

1.4

1.3

1.49

1.45

nmol/l

0.37

556

2971

Degeneration of macula and posterior pole

283

1623

1.35

5.38

1.3

1.36

1.52

nmol/l

1.57

249

1483

Transport accidents

314

1976

1.33

5.36

1.4

1.3

1.40

1.47

nmol/l

0.51

283

1792

Eating disorders

315

1.91

5.30

1.5

1.4

1.74

1.40

nmol/l

1.27

289

Other diseases of blood and blood-forming organs, wide

149

998

1.50

5.30

1.3

1.49

1.53

nmol/l

0.20

135

902

Other problems related to primary support group, including family circumstances

341

1.86

5.30

1.4

1.5

1.59

1.39

nmol/l

0.62

310

Hypopituitarism

309

1.93

5.30

1.3

1.4

1.76

1.42

nmol/l

1.15

280

Organic, including symptomatic, mental disorders

329

1759

1.32

5.29

1.2

1.3

1.34

1.50

nmol/l

1.74

296

1589

Superficial injury of thorax

108

674

1.61

5.27

1.6

1.3

1.41

1.54

nmol/l

0.60

609

Superficial injury of hip and thigh

103

635

1.63

5.27

1.2

1.3

1.57

1.52

nmol/l

0.17

569

Cervicalgia

134

882

1.53

5.18

1.4

1.3

1.51

1.46

nmol/l

0.24

127

778

Neoplasms

494

2067

1.26

5.18

1.4

1.3

1.42

1.43

nmol/l

0.06

448

1877

Somatoform disorder

100

615

1.63

5.18

1.6

1.3

1.82

1.49

nmol/l

1.48

558

Lichen simplex chronicus and prurigo

263

2.00

5.18

1.4

1.53

1.43

nmol/l

0.26

235

Soft tissue disorders related to use, overuse and pressure

182

1274

1.43

5.17

1.3

1.54

1.44

nmol/l

0.58

170

1145

Nonorganic sleeping disorders

137

907

1.52

5.16

1.4

1.36

1.46

nmol/l

0.49

128

811

Oxicams

163

623

1.49

5.16

1.2

1.3

1.75

1.42

nmol/l

1.98

148

564

Bacterial pneumonia, not elsewhere classified

240

1542

1.37

5.15

1.3

1.44

1.42

nmol/l

0.07

223

1388

Insomnia

582

3308

1.23

5.14

1.4

1.3

1.50

1.45

nmol/l

0.48

541

2976

Other disorders starting during childhood or adolescence

114

2.54

5.09

1.3

1.66

1.29

nmol/l

0.72

104

Vitamin B12 deficiency anaemia

393

1.79

5.07

1.6

1.3

1.27

1.48

nmol/l

0.81

352

Benign neoplasm: Adrenal gland

350

1.85

5.06

1.5

1.3

1.47

1.49

nmol/l

0.05

320

Transient ischemic attack

330

2018

1.31

5.05

1.3

1.47

1.44

nmol/l

0.14

290

1836

All influenza (not pneumonia)

101

627

1.62

5.05

1.5

1.3

1.60

1.48

nmol/l

0.57

560

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

649

3390

1.21

5.04

1.4

1.50

1.44

nmol/l

0.57

590

3065

Assault

560

1.65

4.99

1.6

1.4

1.20

1.42

nmol/l

1.28

511

Other specified/unspecified arthritis

178

1251

1.43

4.96

1.3

1.69

1.38

nmol/l

3.22

160

1128

Adhesive capsulitis of shoulder

114

732

1.57

4.96

1.4

1.3

1.45

1.50

nmol/l

0.17

658

Gonarthrosis

435

1946

1.27

4.95

1.4

1.3

1.61

1.39

nmol/l

3.52

399

1766

Zoster [herpes zoster], including avohilmo

327

2435

1.30

4.95

1.3

1.55

1.44

nmol/l

1.06

298

2194

Glaucoma

355

2348

1.29

4.93

1.4

1.3

1.36

1.46

nmol/l

1.10

321

2121

ILD medications: azathioprine

570

1.64

4.91

1.4

1.3

1.72

1.43

nmol/l

1.47

500

Monoamine oxidase A inhibitors

434

1.74

4.91

1.3

1.72

1.41

nmol/l

0.90

384

Nail disorders

347

1.83

4.88

1.3

1.4

1.58

1.49

nmol/l

0.22

313

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

962

0.58

4.86

1.2

1.3

1.20

1.45

nmol/l

1.87

875

Paralytic ileus and intestinal obstruction

167

1166

1.44

4.82

1.4

1.3

1.50

1.42

nmol/l

0.35

152

1040

162

963

1.45

4.82

1.3

1.2

1.33

1.55

nmol/l

1.65

147

875

Other disorders of bone

126

833

1.52

4.81

1.6

1.3

1.77

1.47

nmol/l

1.64

115

750

Disorders of synovium and tendon

338

2226

1.29

4.81

1.4

1.3

1.48

1.45

nmol/l

0.26

307

2013

Wet age-related macular degeneration

574

1.62

4.81

1.3

1.2

1.22

1.51

nmol/l

2.37

510

Benign neoplasm of other and unspecified endocrine glands

574

1.63

4.79

1.4

1.3

1.50

1.53

nmol/l

0.12

519

Inflammatory disease of uterus

437

1.72

4.79

1.4

1.5

1.68

1.48

nmol/l

0.97

394

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

156

1065

1.45

4.77

1.5

1.4

1.42

1.51

nmol/l

0.47

135

954

Unspecified jaundice

183

2.15

4.76

1.4

1.2

1.25

1.54

nmol/l

0.96

165

Other orthopaedic follow-up care

230

2.02

4.76

1.3

1.4

1.28

1.44

nmol/l

0.37

203

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

286

1.90

4.73

1.3

1.49

nmol/l

0.00

258

Other respiratory disorders and diseases

130

870

1.50

4.70

1.4

1.3

1.55

1.51

nmol/l

0.14

110

783

Other diseases of the respiratory system

130

870

1.50

4.70

1.4

1.3

1.55

1.51

nmol/l

0.14

110

783

Gonarthrosis [arthrosis of knee](FG)

507

2368

1.23

4.68

1.4

1.3

1.59

1.37

nmol/l

4.26

467

2143

Other CVD

130

871

1.50

4.67

1.5

1.2

1.43

1.51

nmol/l

0.33

118

776

Irritable bowel syndrome

168

1185

1.42

4.62

1.7

1.3

1.51

1.45

nmol/l

0.28

154

1060

Other infectious diseases, including avohilmo

368

1.78

4.62

1.2

1.3

1.53

1.49

nmol/l

0.08

332

Hypotension

114

745

1.54

4.61

1.5

1.3

1.44

1.48

nmol/l

0.13

105

663

Other disorders of penis

480

1.68

4.61

1.3

1.39

1.41

nmol/l

0.06

435

Preterm labour and delivery

134

906

1.48

4.60

1.5

1.4

1.38

1.51

nmol/l

0.86

120

817

Non-ischemic cardiomyopathy

174

975

1.42

4.59

1.2

1.3

1.61

1.40

nmol/l

1.43

154

883

Weight loss

421

1.72

4.58

1.6

1.3

1.31

1.54

nmol/l

1.14

380

Viral hepatitis, including avohilmo

311

1.85

4.57

1.3

1.4

1.45

1.44

nmol/l

0.01

279

Hyperparathyroidism

107

683

1.56

4.57

1.4

1.3

1.56

1.47

nmol/l

0.35

617

Urticaria

181

1297

1.40

4.55

1.6

1.4

1.59

1.48

nmol/l

0.64

161

1157

Menorrhagia

177

693

1.43

4.55

1.4

1.63

1.43

nmol/l

1.60

159

625

Supplementary factors related to causes of morbidity and mortality classified elsewhere

202

1475

1.37

4.55

1.4

1.3

1.55

1.46

nmol/l

0.61

190

1313

Otitis externa, unspecified

467

1.68

4.54

1.5

1.3

1.55

1.46

nmol/l

0.31

429

Functional dyspepsia

164

1157

1.42

4.52

1.3

1.55

1.47

nmol/l

0.41

142

1041

Sequelae of other external causes

221

2.01

4.51

1.5

1.3

1.65

1.43

nmol/l

0.62

197

Other arthritis (FG)

198

1448

1.37

4.43

1.3

1.67

1.37

nmol/l

3.38

178

1304

Disorders of parathyroid gland

118

776

1.51

4.40

1.4

1.3

1.57

1.50

nmol/l

0.31

110

701

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

140

2.25

4.39

1.3

1.58

1.32

nmol/l

0.53

130

Infections with a predominantly sexual mode of transmission

174

1244

1.40

4.39

1.5

1.4

1.28

1.50

nmol/l

1.92

149

1125

Disorders of conjunctiva

525

3352

1.21

4.39

1.4

1.48

1.46

nmol/l

0.15

471

3037

Maternal care for known or suspected abnormality of pelvic organs

124

556

1.51

4.39

1.7

1.4

1.51

1.44

nmol/l

0.27

109

498

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

118

786

1.51

4.38

1.3

1.42

1.52

nmol/l

0.39

109

712

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

107

698

1.54

4.38

1.3

1.40

1.54

nmol/l

0.68

632

Malignant neoplasm of prostate

117

1031

0.67

4.37

1.3

1.50

1.46

nmol/l

0.15

104

946

Bacterial intestinal infections, IBD co-morbidities

118

787

1.51

4.37

1.6

1.3

1.66

1.50

nmol/l

0.66

108

705

Intentional self-harm by sharp object

2.76

4.36

1.2

1.3

1.63

1.40

nmol/l

0.34

Diabetic retinopathy

657

3436

1.19

4.32

1.4

1.3

1.20

1.51

nmol/l

10.70

562

3151

Arthrosis

471

2099

1.23

4.28

1.4

1.3

1.61

1.39

nmol/l

3.42

424

1899

Conductive and sensorineural hearing loss

524

2870

1.21

4.26

1.3

1.50

1.45

nmol/l

0.38

475

2603

Viral hepatitis

304

1.82

4.26

1.3

1.4

1.41

1.46

nmol/l

0.11

272

Azathioprine

593

1.58

4.23

1.4

1.3

1.72

1.43

nmol/l

1.49

523

Abnormal findings on diagnostic imaging of other body structures

100

649

1.55

4.22

1.4

1.3

1.52

1.53

nmol/l

0.00

584

Chronic sinusitis

272

2097

1.30

4.21

1.5

1.3

1.42

1.46

nmol/l

0.23

242

1886

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

431

3050

1.23

4.20

1.4

1.3

1.47

1.45

nmol/l

0.12

388

2760

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

227

1698

1.32

4.03

1.5

1.4

1.57

1.47

nmol/l

0.62

212

1529

Fracture of lumbar spine and pelvis

136

948

1.44

4.00

1.4

1.3

1.27

1.53

nmol/l

1.79

124

849

Diseases of the myoneural junction and muscle

547

1.58

3.99

1.4

1.3

1.66

1.55

nmol/l

0.33

492

Diagnoses used for exclusion with ILD

161

1160

1.39

3.99

1.4

1.3

1.46

1.47

nmol/l

0.03

138

1044

Enlarged lymph nodes

619

1.54

3.96

1.3

1.49

nmol/l

0.01

552

malignant neoplasm of male genital organs

124

1075

0.69

3.92

1.3

1.50

1.46

nmol/l

0.15

109

986

Other diseases of intestine

107

719

1.50

3.87

1.4

1.3

1.43

1.46

nmol/l

0.10

642

Abnormal involuntary movements

567

1.56

3.87

1.5

1.3

1.76

1.52

nmol/l

0.79

518

Artrosis, including avohilmo

543

2480

1.20

3.86

1.4

1.3

1.56

1.41

nmol/l

1.99

487

2243

Other arthrosis

353

1895

1.25

3.86

1.4

1.3

1.57

1.39

nmol/l

1.92

319

1717

Deforming dorsopathies

166

1209

1.38

3.85

1.3

1.50

1.43

nmol/l

0.29

143

1074

Fracture of shoulder and upper arm

220

1671

1.32

3.84

1.4

1.3

1.35

1.43

nmol/l

0.43

208

1497

Sensorineural hearing loss

494

2733

1.21

3.84

1.3

1.48

1.46

nmol/l

0.17

447

2474

Cerebral palsy and other paralytic syndromes

451

1.63

3.83

1.4

1.3

1.36

1.50

nmol/l

0.49

411

Epilepsy

168

1225

1.37

3.81

1.4

1.3

1.51

1.36

nmol/l

0.95

150

1098

Malignant neoplasm of prostate, including Hilmo

125

1053

0.70

3.78

1.3

1.41

1.46

nmol/l

0.21

111

967

Need for other prophylactic measures

237

1.87

3.74

1.3

1.31

1.40

nmol/l

0.14

211

Other inflammatory liver diseases

259

1.83

3.72

1.8

1.4

1.24

1.48

nmol/l

1.01

232

Atopic dermatitis, strict definition with reimbursement

167

1179

1.36

3.67

1.4

1.50

1.45

nmol/l

0.22

154

1063

Conjunctivitis

463

3098

1.20

3.65

1.4

1.45

1.46

nmol/l

0.03

414

2802

Acute and transient psychotic disorders

481

1.59

3.64

1.3

1.4

1.58

1.44

nmol/l

0.54

429

Other chronic obstructive pulmonary disease

268

1722

1.28

3.61

1.4

1.3

1.52

1.40

nmol/l

0.93

236

1566

Somnolence, stupor and coma

163

2.04

3.61

1.2

1.3

1.35

1.43

nmol/l

0.16

145

Dilated cardiomyopathy

562

1.54

3.59

1.3

1.86

1.49

nmol/l

1.67

497

Malignant neoplasm, including Hilmo

574

2826

1.18

3.59

1.3

1.4

1.52

1.46

nmol/l

0.55

519

2566

Pain in thoracic spine

626

1.51

3.58

1.3

1.77

1.44

nmol/l

1.83

555

Spondyloarthritis

108

740

1.46

3.57

1.5

1.3

1.59

1.49

nmol/l

0.42

663

Persons encountering health services in circumstances related to reproduction

246

2107

0.78

3.57

1.4

1.43

1.46

nmol/l

0.21

231

1895

Acne

320

1.72

3.56

1.8

1.5

1.14

1.37

nmol/l

1.07

298

Acute suppurative otitis media

149

1007

1.38

3.56

1.4

1.38

1.45

nmol/l

0.33

130

918

Persons with potential health hazards related to communicable diseases

210

1593

1.31

3.53

1.5

1.4

1.47

1.48

nmol/l

0.02

188

1435

Other viral diseases

172

1276

1.35

3.52

1.5

1.4

1.43

1.47

nmol/l

0.16

153

1148

Diseases of salivary glands

202

1540

1.32

3.52

1.4

1.76

1.48

nmol/l

2.41

186

1385

Restless leg syndrome

597

1.51

3.51

1.5

1.3

1.44

1.51

nmol/l

0.22

541

Benign neoplasm: Parotid gland

339

1.69

3.50

1.3

1.77

1.49

nmol/l

0.76

303

Valvular heart disease excluding rheumatic fever

285

1613

1.26

3.49

1.3

1.54

1.39

nmol/l

1.45

255

1462

Diaphragmatic hernia

218

1681

1.30

3.49

1.5

1.3

1.34

1.47

nmol/l

0.95

198

1512

Medical abortion

307

1322

1.26

3.48

1.3

1.4

1.38

1.53

nmol/l

1.62

274

1198

Pulmonary heart disease, diseases of pulmonary circulation

189

1431

1.32

3.46

1.3

1.72

1.45

nmol/l

2.04

165

1293

DVT of lower extremities and pulmonary embolism

249

1947

1.28

3.45

1.3

1.66

1.45

nmol/l

1.99

224

1757

Alzheimer disease, excluding more controls

408

1.51

3.44

1.2

1.15

1.48

nmol/l

3.11

373

Sarcoidosis

600

1.51

3.44

1.3

1.62

1.51

nmol/l

0.38

542

Ovarian cyst

172

726

1.36

3.43

1.5

1.4

1.43

nmol/l

0.01

154

654

Spondylolisthesis/Spondylolysis

114

797

1.44

3.42

1.3

1.51

1.46

nmol/l

0.15

710

COPD

278

1794

1.26

3.41

1.4

1.3

1.51

1.39

nmol/l

0.93

245

1629

Ulcerative colitis, NAS

594

1.51

3.38

1.4

1.3

1.65

1.45

nmol/l

0.76

535

Fibroblastic disorders

142

1034

1.38

3.37

1.4

1.3

1.28

1.47

nmol/l

1.33

128

931

malignant neoplasm of male genital organs, including Hilmo

132

1097

0.72

3.37

1.3

1.39

1.46

nmol/l

0.35

116

1008

Salpingitis and oophoritis

619

1.49

3.36

1.4

1.62

1.45

nmol/l

0.69

561

Fitting and adjustment of other devices

216

1470

1.30

3.36

1.2

1.3

1.65

1.44

nmol/l

1.40

195

1333

Exposure to other specified factors

515

3744

1.18

3.36

1.5

1.3

1.45

nmol/l

0.04

467

3390

COPD (mode)

189

1117

1.32

3.34

1.4

1.3

1.50

1.42

nmol/l

0.36

163

1013

Zoster [herpes zoster]

114

801

1.43

3.34

1.4

1.3

1.59

1.46

nmol/l

0.69

109

714

Allergic urticaria

291

1.73

3.33

1.7

1.3

2.03

1.47

nmol/l

2.05

261

Other viral diseases, including avohilmo

223

1719

1.29

3.33

1.5

1.4

1.42

1.49

nmol/l

0.40

201

1549

Type of accident

181

1371

1.32

3.33

1.4

1.3

1.57

1.46

nmol/l

0.71

169

1225

Non-rheumatic valve diseases

282

1604

1.26

3.32

1.3

1.54

1.39

nmol/l

1.45

252

1454

Car occupant injured in other and unspecified transport accidents

111

777

1.43

3.32

1.5

1.4

1.44

1.49

nmol/l

0.16

697

Malignant neoplasm, wide definition

571

2830

1.18

3.31

1.4

1.51

1.46

nmol/l

0.44

515

2571

Visual field defects

337

1.67

3.31

1.3

1.40

1.51

nmol/l

0.32

309

Pilonidal cyst

322

1.69

3.30

1.5

1.3

1.39

1.36

nmol/l

0.07

295

Biological medication for rheuma

106

737

1.44

3.29

1.5

1.4

1.60

1.45

nmol/l

0.75

669

Coagulation defects, purpura and other haemorrhagic conditions

117

829

1.42

3.27

1.3

1.50

1.51

nmol/l

0.01

107

743

Benign neoplasm: salivary glands, exclude unknown (D119)

377

1.63

3.26

1.3

1.80

1.50

nmol/l

0.91

339

Injuries to the wrist and hand

649

3713

1.16

3.24

1.4

1.3

1.40

1.47

nmol/l

0.85

584

3367

Enterocolitis due to Clostridium difficile

440

1.58

3.24

1.6

1.3

1.53

1.52

nmol/l

0.03

396

Other condition

633

1.48

3.23

1.2

1.3

1.41

1.50

nmol/l

0.36

577

Benign neoplasm of major salivary glands

417

1.59

3.23

1.3

1.85

1.55

nmol/l

0.99

376

Diabetic retinopathy, strict definition

325

2360

1.23

3.22

1.4

1.3

1.08

1.51

nmol/l

11.72

259

2156

Sequelae of cerebrovascular disease

217

1443

1.29

3.20

1.3

1.40

1.45

nmol/l

0.33

202

1308

Mouth breathing

259

2067

1.25

3.15

1.3

1.69

1.43

nmol/l

2.15

232

1862

Other spirochaetal diseases

123

1689

0.73

3.15

1.4

1.3

1.38

1.49

nmol/l

0.39

102

1522

Benign neoplasm of mouth and pharynx

460

1.55

3.13

1.4

1.3

1.52

1.54

nmol/l

0.04

414

Iridocyclitis

139

1024

1.36

3.11

1.5

1.3

1.32

1.49

nmol/l

1.22

126

920

Other systemic involvement of connective tissue (FG)

143

1038

1.36

3.10

1.5

1.3

1.73

1.40

nmol/l

2.29

134

927

Coxibs

168

658

1.34

3.10

1.4

1.3

1.63

1.42

nmol/l

1.24

149

597

Subjective visual disturbances

150

1120

1.34

3.07

1.3

1.58

1.49

nmol/l

0.35

136

1017

L04AX Other immunosuppressants

344

2839

1.21

3.07

1.4

1.3

1.60

1.45

nmol/l

1.68

310

2559

Solid cancers, including Hilmo

560

2796

1.17

3.04

1.3

1.4

1.52

1.46

nmol/l

0.54

503

2542

Stomatitis and related lesions

118

850

1.39

3.03

1.5

1.3

1.47

1.48

nmol/l

0.05

109

761

Gingival hyperplasia

133

2.05

3.02

1.1

1.2

1.89

1.52

nmol/l

0.72

116

Superficial injury of abdomen, lower back and pelvis

659

1.45

3.02

1.7

1.3

1.24

1.51

nmol/l

1.70

595

Spontaneous abortion

220

1155

1.28

2.99

1.5

1.4

1.49

1.53

nmol/l

0.19

199

1045

Lyme disease

123

1672

0.73

2.97

1.4

1.3

1.38

1.49

nmol/l

0.41

102

1507

Lyme disease, including avohilmo

123

1672

0.73

2.97

1.4

1.3

1.38

1.49

nmol/l

0.41

102

1507

Oter anti-inflammatory and antirheumatic agents, non-steroids

145

587

1.36

2.96

1.4

1.3

1.64

1.42

nmol/l

1.33

129

534

Other spirochaetal diseases, including avohilmo

127

1715

0.74

2.94

1.4

1.3

1.40

1.48

nmol/l

0.27

106

1547

Disturbances of skin sensation

164

1250

1.32

2.93

1.4

1.35

1.51

nmol/l

1.07

154

1130

Other extrapyramidal and movement disorders in other diseases

150

1129

1.33

2.93

1.4

1.3

1.50

1.48

nmol/l

0.07

139

1013

Rash and other nonspecific skin eruption

357

1.60

2.92

1.2

1.3

1.63

1.52

nmol/l

0.21

323

Maternal care for known or suspected malpresentation of fetus

393

1.49

2.91

1.8

1.4

1.27

1.48

nmol/l

1.17

353

Spirochaetal infections, other/unspecified, including avohilmo

125

1687

0.74

2.89

1.4

1.3

1.38

1.49

nmol/l

0.41

104

1520

Pneumonia derived septicemia

115

2.11

2.89

1.3

1.2

1.43

1.56

nmol/l

0.19

104

Appendicitis, broad definition

466

3564

1.17

2.89

1.4

1.49

1.45

nmol/l

0.37

425

3222

Unspecified fall

308

2486

1.22

2.89

1.3

1.43

1.44

nmol/l

0.04

279

2248

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

289

1.67

2.88

1.2

1.3

1.50

1.52

nmol/l

0.03

261

Diplopia

567

1.47

2.88

1.6

1.3

1.74

1.55

nmol/l

0.52

513

Symptoms and signs involving the skin and subcutaneous tissue

445

3572

1.18

2.88

1.3

1.4

1.49

1.46

nmol/l

0.20

406

3232

Infections with a predominantly sexual mode of transmission, including avohilmo

215

1556

1.27

2.85

1.5

1.4

1.27

1.50

nmol/l

2.63

184

1417

235

1690

1.25

2.85

1.3

1.41

1.48

nmol/l

0.45

208

1531

Acute and subacute iridocyclitis

115

835

1.38

2.85

1.5

1.3

1.32

1.49

nmol/l

1.09

104

746

Other symptoms and signs involving the urinary system

471

1.52

2.84

1.2

1.3

1.41

1.49

nmol/l

0.22

420

Diseases of appendix

468

3573

1.17

2.84

1.4

1.49

1.45

nmol/l

0.34

427

3229

Second line medication for Crohn's disease

352

2935

1.20

2.84

1.4

1.3

1.60

1.45

nmol/l

1.72

318

2648

Other disorders of nervous system

283

1.67

2.83

1.6

1.3

1.07

1.49

nmol/l

2.31

262

Suggestive for eosinophilic asthma

392

1.56

2.82

1.5

1.3

1.27

1.47

nmol/l

0.71

355

Gonarthrosis,primary

576

3005

1.16

2.81

1.4

1.3

1.63

1.43

nmol/l

3.75

526

2718

Other infectious diseases

307

1.64

2.79

1.1

1.3

1.65

1.47

nmol/l

0.43

275

Other diseases of anus and rectum

179

1387

1.29

2.77

1.3

1.51

1.42

nmol/l

0.47

158

1245

Acute generalized exanthematous pustulosis

159

1.90

2.76

1.4

1.53

1.41

nmol/l

0.20

141

Panniculitis affecting regions of neck and back

138

1.97

2.76

1.5

1.3

1.55

1.35

nmol/l

0.39

124

Benign paroxysmal vertigo

172

1333

1.29

2.75

1.4

1.3

1.55

1.49

nmol/l

0.34

159

1197

Other contact dermatitis

293

1.65

2.74

1.3

1.4

1.42

nmol/l

0.01

263

Abnormal results of function studies

387

1.56

2.74

1.4

1.50

1.53

nmol/l

0.06

347

D07AA Corticosteroids, weak (group I)

564

1.46

2.73

1.5

1.4

1.67

1.44

nmol/l

1.03

510

Intestinal stricture

185

1449

1.28

2.72

1.5

1.3

1.47

1.46

nmol/l

0.04

168

1300

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

616

1.43

2.70

1.5

1.67

1.52

nmol/l

0.52

557

Arthropathic psoriasis

485

1.49

2.70

1.4

1.72

1.47

nmol/l

0.82

442

Thyrotoxicosis, other and/or unspecified

108

784

1.38

2.70

1.4

1.52

1.47

nmol/l

0.15

710

Other joint disorders

528

2371

1.16

2.70

1.4

1.3

1.59

1.39

nmol/l

3.00

472

2155

Pulmonary heart disease

170

1319

1.29

2.70

1.3

1.73

1.44

nmol/l

2.17

151

1196

Myocardial infarction, unclassifiable

122

805

1.36

2.69

1.2

1.53

1.45

nmol/l

0.28

106

723

Contusion of toe(s) without damage to nail

2.19

2.68

1.5

1.3

1.06

1.56

nmol/l

1.57

Pulmonary embolism

170

1322

1.29

2.65

1.3

1.73

1.44

nmol/l

2.15

151

1199

Other symptoms and signs involving the circulatory and respiratory systems

250

1.69

2.65

1.3

1.98

1.41

nmol/l

1.55

226

Other acute viral hepatitis

2.70

2.64

1.3

1.2

1.13

1.53

nmol/l

0.64

Arthropod-borne viral fevers and viral haemorrhagic fevers

431

1.52

2.64

1.4

1.3

1.52

nmol/l

0.02

389

Coxarthrosis

319

1708

1.21

2.62

1.4

1.3

1.61

1.37

nmol/l

3.08

285

1546

Injuries to the hip and thigh

288

2131

1.21

2.62

1.4

1.3

1.49

1.44

nmol/l

0.34

259

1923

Orthopaedic devices associated with adverse incidents

0.00

2.61

0.0

1.2

—

1.48

—

Other viral diseases, not elsewhere classified, including avohilmo

152

1161

1.30

2.60

1.5

1.4

1.37

1.45

nmol/l

0.38

139

1035

Dementia, including avohilmo

261

1453

1.23

2.56

1.3

1.24

1.51

nmol/l

4.73

233

1307

Adalimumab

394

1.53

2.55

1.8

1.4

1.69

1.49

nmol/l

0.72

357

Impotence

292

1.62

2.54

1.4

1.3

1.34

1.55

nmol/l

0.59

267

Other/unspecified enthesopathies, not elsewhere classified

331

1.58

2.54

1.4

1.3

1.49

1.50

nmol/l

0.01

301

Other psoriatic arthropathies

444

1.49

2.52

1.4

1.66

1.48

nmol/l

0.50

404

Pneumococcal septicemia

122

1.98

2.51

1.3

1.43

1.56

nmol/l

0.18

109

Artificial opening status

217

1.72

2.49

1.1

1.3

1.58

1.48

nmol/l

0.15

190

Anterior Iridocyclitis

120

899

1.34

2.49

1.5

1.3

1.30

1.50

nmol/l

1.35

108

803

Hyperkinetic disorders

418

1.50

2.48

1.6

1.5

1.70

1.34

nmol/l

1.57

377

Disorders of eyelid, lacrimal system and orbit

537

3430

1.15

2.47

1.4

1.3

1.47

1.45

nmol/l

0.16

490

3101

Benign neoplasm: Rectum, anus and anal canal

123

926

1.33

2.47

1.4

1.3

1.56

1.49

nmol/l

0.21

110

831

Psoriatic and enteropathic arthropathies

512

1.45

2.46

1.4

1.3

1.63

1.44

nmol/l

0.61

464

Appendectomy

390

3170

1.17

2.45

1.5

1.4

1.49

1.45

nmol/l

0.28

353

2861

Enthesopathies of lower limb, excluding foot

135

1032

1.31

2.44

1.4

1.3

1.56

1.44

nmol/l

0.60

122

911

Strabismus

147

1134

1.30

2.43

1.4

1.56

1.47

nmol/l

0.35

130

1019

Cardiac murmurs and other cardiac sounds

292

1.60

2.42

1.3

1.44

1.42

nmol/l

0.05

267

Schizotypal disorder

2.19

2.42

1.2

1.57

1.31

nmol/l

0.58

Pericarditis

138

1.90

2.42

1.2

1.3

1.57

1.35

nmol/l

0.46

122

Inflammatory bowel disease

185

1475

1.26

2.40

1.5

1.4

1.45

1.48

nmol/l

0.11

166

1318

Lateral epicondylitis

556

1.43

2.40

1.6

1.3

1.46

1.48

nmol/l

0.05

502

Superficial injury of wrist and hand

121

913

1.33

2.40

1.4

1.3

1.55

1.45

nmol/l

0.43

113

828

Herpesviral [herpes simplex] infections

482

1.46

2.39

1.3

1.40

1.50

nmol/l

0.38

438

Ulcerative colitis

143

1107

1.30

2.36

1.5

1.3

1.48

nmol/l

0.02

127

992

Coxarthrosis [arthrosis of hip](FG)

342

1989

1.18

2.36

1.4

1.3

1.62

1.35

nmol/l

4.38

306

1805

Atopic dermatitis, strict definition

155

1185

1.28

2.36

1.4

1.54

1.47

nmol/l

0.36

143

1071

Systemic connective tissue disorders

190

1524

1.25

2.35

1.4

1.3

1.73

1.48

nmol/l

1.86

174

1366

Methotrexate

542

1.43

2.35

1.4

1.3

1.68

1.47

nmol/l

0.90

484

Injuries to the neck

136

1048

1.30

2.33

1.5

1.3

1.43

1.49

nmol/l

0.17

125

941

Psoriatic arthropathies

452

1.47

2.33

1.4

1.3

1.66

1.48

nmol/l

0.53

412

Scabies, including avohilmo

593

1.40

2.33

1.3

1.4

1.51

1.43

nmol/l

0.16

532

Retinal detachments and breaks

197

1591

1.24

2.30

1.3

1.46

1.50

nmol/l

0.16

179

1454

Radial styloid tenosynovitis [de Quervain]

192

1.73

2.30

1.5

1.3

1.85

1.41

nmol/l

1.03

179

Other or unspecified ileus, impaction or obstruction

108

807

1.34

2.30

1.4

1.3

1.51

1.44

nmol/l

0.25

720

Other and unspecified visual disturbances

437

1.47

2.30

1.4

1.44

1.55

nmol/l

0.32

401

Other articular cartilage disorders

2.14

2.30

2.0

1.2

1.90

1.62

nmol/l

0.29

Acute appendicitis

431

3462

1.16

2.29

1.5

1.4

1.49

1.45

nmol/l

0.33

393

3134

Other symptoms and signs involving the digestive system and abdomen

595

1.40

2.29

1.4

1.3

1.54

1.45

nmol/l

0.30

530

Dislocation, sprain and strain of joints and ligaments at neck level

629

1.39

2.28

1.6

1.4

1.48

1.46

nmol/l

0.04

569

Benign neoplasm: Duodenum

2.09

2.28

1.6

1.1

1.46

1.62

nmol/l

0.25

Fall on same level involving ice and snow

346

2949

1.17

2.27

1.4

1.46

1.44

nmol/l

0.08

313

2654

Benign neoplasm: Sigmoid colon

118

896

1.32

2.26

1.4

1.3

1.55

1.53

nmol/l

0.10

111

801

Suppurative and unspecified otitis media

195

1394

1.24

2.25

1.4

1.43

1.46

nmol/l

0.13

167

1267

Follicular cysts of skin and subcutaneous tissue

112

845

1.33

2.25

1.3

1.59

1.47

nmol/l

0.43

760

Psoriatic arthropathies, ICD10

456

1.45

2.24

1.4

1.66

1.48

nmol/l

0.54

414

Other viral diseases, not elsewhere classified

104

774

1.34

2.24

1.6

1.3

1.38

1.47

nmol/l

0.28

701

Other disorders of lacrimal gland

208

1697

1.23

2.22

1.4

1.3

1.51

1.49

nmol/l

0.13

185

1521

Excessive attrition of teeth

370

3145

1.17

2.22

1.4

1.40

1.46

nmol/l

0.63

342

2839

Glomerulonephritis

416

1.47

2.22

1.4

1.3

1.52

1.49

nmol/l

0.05

373

Nonischemic cardiomyopathy

367

1.50

2.21

1.2

1.3

1.81

1.42

nmol/l

1.21

335

Actinic keratosis

209

1551

1.23

2.20

1.3

1.43

1.49

nmol/l

0.36

184

1404

Viral warts

384

1.49

2.20

1.4

1.3

1.75

1.46

nmol/l

0.89

344

Benign neoplasm: Stomach

393

1.48

2.18

1.3

1.59

1.56

nmol/l

0.11

356

Polypectomy (DHB20)

305

1.55

2.16

1.4

1.3

1.38

1.46

nmol/l

0.20

281

Polyarthrosis

118

811

1.31

2.16

1.4

1.3

1.76

1.43

nmol/l

2.32

112

733

Pediculosis, acariasis and other infestations, including avohilmo

730

1.35

2.15

1.3

1.4

1.48

1.47

nmol/l

0.03

659

Disturbance of activity and attention

384

1.48

2.15

1.7

1.5

1.67

1.34

nmol/l

1.20

351

Other chronic obstructive pulmonary disease, including avohilmo

332

2324

1.17

2.15

1.3

1.56

1.42

nmol/l

1.21

296

2111

Reimbursement for rheumatic diseases

325

2754

1.17

2.15

1.4

1.3

1.57

1.45

nmol/l

1.18

293

2481

Superficial injury of shoulder and upper arm

502

1.42

2.14

1.3

1.90

1.49

nmol/l

1.47

451

Other skin changes

115

879

1.31

2.13

1.2

1.3

1.66

1.50

nmol/l

0.82

106

786

Rheumatoid arthritis

178

1269

1.24

2.13

1.4

1.3

1.55

1.40

nmol/l

0.92

162

1148

Non-allergic asthma

330

1.52

2.13

1.5

1.3

1.44

1.45

nmol/l

0.03

301

Disorders of vestibular function (Vertigo)

268

2193

1.19

2.11

1.4

1.3

1.51

1.47

nmol/l

0.26

243

1974

Impingement syndrome of shoulder

144

1135

1.27

2.11

1.5

1.3

1.65

1.43

nmol/l

1.37

128

1027

Seronegative rheumatoid arthritis

462

1.43

2.11

1.5

1.3

1.66

1.40

nmol/l

0.87

420

Adjustment and management of implanted device

742

1.34

2.10

1.4

1.3

1.40

1.47

nmol/l

0.31

663

Other disorders of eyelid

254

2005

1.20

2.10

1.4

1.3

1.48

1.47

nmol/l

0.04

243

1802

Dermatopolymyositis (FG)

2.59

2.09

1.9

1.2

2.04

1.28

nmol/l

1.92

Poor fetal growth

356

1.49

2.09

1.5

1.6

1.61

1.44

nmol/l

0.54

320

Acute gastritis

284

1.56

2.08

1.5

1.3

1.57

1.51

nmol/l

0.12

254

Donors of organs and tissues

0.00

2.07

0.0

1.2

—

1.41

—

Alzheimer’s disease (Late onset), excluding more controls

319

1.43

2.07

1.2

1.15

1.49

nmol/l

2.83

292

Benign neoplasm of ovary

599

1.37

2.06

1.3

1.4

1.82

1.42

nmol/l

1.82

541

Plantar fascial fibromatosis

382

1.47

2.05

1.4

1.3

1.51

1.46

nmol/l

0.10

349

False labour

124

592

1.30

2.05

1.4

1.58

1.43

nmol/l

0.77

117

537

Nontoxic multinodular goitre

686

1.34

2.03

1.4

1.3

1.42

nmol/l

0.00

628

Coeliac disease

449

1.43

2.03

1.5

1.3

1.35

1.51

nmol/l

0.58

405

Other maltreatment syndromes

125

1.86

2.03

1.3

0.94

1.43

nmol/l

1.81

113

Previous suicide attempt

2.67

2.01

1.4

1.3

1.85

1.50

nmol/l

—

Malignant neoplasm

538

2788

1.13

2.00

1.3

1.4

1.52

1.46

nmol/l

0.59

484

2534

Meniscus derangement

344

1962

1.16

1.99

1.5

1.3

1.56

1.39

nmol/l

2.13

312

1779

Skin changes due to chronic exposure to nonionizing radiation

213

1596

1.21

1.98

1.3

1.43

1.48

nmol/l

0.32

188

1443

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

179

1459

1.23

1.97

1.6

1.3

1.44

1.42

nmol/l

0.04

165

1304

Purpura and other haemorrhagic conditions

587

1.37

1.97

1.3

1.56

1.53

nmol/l

0.07

528

Other disorders of conjunctiva

613

1.36

1.96

1.3

1.56

1.49

nmol/l

0.21

550

Procreative management

125

1309

0.78

1.96

1.3

1.4

1.42

1.48

nmol/l

0.21

112

1175

L01XX Other antineoplastic agents

243

0.45

1.96

1.4

1.2

1.30

1.48

nmol/l

0.21

216

Female infertility

133

623

1.28

1.96

1.6

1.4

1.58

1.43

nmol/l

0.81

122

563

Other respiratory diseases principally affecting the interstitium

104

795

1.31

1.95

1.4

1.3

1.55

1.47

nmol/l

0.29

707

L02BB Anti-androgens

399

0.57

1.94

1.0

1.2

1.56

1.49

nmol/l

0.13

357

Hypermobility syndrome

157

1.73

1.92

1.9

1.5

2.09

1.44

nmol/l

1.48

140

Fissure and fistula of anal and rectal regions

142

1132

1.26

1.92

1.3

1.56

1.44

nmol/l

0.58

128

1006

Other menopausal disorders

584

0.73

1.92

1.8

1.4

1.38

1.43

nmol/l

0.19

524

Thyrotoxicosis

132

1044

1.27

1.91

1.3

1.54

1.51

nmol/l

0.12

116

937

Benign neoplasm of bone and articular cartilage

331

1.49

1.91

1.3

1.4

1.85

1.47

nmol/l

1.18

296

Dementia

237

1356

1.20

1.91

1.2

1.3

1.23

1.51

nmol/l

4.21

211

1214

Other arrhythmias

367

2379

1.15

1.90

1.5

1.4

1.59

1.41

nmol/l

2.03

339

2144

Maternal care for known or suspected fetal abnormality and damage

385

1.41

1.88

1.3

1.4

1.38

1.49

nmol/l

0.33

348

Other noninflammatory disorders of uterus, except cervix

104

530

1.31

1.87

1.4

1.3

1.55

1.42

nmol/l

0.65

477

Inflammatory diseases of the central nervous system

341

1.47

1.86

1.3

1.4

1.21

1.46

nmol/l

1.15

309

Malignant neoplasm of liver and intrahepatic bile ducts

129

1.80

1.86

1.2

2.19

1.48

nmol/l

1.41

113

Benign neoplasm: Colon, unspecified

150

1209

1.24

1.86

1.4

1.3

1.40

1.47

nmol/l

0.34

133

1085

Congenital deformities of feet, including avohilmo

129

1.79

1.86

1.3

1.4

1.56

1.39

nmol/l

0.28

117

Other systemic involvement of connective tissue

145

1165

1.25

1.85

1.5

1.3

1.72

1.47

nmol/l

1.53

136

1050

Fall on and from stairs and steps

148

1192

1.24

1.85

1.4

1.3

1.36

1.49

nmol/l

0.62

130

1071

Tumor necrosis factor alpha inhibitors

663

1.33

1.85

1.6

1.4

1.57

1.45

nmol/l

0.51

602

Malignant neoplasm

534

2785

1.12

1.82

1.3

1.4

1.52

1.46

nmol/l

0.56

480

2531

Hypertrophy of breast in women and men

761

1.30

1.81

1.6

1.4

1.62

1.50

nmol/l

0.62

677

Chronic rhinitis, nasopharyngitis and pharyngitis

187

1547

1.21

1.81

1.3

1.51

1.47

nmol/l

0.25

165

1390

Volvulus

1.93

1.80

1.3

1.1

1.26

1.62

nmol/l

0.74

Congenital deformities of feet

2.02

1.80

1.3

1.52

1.31

nmol/l

0.28

Otalgia

319

1.48

1.80

1.8

1.4

1.35

1.51

nmol/l

0.60

287

COPD, early/later onset

269

1926

1.17

1.80

1.4

1.3

1.52

1.44

nmol/l

0.55

237

1744

ILD, hospital admission 2, with pulmonary infections

402

1.42

1.80

1.4

1.3

1.58

1.48

nmol/l

0.26

359

Dermatopolymyositis

2.37

1.78

1.9

1.1

2.04

1.44

nmol/l

1.39

COPD, hospital admissions

265

1904

1.17

1.78

1.4

1.3

1.53

1.44

nmol/l

0.60

234

1728

Early lumbar disc prolapse, operated

386

1.43

1.78

1.6

1.4

1.62

1.36

nmol/l

0.77

352

Migraine without aura and triptan purchases

598

1.34

1.78

1.5

1.53

1.49

nmol/l

0.12

527

Benign neoplasm: Rectum

108

843

1.28

1.77

1.4

1.3

1.57

1.52

nmol/l

0.16

759

Conductive hearing loss, unspecified

337

1.46

1.77

1.1

1.4

1.50

1.49

nmol/l

0.02

303

Transient global amnesia

375

0.58

1.77

1.2

1.3

1.32

1.57

nmol/l

0.91

335

Ocular pain

330

1.46

1.74

1.6

1.4

1.38

1.44

nmol/l

0.17

296

Foreign body in alimentary tract

194

1.61

1.71

1.5

1.4

1.66

1.43

nmol/l

0.58

175

COPD, hospital admission 2, with asthma infections

183

1308

1.21

1.70

1.4

1.3

1.51

1.46

nmol/l

0.24

161

1183

Acetic acid derivatives and related substances

156

654

1.23

1.68

1.4

1.3

1.60

1.43

nmol/l

0.90

141

593

Otitis media, unspecified

344

1.42

1.67

1.3

1.53

1.40

nmol/l

0.33

317

Orchitis and epididymitis

442

1.39

1.67

1.4

1.3

1.41

1.43

nmol/l

0.05

401

Extrapyramidal and movement disorders

218

1846

1.18

1.67

1.3

1.63

1.45

nmol/l

1.22

201

1658

Inguinal hernia

288

2211

0.86

1.66

1.4

1.3

1.36

1.44

nmol/l

0.70

252

2002

Seropositive rheumatoid arthritis

132

1059

1.24

1.66

1.4

1.3

1.60

1.39

nmol/l

1.20

120

951

Other/unspecified synovitis and tenosynovitis

452

1.38

1.64

1.4

1.3

1.49

1.52

nmol/l

0.04

408

IgA nephropathy (IgA glomerulonephritis)

1.85

1.62

1.4

1.2

1.32

1.58

nmol/l

0.38

Any event in cancer register

572

3010

1.11

1.62

1.3

1.4

1.55

1.45

nmol/l

1.20

516

2730

723

1.28

1.60

1.3

1.2

1.43

1.51

nmol/l

0.26

651

Other and unspecified myopathies

387

1.40

1.59

1.3

1.50

1.49

nmol/l

0.02

351

Granuloma annulare

2.35

1.59

1.1

1.23

1.20

nmol/l

—

Pregnancy with abortive outcome

297

1339

1.16

1.58

1.5

1.4

1.34

1.53

nmol/l

2.62

265

1213

Other hearing loss

149

1187

1.22

1.57

1.4

1.3

1.53

1.48

nmol/l

0.21

136

1070

Toxic effect of contact with venomous animals

160

1.63

1.56

1.5

1.4

1.19

1.43

nmol/l

0.65

146

Acute appendicitis, no complications

330

2885

1.14

1.54

1.5

1.4

1.46

1.45

nmol/l

0.06

303

2599

Premature rupture of membranes

471

1.30

1.53

1.6

1.4

1.49

1.47

nmol/l

0.05

424

Unspecified haematuria

250

1756

1.16

1.51

1.2

1.3

1.53

1.42

nmol/l

0.78

223

1591

Other and unspecified rosacea

366

1.40

1.51

1.4

1.85

1.47

nmol/l

1.29

336

Other embolism and thrombosis

546

1.32

1.50

1.2

1.3

1.45

1.52

nmol/l

0.25

489

Primary gonarthrosis, bilateral

310

2275

1.14

1.50

1.4

1.3

1.76

1.42

nmol/l

5.20

276

2057

Any dementia, excluding more controls

182

1049

1.19

1.49

1.2

1.3

1.15

1.48

nmol/l

5.11

162

943

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

657

1.29

1.49

1.3

1.48

1.51

nmol/l

0.08

596

Solid cancers

518

2739

1.11

1.48

1.3

1.4

1.53

1.46

nmol/l

0.63

466

2489

Lichen planus

532

1.32

1.45

1.2

1.3

1.53

1.51

nmol/l

0.05

482

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

403

1.37

1.45

1.5

1.3

1.32

1.51

nmol/l

0.65

363

Later onset COPD

102

1022

0.80

1.45

1.2

1.66

1.46

nmol/l

0.86

923

Lichen ruber planus, wide definition including periferal and oral lichen planus

128

1048

1.22

1.45

1.2

1.3

1.66

1.50

nmol/l

0.82

111

945

Anogenital herpesviral [herpes simplex] infection, including avohilmo

369

1.39

1.44

1.5

1.46

nmol/l

0.02

332

Other disorders of eye and adnexa

559

1.31

1.44

1.4

1.3

1.55

1.51

nmol/l

0.11

509

Burns classified according to extent of body surface involved

2.34

1.44

1.2

1.20

1.69

nmol/l

—

Secondary parkinsonism, excluding more controls

1.98

1.43

1.2

2.33

1.54

nmol/l

0.54

Ulcerative colitis (strict definition, require KELA)

718

1.27

1.43

1.4

1.3

1.55

1.48

nmol/l

0.23

645

Hallux valgus (acquired)

121

1059

0.82

1.42

1.4

1.3

1.37

1.43

nmol/l

0.30

110

958

Sequelae of injuries of lower limb

396

1.37

1.42

1.4

1.28

1.46

nmol/l

0.62

356

Macular pucker

648

1.28

1.42

1.3

1.2

1.45

1.61

nmol/l

0.59

582

Other diseases of pleura

255

1926

1.15

1.42

1.4

1.3

1.46

1.43

nmol/l

0.14

227

1751

Other (seronegative) rheumatoid arthritis, wide

790

1.26

1.42

1.4

1.3

1.60

1.51

nmol/l

0.31

710

Benign thyroid growths and nodules

159

1237

1.20

1.42

1.4

1.3

1.42

1.46

nmol/l

0.19

143

1122

Neuromuscular dysfunction of bladder

388

1.37

1.41

1.3

1.23

1.56

nmol/l

1.47

353

Peritonsillar abscess

120

980

1.23

1.40

1.5

1.4

1.44

1.47

nmol/l

0.08

107

884

LeFortI or BSSO operation

138

0.43

1.40

1.5

1.89

1.34

nmol/l

—

127

Other and unspecified disorders of vitreous body

238

2018

1.15

1.39

1.4

1.3

1.65

1.45

nmol/l

1.54

220

1815

Phlebitis and thrombophlebitis (not including DVT)

128

1053

1.22

1.39

1.4

1.3

1.50

1.48

nmol/l

0.05

119

949

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

288

2423

1.14

1.39

1.4

1.46

1.48

nmol/l

0.12

253

2193

Colectomy operation

748

1.26

1.39

1.3

1.19

1.55

nmol/l

3.09

665

Chromosomal abnormalities, not elsewhere classified

1.95

1.38

1.4

1.73

1.46

nmol/l

0.36

Other inflammation of eyelid

610

1.28

1.33

1.4

1.3

1.72

1.49

nmol/l

0.75

551

Burns and corrosions of multiple and unspecified body regions

1.79

1.33

1.5

1.3

1.14

1.51

nmol/l

0.94

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

690

1.26

1.33

1.4

1.3

1.57

1.48

nmol/l

0.30

620

Allergic conjunctivitis

303

2581

1.13

1.31

1.4

1.45

1.49

nmol/l

0.22

267

2339

Open wound of wrist and hand

277

2357

1.14

1.31

1.5

1.3

1.40

1.45

nmol/l

0.37

252

2133

Mandibular retrognathia

219

0.54

1.30

1.3

1.4

1.46

1.41

nmol/l

0.07

202

Other specified/unspecified spondylopathies

1.77

1.29

1.6

1.2

1.83

1.38

nmol/l

0.95

Complications predominantly related to the puerperium

117

963

1.22

1.29

1.3

1.5

1.63

1.50

nmol/l

0.56

108

865

Contraceptive management

185

1507

0.86

1.29

1.6

1.4

1.54

1.44

nmol/l

0.55

171

1361

Rosacea

517

1.30

1.28

1.4

1.3

1.77

1.48

nmol/l

1.21

470

Leiomyoma of uterus

294

1454

1.13

1.28

1.5

1.4

1.59

1.48

nmol/l

0.76

259

1320

Congenital malformations, deformations and chromosomal abnormalities

325

2745

1.12

1.28

1.4

1.49

1.45

nmol/l

0.21

296

2477

Other deformities of toe(s)

134

0.45

1.28

2.8

1.2

1.69

1.53

nmol/l

—

122

Other hammer toe(s) (acquired)

650

0.75

1.28

1.6

1.3

1.38

1.41

nmol/l

0.07

591

Speech therapy

140

1174

1.19

1.27

1.2

1.3

1.28

1.50

nmol/l

2.11

128

1056

Herpesviral [herpes simplex] infections, including avohilmo

132

1101

1.20

1.27

1.5

1.4

1.50

1.48

nmol/l

0.05

117

990

Dislocation, sprain and strain of joints and ligaments of knee

355

2877

1.12

1.25

1.4

1.44

1.46

nmol/l

0.14

322

2606

Achilles tendinitis

458

1.31

1.25

1.3

1.63

1.46

nmol/l

0.51

408

Abnormal serum enzyme levels

187

1553

1.16

1.25

1.4

1.3

1.42

1.44

nmol/l

0.12

167

1412

Female infertility, cervical, vaginal, other or unspecified origin

117

615

1.22

1.24

1.6

1.4

1.60

1.42

nmol/l

0.85

105

555

Diseases of inner ear

304

2589

1.12

1.23

1.4

1.3

1.50

1.46

nmol/l

0.27

275

2340

Disorders of eyelid in diseases classified elsewhere

116

1.65

1.21

1.3

1.4

1.79

1.38

nmol/l

0.73

101

Traumatic subarachnoid haemorrhage

116

1.65

1.21

1.4

1.3

1.31

1.52

nmol/l

0.25

104

Superficial injury of forearm

391

1.33

1.20

1.6

1.3

1.80

1.51

nmol/l

0.78

353

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

252

2216

0.88

1.20

1.5

1.4

1.51

1.50

nmol/l

0.04

232

1999

Lichen planus, including avohilmo

105

863

1.22

1.20

1.2

1.3

1.61

1.50

nmol/l

0.49

786

Propionic acid derivatives

158

673

1.18

1.3

1.42

1.41

nmol/l

0.01

141

611

Toxic effect of carbon monoxide

1.89

1.18

2.1

1.2

1.44

1.52

nmol/l

0.09

Melanocytic naevi, other sites/unspecified

332

1.36

1.18

1.5

1.4

1.58

1.51

nmol/l

0.14

297

Other and unspecified urticaria

783

1.23

1.18

1.7

1.4

1.36

1.49

nmol/l

0.58

705

Ectopic pregnancy

595

1.26

1.18

1.6

1.4

1.43

1.58

nmol/l

0.72

536

Noninflammatory disorders of female genital tract

174

746

1.17

1.5

1.4

1.48

1.43

nmol/l

0.21

156

673

Thyrotoxicosis with diffuse goitre

489

1.29

1.17

1.2

1.4

1.59

1.46

nmol/l

0.32

443

Agranulocytosis

454

1.30

1.17

1.2

1.4

1.59

1.56

nmol/l

0.08

412

Open wound of head

324

2728

1.12

1.17

1.4

1.3

1.38

1.44

nmol/l

0.38

304

2460

Abnormal blood-pressure reading, without diagnosis

157

1.53

1.17

1.6

1.3

1.38

1.45

nmol/l

0.14

141

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.02

1.17

1.3

1.1

1.37

1.59

nmol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

186

939

1.16

1.17

1.6

1.4

1.60

1.44

nmol/l

1.23

170

844

Other superficial mycoses, including avohilmo

420

1.31

1.16

1.4

1.42

1.43

nmol/l

0.03

377

Pneumocystosis, including avohilmo

1.82

1.15

1.2

1.38

1.78

nmol/l

0.47

Pneumocystosis

1.82

1.15

1.2

1.38

1.78

nmol/l

0.47

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

786

1.22

1.15

1.4

1.3

1.53

1.48

nmol/l

0.16

706

Infectious mononucleosis, including avohilmo

249

1.41

1.14

1.4

1.3

1.61

1.42

nmol/l

0.41

227

Infectious mononucleosis

249

1.41

1.14

1.4

1.3

1.61

1.42

nmol/l

0.41

227

Disorders of ocular muscles, binocular movement, accommodation and refraction

261

2298

1.13

1.4

1.49

1.45

nmol/l

0.21

233

2069

Pyothorax

175

1.49

1.13

1.3

1.2

1.52

1.46

nmol/l

0.10

161

Medicines for HER+ breast cancer

122

1348

0.84

1.12

1.4

1.3

1.66

1.50

nmol/l

0.80

111

1213

Bilateral sagittal split ramus osteotomy operation

115

0.43

1.12

1.6

1.5

2.04

1.32

nmol/l

—

105

malignant neoplasm of female genital organs, including Hilmo

588

1.25

1.11

1.2

1.4

1.79

1.40

nmol/l

2.04

532

Benign neoplasm: Liver/bile ducts

1.71

1.11

1.5

1.4

1.97

1.43

nmol/l

0.66

Other and unspecified vasculitis limited to skin

1.79

1.11

1.3

1.2

1.11

1.56

nmol/l

0.96

Uterine polyps

129

633

1.19

1.11

1.4

1.69

1.43

nmol/l

1.53

118

569

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

109

908

1.20

1.11

1.2

1.3

1.31

1.44

nmol/l

0.69

104

823

IBD patients in KELA-register

123

1036

1.19

1.10

1.4

1.57

1.46

nmol/l

0.53

111

930

Complications of internal orthopaedic prosthetic devices, implants and grafts

116

972

1.20

1.10

1.5

1.3

1.57

1.47

nmol/l

0.45

105

878

Rheumatoid arthritis, including avohilmo

198

1732

1.14

1.10

1.4

1.3

1.57

1.47

nmol/l

0.54

181

1552

Hyperplasia of prostate

245

1218

1.13

1.10

1.3

1.50

1.42

nmol/l

0.44

219

1104

Chondropathies

646

1.24

1.10

1.5

1.3

1.75

1.47

nmol/l

1.08

588

Sexual dysfunction

1.74

1.09

1.1

1.3

1.21

1.47

nmol/l

0.53

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

715

1.22

1.09

1.3

1.53

1.50

nmol/l

0.10

648

Covid-19 suspected case

106

882

1.20

1.09

1.3

1.4

1.37

1.48

nmol/l

0.56

100

793

Other sexually transmitted chlamydial diseases, including avohilmo

304

0.66

1.08

2.0

1.5

0.73

1.46

nmol/l

4.36

273

Heart failure and hypertrophic cardiomyopathy

1.77

1.07

1.5

1.2

1.87

1.65

nmol/l

0.26

Dementia in Alzheimer disease

526

1.24

1.06

1.3

1.2

1.26

1.52

nmol/l

1.69

462

Endometriosis

145

719

1.17

1.05

1.4

1.67

1.43

nmol/l

1.57

128

648

Congenital ovarian cysts

122

0.49

1.05

1.2

1.5

1.84

1.35

nmol/l

—

114

Allergic contact dermatitis

489

1.27

1.05

1.3

1.4

1.40

1.42

nmol/l

0.05

441

Anti-inflammatory and antirheumatic products, non-steroids

156

673

1.17

1.04

1.3

1.47

1.41

nmol/l

0.22

142

611

Carbimazole or st.post thyroidectomy, condition for graves disease

102

851

1.20

1.03

1.4

1.31

1.50

nmol/l

1.06

768

Complications of labour and delivery

271

1343

1.12

1.03

1.5

1.4

1.50

1.51

nmol/l

0.05

246

1217

Ulcerative colitis (strict definition, all Crohn cases excluded)

607

1.24

1.02

1.3

1.58

1.47

nmol/l

0.34

545

Dentofacial anomalies [including malocclusion]

338

2912

0.91

1.02

1.4

1.59

1.46

nmol/l

1.58

316

2621

Contact with and exposure to communicable diseases

143

1224

1.16

1.02

1.6

1.4

1.55

1.43

nmol/l

0.60

133

1102

Other inflammation of eyelid, including avohilmo

241

2148

1.12

1.02

1.4

1.47

nmol/l

0.02

218

1932

Colonic or urogenital fistula

148

1277

1.16

1.02

1.3

1.52

1.48

nmol/l

0.15

134

1150

Other disorders of the genitourinary system

447

1.28

1.02

1.2

1.3

1.44

1.58

nmol/l

0.64

401

Disorders of acoustic nerve

106

0.47

1.01

1.2

1.41

1.49

nmol/l

—

Benign neoplasm: Cranial nerves

107

0.46

1.01

1.2

1.41

nmol/l

—

Serous carcinoma of ovary, including Hilmo

108

0.46

1.01

1.6

1.5

1.96

1.20

nmol/l

—

Viral warts, including avohilmo

114

964

1.18

1.00

1.6

1.3

1.47

1.46

nmol/l

0.06

101

860

Localized scleroderma [morphea]

2.01

1.00

1.4

1.2

1.14

1.24

nmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

664

1.22

0.99

1.2

1.3

1.57

1.51

nmol/l

0.19

599

Effects of foreign body entering through natural orifice

140

1207

1.16

0.98

1.4

1.3

1.55

1.44

nmol/l

0.62

128

1086

Blepharochalasis

153

1328

1.15

0.98

1.4

1.3

1.49

1.47

nmol/l

0.05

147

1196

Inflammatory bowel disease, strict (require KELA)

123

1050

1.17

0.98

1.4

1.3

1.57

1.46

nmol/l

0.55

111

943

Seborrhoeic dermatitis

441

1.27

0.98

1.4

1.3

1.63

1.44

nmol/l

0.71

393

Leisure time condition

784

1.20

0.97

1.5

1.3

1.72

1.48

nmol/l

1.26

703

Exposure to smoke, fire and flames

108

1.58

0.97

1.6

1.2

1.79

1.50

nmol/l

0.48

100

Disorders of lacrimal system

233

2049

1.12

0.95

1.4

1.3

1.51

1.48

nmol/l

0.15

210

1833

Early lumbar disc prolapse operation

434

1.27

0.95

1.6

1.4

1.62

1.41

nmol/l

0.59

396

Other abnormal uterine and vaginal bleeding

100

602

1.19

0.95

1.6

1.3

1.62

1.44

nmol/l

0.93

539

Amiodarone users

470

1.26

0.95

1.3

1.2

1.98

1.52

nmol/l

1.32

423

Kela reimbursement Agammaglobulinemia (D80-84)

1.91

0.94

1.0

1.2

1.79

1.35

nmol/l

—

DVT of lower extremities

100

843

1.19

0.93

1.4

1.3

1.59

1.51

nmol/l

0.28

757

Long labour

682

1.19

0.93

1.3

1.5

1.34

1.52

nmol/l

1.13

617

Ankylosing hyperostosis [Forestier]

1.74

0.92

1.1

1.2

2.12

1.51

nmol/l

—

Seropositive rheumatoid arthritis, wide

131

1131

1.16

0.92

1.4

1.3

1.60

1.47

nmol/l

0.61

119

1018

Spondylopathies (FG)

580

1.23

0.92

1.5

1.4

1.66

1.43

nmol/l

1.01

525

Other otitis externa (chronic)

252

1.35

0.92

1.4

1.41

1.48

nmol/l

0.18

227

Glaucoma-related operations

208

0.62

0.92

1.4

1.2

1.28

1.45

nmol/l

0.23

184

Benign neoplasm: Liver

1.68

0.92

1.5

1.4

1.55

1.47

nmol/l

0.08

malignant neoplasm of female genital organs

524

1.23

0.90

1.2

1.4

1.78

1.40

nmol/l

1.85

472

Communicating hydrocephalus

1.76

0.90

1.4

1.2

1.23

1.59

nmol/l

0.58

Anogenital herpesviral [herpes simplex] infection

210

1.38

0.90

1.6

1.3

1.52

1.47

nmol/l

0.09

194

Open wound of neck

2.09

0.89

1.3

1.2

1.14

1.59

nmol/l

—

Panhypopituitarism

1.70

0.89

1.2

1.1

1.91

1.64

nmol/l

0.35

Deviated nasal septum

196

1742

1.13

0.89

1.3

1.38

1.45

nmol/l

0.44

176

1579

Other disorders of cornea

394

1.27

0.89

1.3

1.59

1.57

nmol/l

0.05

355

Crohn disease

547

1.23

0.88

1.6

1.3

1.48

1.49

nmol/l

0.04

492

Burn and corrosion of trunk

111

1.54

0.88

1.2

1.36

1.50

nmol/l

0.26

102

Vasculitis limited to skin, not elsewhere classified

1.62

0.88

1.3

1.2

1.12

1.52

nmol/l

0.90

Temporomandibular joint disorders, including avohilmo

183

1994

0.89

0.87

1.5

1.4

1.61

1.48

nmol/l

0.92

172

1794

Other/unspecified seropositive rheumatoid arthritis

129

1118

1.16

0.87

1.4

1.3

1.59

1.47

nmol/l

0.58

118

1007

Seborrhoeic keratosis

127

1100

1.16

0.87

1.3

1.62

1.46

nmol/l

0.81

112

990

Other benign neoplasms of skin

194

1730

1.12

0.86

1.3

1.53

1.47

nmol/l

0.37

176

1554

Crowding of teeth, including avohilmo

209

0.67

0.85

1.5

1.4

1.35

1.44

nmol/l

0.19

192

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

127

1102

1.15

0.85

1.4

1.3

1.59

1.47

nmol/l

0.52

116

993

Secondary and unspecified malignant neoplasm of lymph nodes

379

1.27

0.85

1.3

1.19

1.43

nmol/l

1.31

338

Disorders of globe

1.60

0.84

1.2

1.33

1.47

nmol/l

0.18

Disorder of the sleep-wake schedule

1.76

0.84

1.6

1.3

1.15

1.55

nmol/l

—

Diseases of middle ear and mastoid

308

2300

1.09

0.82

1.4

1.49

1.47

nmol/l

0.12

266

2075

Motorcycle rider injured in other and unspecified transport accidents

240

1.34

0.82

1.3

1.4

1.79

1.47

nmol/l

0.57

224

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.65

0.82

1.1

1.2

1.26

1.65

nmol/l

1.06

Unspecified urinary incontinence

330

0.73

0.81

1.4

1.16

1.54

nmol/l

0.95

298

Internal derangement of knee

210

1870

1.11

0.81

1.5

1.3

1.44

1.38

nmol/l

0.42

187

1691

Other interstitial pulmonary diseases

682

1.19

0.80

1.4

1.3

1.58

1.48

nmol/l

0.36

603

Presbycusis

502

1.22

0.80

1.3

1.2

1.77

1.46

nmol/l

1.05

441

Myocardial infarction, with ST-elevation

793

1.17

0.79

1.2

1.3

1.46

1.47

nmol/l

0.02

712

Female genital prolapse

127

613

1.15

0.79

1.4

1.44

1.43

nmol/l

0.06

112

550

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

1.83

0.79

1.2

1.91

1.74

nmol/l

—

Inguinal hernia, bilateral

553

0.79

1.4

1.2

1.16

1.49

nmol/l

2.17

491

Interstitial lung disease

683

1.19

0.79

1.4

1.3

1.58

1.48

nmol/l

0.37

603

Interstitial lung disease endpoints

683

1.19

0.79

1.4

1.3

1.58

1.48

nmol/l

0.37

603

Contusion of toe(s) with damage to nail

1.68

0.79

1.5

1.1

1.28

1.55

nmol/l

—

Osteonecrosis

277

1.30

0.79

1.6

1.3

1.55

1.47

nmol/l

0.16

250

Other disorders of the musculoskeletal system and connective tissue

656

1.19

0.78

1.4

1.3

1.46

1.54

nmol/l

0.28

587

Delivery, wide proxy

135

625

1.15

0.78

1.4

1.3

1.44

1.53

nmol/l

0.39

123

554

Malignant neoplasm of ovary

151

0.59

0.78

1.6

1.4

1.78

1.24

nmol/l

—

134

Labour and delivery complicated by umbilical cord complications

131

1.45

0.78

1.2

1.5

1.43

1.42

nmol/l

0.01

118

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

776

1.17

0.78

1.5

1.4

1.27

1.44

nmol/l

0.84

702

Deep endometriosis

304

0.72

0.78

1.8

1.4

1.36

1.51

nmol/l

0.44

273

therapeutic use

125

0.56

0.77

1.6

1.2

1.79

1.48

nmol/l

—

107

Malignant neoplasm of breast

150

1093

0.88

0.77

1.4

1.73

1.46

nmol/l

1.79

135

989

Malignant neoplasm of breast, HER2-negative

150

1093

0.88

0.77

1.4

1.73

1.46

nmol/l

1.79

135

989

Mucosal proctocolitis

539

1.21

0.76

1.4

1.3

1.59

1.44

nmol/l

0.43

485

Deep bite

356

0.76

1.4

1.68

1.42

nmol/l

0.69

325

Guillain-Barre syndrome

1.71

0.76

1.6

1.2

0.82

1.43

nmol/l

—

Secondary right heart disease

149

1.41

0.75

1.4

1.2

1.72

1.53

nmol/l

0.31

131

Other localized connective tissue disorders

1.71

0.75

1.3

1.2

0.97

1.35

nmol/l

—

Malignant neoplasm of rectosigmoid junction

1.65

0.75

1.5

1.2

1.36

1.56

nmol/l

0.26

Left bundle-branch block

288

1.29

0.75

1.4

1.3

1.59

1.36

nmol/l

0.83

256

Single delivery by caesarean section

384

1.19

0.75

1.6

1.4

1.52

1.44

nmol/l

0.26

340

Other predominantly sexually transmitted diseases, not elsewhere classified

641

1.19

0.75

1.5

1.4

1.30

1.44

nmol/l

0.52

581

Carrier of infectious disease

1.57

0.75

1.5

1.2

1.34

1.44

nmol/l

0.14

L02BG Aromatase inhibitors

100

1141

0.86

0.75

1.4

1.3

1.59

1.47

nmol/l

0.50

1022

Other specified transport accidents

2.10

0.75

1.4

1.2

1.18

1.83

nmol/l

—

Atrophic disorders of skin

577

1.20

0.75

1.5

1.3

1.33

1.47

nmol/l

0.52

517

Other disorders of veins

218

1946

1.10

0.74

1.3

1.44

1.46

nmol/l

0.10

203

1751

Focal epilepsy

106

920

1.15

0.74

1.5

1.3

1.61

1.48

nmol/l

0.52

825

Perforation of tympanic membrane

406

1.23

0.73

1.5

1.3

1.47

1.51

nmol/l

0.08

371

Palmar fascial fibromatosis [Dupuytren]

662

1.18

0.72

1.5

1.2

1.09

1.45

nmol/l

2.55

596

Perichondritis of external ear

1.62

0.72

1.7

1.1

0.91

1.76

nmol/l

—

5-aminosalicylic acid

106

922

1.15

0.72

1.4

1.3

1.51

1.42

nmol/l

0.38

816

Vascular dementia (mixed)

1.61

0.72

1.3

1.1

1.85

1.80

nmol/l

—

Schizoid personality disorder

1.59

0.72

1.2

2.19

1.39

nmol/l

1.37

Nontraumatic intracranial haemmorrhage

849

1.16

0.71

1.4

1.3

1.35

1.51

nmol/l

0.92

762

Drug-induced neutropenia

291

1.27

0.71

1.2

1.4

1.65

1.51

nmol/l

0.33

266

Mixed conductive and sensorineural hearing loss

526

1.20

0.71

1.2

1.3

1.50

1.49

nmol/l

0.03

465

Personal history of allergy to drugs, medicaments and biological substances

1.72

0.70

1.1

1.2

1.30

1.64

nmol/l

—

Other disorders of binocular vision

1.72

0.70

1.0

1.3

2.54

1.33

nmol/l

—

Other puerperal infections

212

1.32

0.70

1.5

1.6

1.73

1.49

nmol/l

0.44

193

Dermatitis herpetiformis

1.56

0.70

1.1

1.2

0.99

1.33

nmol/l

—

Endometriosis of rectovaginal septum and vagina

240

0.71

0.70

1.8

1.3

1.46

1.44

nmol/l

0.04

213

Sequelae of injuries, of poisoning and of other consequences of external causes

128

1132

1.13

0.69

1.6

1.3

1.30

1.49

nmol/l

1.29

107

1018

Spermatocele

376

0.77

0.69

1.3

1.71

1.49

nmol/l

0.61

347

Blood alcohol or alcohol intoxication level

1.54

0.69

1.2

1.4

1.10

1.34

nmol/l

0.35

Haemorrhoids and perianal venous thrombosis

179

1604

1.11

0.69

1.4

1.3

1.59

1.42

nmol/l

0.90

160

1437

Other congenital malformations, not elsewhere classified

1.86

0.68

1.4

1.3

2.54

1.48

nmol/l

—

Evidence of alcohol involvement determined by blood alcohol level

1.53

0.68

1.1

1.2

1.20

1.42

nmol/l

—

Other abnormalities of plasma proteins

1.53

0.68

1.2

1.49

1.79

nmol/l

—

Sequelae of injuries of upper limb

431

0.79

0.68

1.6

1.4

1.50

1.53

nmol/l

0.05

389

Other pulmonary heart/vessel disease

161

1.37

0.68

1.4

1.2

1.90

1.51

nmol/l

0.64

142

ILD, hospital admissions

676

1.17

0.68

1.4

1.3

1.57

1.48

nmol/l

0.27

597

severe traumatic brain injury, does not include concussion

117

1031

1.14

0.68

1.4

1.3

1.47

1.46

nmol/l

0.03

108

928

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

352

2983

1.07

0.67

1.4

1.52

1.45

nmol/l

0.49

322

2687

Abnormalities of forces of labour

311

1.26

0.67

1.2

1.5

1.71

1.48

nmol/l

0.60

280

Postpartum care and examination

267

1.22

0.67

1.4

1.5

1.68

1.52

nmol/l

0.46

240

Endometriosis ASRM stages 3,4

812

0.85

0.67

1.5

1.4

1.64

1.49

nmol/l

0.49

727

Primary coxarthrosis, bilateral

147

1315

1.12

0.67

1.4

1.3

1.61

1.45

nmol/l

1.02

136

1189

Any death

340

2556

0.93

0.67

1.2

1.3

1.50

1.44

nmol/l

0.34

303

2323

Malignant melanoma of skin, including Hilmo

668

1.17

0.67

1.2

1.3

1.41

1.46

nmol/l

0.15

602

Inflammation of lacrimal passages (chronic)

1.64

0.67

1.1

1.0

1.48

1.88

nmol/l

—

Eosinophilic disease (BM)

1.64

0.67

1.1

1.33

2.16

nmol/l

—

Pollen allergy

677

1.17

0.66

1.4

1.44

1.39

nmol/l

0.15

611

Malignant neoplasm of head and neck, including Hilmo

473

0.80

0.66

1.3

1.34

1.50

nmol/l

0.45

425

Focal epilepsy, mode (most common among epilepsy diagnosis)

818

1.15

0.65

1.5

1.3

1.59

1.50

nmol/l

0.34

737

Exposure to unspecified smoke, fire and flames

1.60

0.65

1.7

1.2

1.47

1.45

nmol/l

—

Hydrocele

531

1.19

0.65

1.3

1.54

1.45

nmol/l

0.28

481

Benign neoplasm: Tonsil

1.60

0.65

1.6

1.1

1.22

1.53

nmol/l

—

Residual foreign body in soft tissue

206

1.31

0.65

1.3

1.59

1.46

nmol/l

0.29

189

Other bursitis of hip

1.58

0.65

1.3

1.1

1.48

1.39

nmol/l

0.09

Oral lichen planus and hypothyroidism or thyroxine medication

1.62

0.65

1.2

2.20

1.15

nmol/l

—

Nonsuppurative otitis media, including avohilmo

147

1139

1.12

0.64

1.4

1.48

1.47

nmol/l

0.04

135

1030

Chorioretinal inflammation

1.48

0.64

1.4

1.86

1.36

nmol/l

1.00

Inguinal or femoral hernia, bilateral

558

0.82

0.64

1.3

1.2

1.17

1.49

nmol/l

2.00

496

Separation of retinal layers (serosa)

177

0.68

0.63

1.4

1.2

1.58

1.54

nmol/l

0.07

163

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

153

1378

1.11

0.63

1.4

1.44

1.47

nmol/l

0.10

140

1245

Malignant neoplasm of breast, ER-positive, including Hilmo

115

965

0.89

0.63

1.4

1.67

1.45

nmol/l

1.21

105

871

Congenital malformations of ovaries, fallopian tubes and broad ligaments

153

0.65

0.62

1.1

1.5

1.60

1.34

nmol/l

—

140

Other bullous disorders

1.46

0.61

1.1

1.4

1.41

nmol/l

0.00

Malignant neoplasm of breast, HER-positive

115

964

0.89

0.61

1.4

1.67

1.45

nmol/l

1.21

105

870

Malignant neoplasm of breast, including Hilmo

155

1100

0.90

0.61

1.4

1.70

1.46

nmol/l

1.54

139

996

Any dementia

190

1196

1.10

0.61

1.2

1.3

1.18

1.51

nmol/l

4.93

170

1071

Malignant neoplasm of breast, HER2-negative, including Hilmo

155

1100

0.90

0.61

1.4

1.70

1.46

nmol/l

1.54

139

996

Budesonide

563

1.17

0.61

1.4

1.3

1.44

1.43

nmol/l

0.04

497

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.57

0.60

1.5

1.2

1.26

1.58

nmol/l

—

Obstructed labour due to maternal pelvic abnormality

527

1.18

0.60

1.5

1.4

1.71

1.49

nmol/l

0.80

476

Use of donepezil

734

0.86

0.60

1.3

1.2

1.08

1.47

nmol/l

4.24

653

COPD-related respiratory insufficiency

518

1.18

0.60

1.4

1.3

1.60

1.48

nmol/l

0.36

460

Respiratory insufficiency

307

1.24

0.59

1.4

1.2

1.50

1.54

nmol/l

0.07

273

Primary open-angle glaucoma, strict

124

1106

1.12

0.59

1.3

1.29

1.49

nmol/l

1.49

112

994

Pregnancy, childbirth and the puerperium

112

517

1.13

0.59

1.5

1.3

1.37

1.53

nmol/l

0.81

101

462

Malignant neoplasm of thyroid gland, including Hilmo

288

0.76

0.59

1.3

1.4

1.59

1.39

nmol/l

0.30

260

Erosion of teeth , including avohilmo

134

1205

1.11

0.58

1.5

1.4

1.32

1.47

nmol/l

0.99

123

1079

Disorders of breast

217

1757

1.09

0.58

1.5

1.4

1.59

1.49

nmol/l

0.66

200

1586

Unspecified dementia

293

1.23

0.58

1.3

1.2

0.99

1.53

nmol/l

2.73

256

Polyp of the female genital tract

128

648

1.12

0.57

1.4

1.62

1.43

nmol/l

0.93

117

582

ILD, hospital admissions 1, main diag only

604

1.16

0.57

1.4

1.3

1.51

1.49

nmol/l

0.06

539

Chalazion

465

1.18

0.57

1.2

1.4

1.51

1.46

nmol/l

0.10

425

Open wound of thorax

1.49

0.57

1.3

1.1

0.74

1.52

nmol/l

—

Exclusion endpoint for clefts

1.48

0.57

1.4

1.2

2.11

1.51

nmol/l

—

Bitten or struck by other mammals

447

1.19

0.57

1.8

1.3

1.26

1.51

nmol/l

1.04

399

Malignant melanoma

717

1.15

0.56

1.1

1.3

1.35

1.45

nmol/l

0.48

648

Primary open-angle glaucoma

150

1308

1.10

0.56

1.3

1.36

1.49

nmol/l

0.86

136

1180

Osteoporosis

121

996

1.12

0.56

1.4

1.3

1.44

1.47

nmol/l

0.10

111

902

Special screening examination for infectious and parasitic diseases

100

645

1.13

0.56

1.4

1.32

1.50

nmol/l

0.83

587

Papillary adenocarcinoma of thyroid gland

195

0.72

0.56

1.4

1.36

1.39

nmol/l

0.04

175

Intracerebral haemorrhage

494

1.18

0.56

1.4

1.3

1.40

1.49

nmol/l

0.27

447

Basal cell carcinoma

217

1603

0.92

0.56

1.3

1.43

1.44

nmol/l

0.06

189

1462

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.63

0.56

1.2

1.69

1.36

nmol/l

—

Bacterial, viral and other infectious agents

384

1.20

0.55

1.4

1.3

1.57

1.46

nmol/l

0.25

346

Other other unspecified disorders of the circulatory system

133

1.36

0.55

1.4

1.33

1.43

nmol/l

0.10

112

Gonarthrosis, primary, with knee surgery

328

2392

1.07

0.55

1.4

1.3

1.65

1.43

nmol/l

3.12

293

2164

Intestinal adhesions without obstruction

358

1.20

0.54

1.5

1.2

1.45

1.51

nmol/l

0.14

316

Malignant melanoma, including Hilmo

796

1.13

0.53

1.2

1.3

1.36

1.46

nmol/l

0.45

720

Disorders of synovium and tendon in diseases classified elsewhere

1.49

0.53

1.2

1.28

1.49

nmol/l

0.41

Localized swelling, mass and lump of skin and subcutaneous tissue

138

1520

0.91

0.53

1.3

1.53

1.47

nmol/l

0.27

126

1361

Fracture at wrist and hand level

186

1705

1.09

0.53

1.4

1.3

1.31

1.45

nmol/l

1.04

168

1532

Benign neoplasm: Oesophagus

1.55

0.53

1.2

1.1

1.32

1.90

nmol/l

—

Triptan medication for migraine, min. 3 purchases

245

1967

0.93

0.52

1.5

1.4

1.47

1.48

nmol/l

0.06

228

1778

Benign mammary dysplasia

468

0.83

0.51

1.5

1.4

1.57

1.45

nmol/l

0.31

421

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.41

0.51

1.2

1.1

1.13

1.45

nmol/l

—

Autism spe

1.41

0.51

1.1

1.5

1.99

1.36

nmol/l

—

In situ neoplasms

197

1822

1.08

0.50

1.3

1.51

1.47

nmol/l

0.23

180

1640

Nasal polyp

103

924

1.12

0.50

1.4

1.3

1.39

1.49

nmol/l

0.39

836

Malignant neoplasm of endocrine gland

280

0.78

0.50

1.3

1.4

1.47

1.42

nmol/l

0.09

254

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

293

2652

1.07

0.49

1.4

1.3

1.42

1.44

nmol/l

0.12

270

2397

Seropositive rheumatoid arthritis, strict definition

613

1.14

0.49

1.3

1.76

1.54

nmol/l

0.76

554

Macular hole

198

1.27

0.49

1.3

1.25

1.58

nmol/l

1.00

181

Congenital malformations of the circulatory system

559

1.15

0.49

1.2

1.3

1.37

1.51

nmol/l

0.56

510

Presence of other devices

111

985

1.11

0.49

1.2

1.3

1.71

1.44

nmol/l

1.11

100

889

Fracture of femur

127

1039

1.10

0.49

1.4

1.3

1.26

1.50

nmol/l

1.61

109

937

Malignant neoplasm of endocrine gland, including Hilmo

323

0.80

0.48

1.2

1.4

1.59

1.43

nmol/l

0.28

289

Other sexually transmitted chlamydial diseases

189

0.74

0.48

2.1

1.4

0.70

1.43

nmol/l

3.55

170

Contact with machinery

568

1.15

0.48

1.3

1.48

nmol/l

0.00

512

Measles

1.50

0.47

1.1

1.7

1.23

1.39

nmol/l

—

Measles, including avohilmo

1.50

0.47

1.1

1.7

1.23

1.39

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

209

1944

1.08

0.47

1.4

1.3

1.65

1.43

nmol/l

2.04

189

1750

Caries of enamel

570

3565

1.05

0.47

1.4

1.33

1.48

nmol/l

2.83

521

3223

Ulcerative rectosigmoiditis

336

1.19

0.47

1.3

1.55

1.52

nmol/l

0.07

304

Retinal detachment with retinal break

569

1.14

0.47

1.3

1.90

1.58

nmol/l

0.70

514

Congenital malformations of heart and great arteries

498

1.15

0.46

1.3

1.43

1.47

nmol/l

0.10

452

Cyst of kidney

328

1.19

0.46

1.5

1.3

2.05

1.47

nmol/l

1.76

293

Obstructive hydrocephalus

1.43

0.46

1.3

1.1

1.50

1.67

nmol/l

—

Postmenopausal bleeding

114

539

1.11

0.46

1.5

1.3

1.47

1.43

nmol/l

0.15

488

Myopia

486

1.15

0.46

1.2

1.4

1.72

1.45

nmol/l

0.62

433

Small cell lung cancer, helper endpoint

1.43

0.45

1.2

1.1

1.18

1.55

nmol/l

0.90

Multiple delivery

309

0.81

0.45

1.2

1.4

1.29

1.45

nmol/l

0.50

273

Migraine, single triptan purchase ok & required. ICD-code if available is included

376

2681

0.95

0.45

1.4

1.52

1.48

nmol/l

0.29

343

2412

Triptan medication for migraine, single purchase ok

376

2681

0.95

0.45

1.4

1.52

1.48

nmol/l

0.29

343

2412

Malignant neoplasm of breast, ER-negative, including Hilmo

749

0.89

0.44

1.4

1.75

1.42

nmol/l

1.14

672

Abnormal findings on diagnostic imaging of lung

266

2370

1.06

0.44

1.3

1.48

1.44

nmol/l

0.27

243

2145

Tonsillectomy and adenotomy

285

1867

1.06

0.44

1.5

1.4

1.42

1.49

nmol/l

0.49

262

1683

Bacterial, viral and other infectious agents, including avohilmo

413

1.16

0.44

1.4

1.3

1.59

1.46

nmol/l

0.34

372

Autism

1.45

0.44

1.1

1.4

1.99

1.37

nmol/l

—

Lung diseases due to external agents

582

1.14

0.44

1.5

1.3

1.26

1.49

nmol/l

1.04

521

Secondary parkinsonism

1.37

0.44

1.2

2.33

1.61

nmol/l

0.47

Other specified disorders of external ear

148

1.29

0.43

1.3

1.2

1.23

1.57

nmol/l

1.08

136

Artificial joint operation, meniscal resection

537

3289

1.04

0.43

1.4

1.3

1.57

1.44

nmol/l

2.04

487

2973

Malignant neoplasm of thyroid gland

252

0.79

0.43

1.3

1.4

1.45

1.39

nmol/l

0.10

227

Acute appendicitis, with complications

101

915

1.10

0.43

1.3

1.59

1.50

nmol/l

0.30

827

Other specified disorders of kidney and ureter

113

1.33

0.42

1.3

2.28

1.58

nmol/l

1.05

101

Additional codes for the location of defect, injury or illness

239

1.22

0.42

1.4

1.47

1.39

nmol/l

0.17

214

Nummular dermatitis

387

1.16

0.42

1.6

1.3

1.65

1.43

nmol/l

0.50

347

Abnormal findings on diagnostic imaging of central nervous system

212

1.23

0.42

1.2

1.4

1.19

1.44

nmol/l

0.91

189

Use of memantine

877

0.91

0.41

1.2

1.25

1.47

nmol/l

2.06

787

Use of other anti-dementia drugs

877

0.91

0.41

1.2

1.25

1.47

nmol/l

2.06

787

Other congenital malformations of ear

1.47

0.40

1.2

1.4

2.33

1.67

nmol/l

—

Injury of eye and orbit

653

1.12

0.40

1.4

1.3

1.59

1.44

nmol/l

0.34

587

Degenerative macular diseases

436

1.15

0.40

1.3

1.58

1.60

nmol/l

0.03

388

Divergent concomitant strabismus

287

1.19

0.40

1.4

1.3

1.30

1.44

nmol/l

0.33

258

Chronic mastoiditis

1.37

0.40

1.2

1.1

1.50

1.67

nmol/l

—

Polyuria

115

1054

1.09

0.40

1.2

1.3

1.47

nmol/l

0.02

109

950

Undefined dementia

316

1.17

0.40

1.3

1.2

0.99

1.46

nmol/l

2.25

278

Liposarcoma, including Hilmo

1.43

0.39

1.2

1.3

1.04

1.36

nmol/l

—

Other and unspecified bullous disorders

1.43

0.39

1.2

1.1

2.17

1.70

nmol/l

—

Malignant neoplasm of stomach

226

0.79

0.39

1.6

1.2

1.28

1.41

nmol/l

0.15

199

Malignant neoplasm of rectum, including Hilmo

570

0.88

0.39

1.3

1.36

1.46

nmol/l

0.28

510

Injury of muscle and tendon at forearm level

1.38

0.38

1.5

1.2

1.72

1.45

nmol/l

0.45

Malnutrition

1.37

0.38

1.7

1.1

1.01

1.78

nmol/l

—

Focal epilepsy, strict definition

865

1.10

0.38

1.5

1.3

1.55

1.50

nmol/l

0.15

780

Malignant neoplasm of oral cavity, including Hilmo

214

0.79

0.38

1.5

1.4

1.30

1.40

nmol/l

0.13

189

Malignant neoplasm of stomach, including Hilmo

268

0.82

0.37

1.6

1.3

1.31

1.43

nmol/l

0.18

237

Evidence of alcohol involvement determined by level of intoxication

1.36

0.37

1.6

1.3

0.75

1.50

nmol/l

—

Contact with other hot fluids

115

0.69

0.37

1.4

1.5

1.20

1.40

nmol/l

—

107

Other strabismus

883

1.09

0.37

1.3

1.4

1.50

1.46

nmol/l

0.11

794

Other bursopathies

563

1.12

0.36

1.4

1.3

1.44

1.52

nmol/l

0.22

505

Benign neoplasm: Skin of upper limb, including shoulder

0.66

0.36

1.4

1.2

0.95

1.66

nmol/l

—

Sequelae of injuries of head

226

1.20

0.35

1.6

1.4

1.12

1.54

nmol/l

1.17

205

Medical treatment for female infertility

681

1.11

0.35

1.6

1.5

1.84

1.47

nmol/l

1.57

611

Morphin

0.63

0.35

1.0

1.2

1.47

1.38

nmol/l

—

Abrasion of teeth

190

1788

1.06

0.35

1.4

1.3

1.59

1.48

nmol/l

0.56

165

1608

Other autoimmune haemolytic anaemias

1.40

0.35

1.0

1.1

3.11

1.71

nmol/l

—

Allergic colitis

1.40

0.35

1.0

1.3

1.10

1.32

nmol/l

—

Colorectal cancer, including Hilmo

121

1216

0.93

0.34

1.2

1.3

1.32

1.45

nmol/l

0.77

111

1108

Malignant neoplasm of breast, HER-negative

703

0.90

0.34

1.4

1.81

1.40

nmol/l

1.49

634

Disorders in reading

1.37

0.34

1.0

1.4

2.25

1.41

nmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

156

0.77

0.34

1.3

1.34

1.44

nmol/l

0.13

141

Non-follicular lymphoma

426

0.87

0.34

1.4

1.3

1.36

1.53

nmol/l

0.59

384

Distal bite

1.33

0.34

1.5

1.31

1.27

nmol/l

0.04

Carcinoma in situ of other and unspecified sites

154

1.24

0.34

1.3

1.2

1.18

1.55

nmol/l

1.20

140

Carcinoma in situ, bladder

145

1.24

0.33

1.3

1.2

1.20

1.56

nmol/l

1.03

131

Generalized epilepsy

145

1.24

0.33

1.1

1.4

1.81

1.49

nmol/l

0.82

133

Secondary parkinsonism+Parkinsonism in other disease

100

1.30

0.33

1.2

2.33

1.55

nmol/l

0.52

Sulfasalazine

140

1307

1.07

0.33

1.4

1.3

1.48

1.43

nmol/l

0.22

122

1161

Labour and delivery complicated by fetal stress [distress]

473

1.10

0.33

1.3

1.5

1.56

1.54

nmol/l

0.05

429

Use of rivastigmine

556

1.11

0.33

1.3

1.2

1.06

1.49

nmol/l

4.18

488

0.69

0.33

1.3

1.1

1.34

1.49

nmol/l

—

Procedures for purposes other than remedying health state

0.70

0.33

1.0

1.5

1.39

1.23

nmol/l

—

Asthma and opportunity respiratory infection

164

1.22

0.32

1.2

1.71

1.49

nmol/l

0.34

146

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.36

0.32

1.1

1.2

1.81

1.46

nmol/l

—

Colorectal neuroendocrine tumor and carcinoma

1.28

0.32

1.3

1.51

1.30

nmol/l

—

Occupational exposure to risk-factors

132

0.76

0.32

1.3

1.2

1.22

1.48

nmol/l

—

120

Contact with sharp glass

154

0.78

0.32

1.2

1.3

1.25

1.42

nmol/l

0.19

140

Benign neoplasm: other/unspecified salivary gland

1.31

0.32

1.2

2.00

1.49

nmol/l

0.64

Benign neoplasm: Larynx

119

1.26

0.32

1.1

1.2

1.28

1.52

nmol/l

0.79

109

Embedded teeth, including avohilmo

276

1.16

0.31

1.4

1.24

1.39

nmol/l

0.47

254

Single spontaneous delivery

145

818

0.94

0.31

1.3

1.54

1.50

nmol/l

0.14

131

730

Intermittent heterotropia

186

0.80

0.31

1.2

1.3

1.79

1.43

nmol/l

0.81

168

Impacted cerumen

494

1.11

0.31

1.3

1.33

1.54

nmol/l

0.73

445

Other malignant neoplasms of skin (=non-melanoma skin cancer)

230

1640

0.95

0.30

1.3

1.47

1.44

nmol/l

0.11

202

1494

Hypersensitivity pneumonitis due to organic dust

1.30

0.30

1.4

1.1

1.17

1.65

nmol/l

—

Graves disease, strict definition

362

1.13

0.30

1.2

1.4

1.40

1.44

nmol/l

0.09

326

Universal erythroderma, KELA reimbursement

1.28

0.30

1.4

1.2

1.46

1.52

nmol/l

—

Small cell lung cancer

1.31

0.30

1.2

1.18

1.50

nmol/l

0.78

Small cell lung cancer, including Hilmo

1.31

0.30

1.2

1.18

1.50

nmol/l

0.78

Postzoster neuralgia

1.28

0.30

1.1

1.80

1.56

nmol/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

102

1.28

0.30

1.2

1.3

1.86

1.42

nmol/l

0.94

Coxarthrosis, primary

327

2606

1.04

0.29

1.4

1.3

1.62

1.43

nmol/l

2.21

292

2367

Use of ropinirole

130

0.77

0.29

1.1

1.2

2.82

1.47

nmol/l

—

116

Acute epiglottitis

1.23

0.29

1.4

1.1

1.47

1.45

nmol/l

—

Voice disturbances

112

1199

0.93

0.28

1.6

1.3

1.66

1.49

nmol/l

0.86

106

1071

Other noninflammatory disorders of vulva and perineum

326

1.14

0.28

2.0

1.3

1.52

1.46

nmol/l

0.08

289

Demyelinating diseases of the central nervous system

298

1.14

0.28

1.3

1.4

1.16

1.39

nmol/l

0.81

271

Melanocytic naevi of scalp and neck

1.32

0.28

2.1

1.2

1.06

1.45

nmol/l

—

Other juvenile arthritis

103

1.26

0.28

1.8

1.3

1.23

1.56

nmol/l

0.52

Major anomalies of jaw size

1.28

0.28

1.3

1.4

2.00

1.47

nmol/l

0.76

Other fall from one level to another

1062

0.93

0.27

1.3

1.32

1.49

nmol/l

0.91

960

Carcinoma in situ of skin of trunk

117

0.77

0.27

1.1

1.24

1.56

nmol/l

—

Other congenital malformations of skin

131

1.22

0.27

1.8

1.4

1.40

1.39

nmol/l

0.00

119

Rheumatic valve diseases

1.23

0.27

1.3

1.1

1.06

1.81

nmol/l

—

Disturbances of smell and taste

161

0.81

0.27

1.2

1.4

1.32

1.36

nmol/l

0.05

144

Other and unspecified nerve root and plexus disorders, also in other diseases

100

933

1.07

0.26

1.5

1.3

1.30

1.48

nmol/l

1.17

840

Nonsuppurative otitis media

759

1.07

0.26

1.4

1.47

1.46

nmol/l

0.05

693

Molar incisor enamel hypoplasia

1.28

0.26

1.3

1.56

1.23

nmol/l

0.48

Nontoxic goitre/thyroid nodule

128

1207

1.06

0.25

1.4

1.3

1.39

1.48

nmol/l

0.49

113

1086

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

597

1.09

0.25

1.4

1.3

1.70

1.51

nmol/l

0.66

541

Assault by sharp object

1.24

0.25

1.7

1.2

0.59

1.38

nmol/l

—

Enterobiasis, including avohilmo

1.23

0.25

3.1

1.3

1.28

1.47

nmol/l

—

Fracture of forearm

261

2438

0.96

0.25

1.4

1.3

1.37

1.47

nmol/l

0.74

237

2198

Ankylosing spondylitis, strict definition

181

0.83

0.25

1.8

1.4

1.51

1.39

nmol/l

0.21

168

Endometriosis of ovary

567

0.91

0.25

1.4

1.71

1.40

nmol/l

1.04

504

Striking against or struck by other objects

174

1654

1.05

0.25

1.5

1.3

1.56

1.45

nmol/l

0.62

158

1486

Malignant neoplasm of rectosigmoid junction, including Hilmo

114

1.23

0.25

1.5

1.2

1.23

1.51

nmol/l

0.52

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

254

1.14

0.25

1.4

1.63

1.47

nmol/l

0.37

232

Basal cell carcinoma, including Hilmo

235

1659

0.96

0.25

1.3

1.45

nmol/l

0.01

204

1511

UC patients in KELA-register (code 208), prior to 1994

170

1.18

0.24

1.2

1.4

1.52

1.45

nmol/l

0.09

155

Later onset COPD, excluding more controls

684

1.07

0.24

1.2

1.70

1.44

nmol/l

1.18

624

Fourth [trochlear] nerve palsy

1.29

0.24

1.2

2.01

1.65

nmol/l

—

Follow-up care involving plastic surgery

126

0.79

0.24

1.6

1.4

1.54

1.41

nmol/l

—

112

Malignant melanoma of skin

561

1.09

0.24

1.2

1.3

1.39

1.44

nmol/l

0.15

507

Impacted teeth

595

0.92

0.23

1.5

1.4

1.38

1.40

nmol/l

0.06

540

Colorectal cancer

109

1109

0.94

0.23

1.3

1.24

1.45

nmol/l

1.43

101

1011

Personal history of medical treatment

1.32

0.23

1.0

1.1

2.32

1.87

nmol/l

—

Malignant neoplasm of skin, including Hilmo

297

1919

1.04

0.23

1.3

1.45

nmol/l

0.04

259

1745

Carcinoma in situ of breast, intraductal

275

1.13

0.23

1.2

1.4

1.62

1.48

nmol/l

0.31

248

Other drug-induced secondary parkinsonism

1.29

0.23

1.0

1.1

1.67

1.48

nmol/l

—

Benign neoplasm of other and unspecified intrathoracic organs

1.29

0.23

1.6

1.1

1.14

1.77

nmol/l

—

Pedestrian injured in other and unspecified transport accidents

1.28

0.23

1.4

1.1

1.13

1.59

nmol/l

—

Acquired absence of limb

1.25

0.22

1.4

1.1

1.92

1.96

nmol/l

—

Malignant neoplasm, without specification of site, including Hilmo

178

0.84

0.22

1.1

1.2

1.75

1.37

nmol/l

0.59

155

Gastrointestinal stromal tumor and sarcoma

1.22

0.22

1.6

1.3

0.50

1.62

nmol/l

—

L01XE Protein kinase inhibitors

210

0.86

0.22

1.4

1.3

1.06

1.48

nmol/l

1.08

186

Hypoplasia of dental enamel , including avohilmo

1.27

0.22

1.3

1.71

1.23

nmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

229

1.14

0.21

1.4

1.61

1.46

nmol/l

0.39

210

Complications specific to multiple gestation

0.00

0.21

0.0

1.2

—

1.04

—

Acne, including avohilmo

613

1.07

0.21

1.6

1.5

1.24

1.45

nmol/l

1.30

561

Femoral hernia, unilateral

101

0.79

0.21

1.1

1.2

1.51

1.37

nmol/l

—

Inguinal of femoral hernia, unilateral

101

0.79

0.21

1.1

1.2

1.51

1.37

nmol/l

—

Inguinal hernia, unilateral

101

0.79

0.21

1.1

1.2

1.51

1.37

nmol/l

—

Disorders of iron metabolism

1.25

0.20

1.3

1.2

1.05

1.44

nmol/l

—

Other and unspecified injuries of wrist and hand

136

1.18

0.20

1.3

1.02

1.38

nmol/l

1.35

124

Other and unspecified mononeuropathies of upper limb

111

0.81

0.20

1.4

1.3

1.60

1.35

nmol/l

—

103

Other disorders of optic disc

1.20

0.19

2.5

1.1

0.86

1.52

nmol/l

—

Congenital malformations of genital organs

269

0.89

0.19

1.3

1.4

1.68

1.42

nmol/l

0.52

242

Benign neoplasm: Pituitary gland, craniopharyngeal duct

212

1.13

0.19

1.1

1.4

1.59

1.44

nmol/l

0.26

193

Tooth agenesis EXCLUDE clefts and syndromes

1.21

0.19

1.1

1.5

1.59

1.47

nmol/l

0.14

Secondary uncertain malignant neoplasm

607

1.07

0.19

1.3

1.33

1.49

nmol/l

0.69

542

Abdominal aortic aneurysm (AAA)

315

1.10

0.19

1.1

1.2

1.66

1.43

nmol/l

0.57

272

Alzheimer’s disease, strict definition

768

0.95

0.19

1.2

1.10

1.50

nmol/l

4.97

691

Other abnormal products of conception

119

743

1.05

0.19

1.5

1.37

1.54

nmol/l

0.93

111

668

Certain zoonotic bacterial diseases, including avohilmo

109

1.19

0.18

1.2

1.3

1.84

1.46

nmol/l

—

Pedal cyclist injured in transport accident

1032

0.95

0.18

1.3

1.45

1.48

nmol/l

0.08

929

Atopic dermatitis

300

2320

1.03

0.18

1.4

1.51

1.44

nmol/l

0.56

273

2091

Other obstetric trauma

128

1.17

0.18

1.2

1.6

1.17

1.39

nmol/l

0.39

114

Tinnitus

118

1126

1.05

0.18

1.5

1.3

1.56

1.46

nmol/l

0.41

103

1013

Parapsoriasis

1.17

0.18

1.3

1.1

1.06

1.58

nmol/l

—

Hereditary corneal dystrophies

119

1.18

0.17

1.6

1.3

1.60

1.38

nmol/l

0.32

101

Other and unspecified hydrocephalus

1.15

0.17

1.3

1.2

1.66

1.51

nmol/l

—

Systemic atrophies primarily affecting the central nervous system

157

1.15

0.17

1.3

1.2

1.26

1.45

nmol/l

0.37

140

FESS (DNB20)

552

1.07

0.17

1.7

1.3

1.34

1.49

nmol/l

0.50

501

Benign neoplasm: Skin of scalp and neck

1.22

0.17

1.4

1.1

1.46

1.60

nmol/l

—

Myasthenia gravis

0.76

0.17

1.4

1.2

1.25

1.52

nmol/l

—

Use of anticholinesterases

140

1124

0.96

0.17

1.3

1.2

1.09

1.49

nmol/l

7.57

127

1008

N06DA Anticholinesterases

140

1124

0.96

0.17

1.3

1.2

1.09

1.49

nmol/l

7.57

127

1008

Benign neoplasm: Kidney

129

1.16

0.17

1.2

2.55

1.38

nmol/l

—

111

Other degenerative diseases of the basal ganglia

0.72

0.17

1.2

1.1

1.87

1.70

nmol/l

—

Other infestations, including avohilmo

0.72

0.17

1.0

1.1

1.04

1.45

nmol/l

—

Contact with other hot metals

0.71

0.16

2.2

1.2

1.10

1.62

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.18

0.16

1.1

1.5

1.42

1.31

nmol/l

—

Crushing injury of wrist and hand

1.16

0.16

1.4

1.3

1.17

1.67

nmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

113

1054

1.05

0.16

1.6

1.5

1.55

1.51

nmol/l

0.12

106

941

Patellar tendinitis

1.14

0.16

1.3

1.4

1.81

1.30

nmol/l

—

Juvenile arthritis (FINNGEN)

120

1.17

0.16

1.8

1.3

1.19

1.50

nmol/l

0.53

112

6-mercaptopurine

120

1.17

0.16

1.3

1.36

1.32

nmol/l

0.04

108

Golimumab

139

1.15

0.16

1.9

1.4

1.82

1.44

nmol/l

0.84

128

Malignant neoplasm of bladder, including Hilmo

518

0.93

0.16

1.3

1.2

1.24

1.48

nmol/l

1.14

467

Idiopathic urticaria

1.11

0.16

1.5

1.3

1.88

1.41

nmol/l

—

Benign lipomatous neoplasm

145

1397

1.04

0.15

1.3

1.55

1.46

nmol/l

0.44

136

1252

Crohn disease (strict definition, require KELA)

235

1.11

0.15

1.4

1.61

1.46

nmol/l

0.39

215

Chronic Coagulation defects

0.79

0.15

1.5

1.2

1.33

1.58

nmol/l

—

Epiphora

0.78

0.15

1.5

1.2

1.38

1.57

nmol/l

—

Foreign body on external eye

750

1.05

0.15

1.4

1.3

1.48

1.46

nmol/l

0.08

678

Protozoal diseases

121

1.16

0.15

1.2

1.42

1.51

nmol/l

0.09

109

Malignant neoplasm of colon, including Hilmo

837

0.95

0.15

1.2

1.3

1.29

1.49

nmol/l

1.00

760

Lesion of plantar nerve

207

1.11

0.15

1.7

1.3

1.86

1.48

nmol/l

0.79

184

Unspecified nephritic syndrome

1.10

0.15

1.2

1.61

1.40

nmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.10

0.15

1.3

1.2

1.08

1.50

nmol/l

—

Ethmoidectomy

576

1.06

0.14

1.7

1.3

1.41

1.48

nmol/l

0.19

524

Symptoms and signs involving speech and voice

150

1552

0.97

0.14

1.5

1.3

1.60

1.48

nmol/l

0.62

142

1388

Embedded and impacted teeth

822

0.96

0.14

1.4

1.36

1.43

nmol/l

0.29

742

Foreign body entering into or through eye or natural orifice

343

1.08

0.14

1.3

1.44

1.47

nmol/l

0.05

311

Benign neoplasm: Rectosigmoid junction

160

1.13

0.14

1.4

1.2

1.25

1.35

nmol/l

0.18

139

Fenamates

446

0.95

0.14

1.4

1.3

1.67

1.45

nmol/l

0.76

400

Injury of muscle and tendon at ankle and foot level

0.83

0.13

1.1

1.5

2.78

1.43

nmol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

115

1107

1.04

0.13

1.4

1.3

1.31

1.50

nmol/l

1.28

100

994

Burn and corrosion confined to eye and adnexa

0.81

0.13

1.3

1.4

1.99

1.35

nmol/l

—

Crohn disease (strict definition, all UC cases excluded)

199

1.11

0.13

1.5

1.4

1.68

1.42

nmol/l

0.63

182

Malignant neoplasm, without specification of site

106

0.85

0.13

1.0

1.2

1.71

1.41

nmol/l

—

Convalescence

190

1.11

0.12

1.5

1.4

1.29

1.40

nmol/l

0.22

167

Dislocation, sprain and strain of joints and ligaments of elbow

229

1.09

0.12

1.6

1.4

1.44

1.43

nmol/l

0.01

205

Abnormal findings in secretions and smears from cervix uteri vagina vulva

198

1494

0.97

0.12

1.5

1.4

1.45

1.50

nmol/l

0.29

182

1350

Postprocedural disorders of nervous system

230

1.09

0.11

1.7

1.4

1.29

1.43

nmol/l

0.40

212

Protozoal diseases, including avohilmo

124

1.13

0.11

1.2

1.42

1.49

nmol/l

0.08

112

Delivery

160

820

1.03

0.11

1.4

1.3

1.56

1.50

nmol/l

0.22

146

732

COPD, hospital admissions 3, with asthma pneumonia sepsis

131

1090

1.03

0.10

1.4

1.3

1.53

1.46

nmol/l

0.28

115

984

Acute nasopharyngitis (common cold)

581

0.96

0.10

1.5

1.3

1.41

1.44

nmol/l

0.06

531

Other injuries of upper limb, level unspecified

1.14

0.10

1.8

1.2

1.73

1.41

nmol/l

—

Postmenopausal atrophic vaginitis

105

554

1.03

0.09

1.3

1.4

1.25

1.44

nmol/l

1.21

498

Mandibular prognathia

1.06

0.09

1.2

1.29

1.48

nmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.04

0.09

1.6

1.3

1.30

1.63

nmol/l

—

Pleural effusion

686

0.96

0.09

1.5

1.3

1.47

1.50

nmol/l

0.09

617

Carcinoma in situ of cervix uteri

301

1.06

0.09

1.8

1.6

1.79

1.43

nmol/l

1.29

267

Malignant neoplasm of skin

266

1831

0.98

0.09

1.3

1.46

1.45

nmol/l

0.04

231

1666

Adenomyosis (Endometriosis of uterus)

477

1.05

0.09

1.3

1.4

1.45

1.41

nmol/l

0.08

423

Assault by blunt object

1.11

0.09

1.5

1.2

0.87

1.55

nmol/l

—

Colorectal adenocarcinoma

945

0.97

0.08

1.3

1.17

1.46

nmol/l

2.35

854

Chronic diseases of tonsils and adenoids

418

2668

0.99

0.08

1.5

1.4

1.46

1.45

nmol/l

0.05

380

2416

Pneumoconiosis due to asbestos and other mineral fibres

0.82

0.08

1.6

1.1

1.48

1.68

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs

0.78

0.08

1.2

1.79

1.52

nmol/l

—

Scissor bite

0.77

0.08

1.2

1.3

0.62

1.34

nmol/l

—

Malignant neoplasm of urinary organs, including Hilmo

541

0.96

0.08

1.4

1.2

1.85

1.48

nmol/l

0.78

486

Muscle strain

127

1.10

0.08

1.5

1.2

1.42

1.46

nmol/l

0.04

116

Obstructed labour due to malposition and malpresentation of fetus

707

0.97

0.07

1.5

1.43

1.48

nmol/l

0.14

640

Exposure to other and unspecified man-made environmental factors

0.83

0.07

1.3

1.2

1.53

1.47

nmol/l

—

Superficial injury of neck

0.82

0.07

1.2

1.24

1.60

nmol/l

—

Non-Hodgkin lymphoma, all, including Hilmo

611

0.97

0.07

1.3

1.36

1.48

nmol/l

0.50

553

Left ventricular outflow tract obstruction (LVOTO), broad definition

471

1.04

0.07

1.4

1.3

1.52

1.49

nmol/l

0.07

428

Erosion and ectropion of cervix uteri

1.03

0.07

1.4

1.3

2.52

1.62

nmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

489

0.96

0.07

1.2

1.3

1.33

1.50

nmol/l

0.55

443

Viral agents as the cause of diseases classified to other chapters

1.05

0.07

1.3

1.2

1.28

1.49

nmol/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.87

0.06

1.4

1.3

1.32

1.35

nmol/l

—

Degenerative diseases of the nervous system

161

1137

1.02

0.06

1.2

1.13

1.49

nmol/l

6.21

144

1024

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

250

1709

0.99

0.06

1.3

1.46

1.45

nmol/l

0.03

218

1554

Benign neoplasm: Tongue

101

0.89

0.06

1.4

1.2

1.60

1.37

nmol/l

—

Alzheimer’s disease (Late onset)

709

0.97

0.06

1.2

1.12

1.50

nmol/l

4.32

635

Contact with sharp object, undetermined intent

105

0.86

0.06

1.4

1.2

1.19

1.43

nmol/l

—

COPD, hospital admissions 1, only main diagnosis

160

1398

0.98

0.06

1.3

1.51

1.47

nmol/l

0.18

136

1264

Antenatal screening

442

1.03

0.05

1.4

1.54

1.47

nmol/l

0.22

396

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

742

1.02

0.05

1.3

1.30

1.48

nmol/l

1.01

672

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

124

1182

1.02

0.05

1.3

1.55

1.45

nmol/l

0.35

112

1077

Benign neoplasm of urinary organs

179

1.06

0.04

1.2

2.27

1.41

nmol/l

0.61

156

Disorders of refraction and accommodation

126

1236

1.02

0.04

1.5

1.4

1.52

1.49

nmol/l

0.10

113

1109

Glucosamine medication

216

1706

1.01

0.04

1.3

1.63

1.47

nmol/l

1.45

195

1540

Burns and corrosions confined to eye and internal organs

111

1.08

0.04

1.5

1.76

1.46

nmol/l

0.48

100

Monoarthritis, not elsewhere classified

159

0.94

0.03

1.3

2.08

1.55

nmol/l

0.85

151

Melanocytic naevi

148

1464

1.01

0.03

1.5

1.4

1.44

1.49

nmol/l

0.18

132

1315

Viral agents as the cause of diseases classified to other chapters, including avohilmo

1.09

0.03

1.3

1.2

1.30

1.46

nmol/l

—

Cardiodefibrillation

177

1780

0.99

0.03

1.3

1.65

1.44

nmol/l

1.52

159

1615

Unspecific neurodegenerative disorder

187

1269

1.01

0.02

1.2

1.17

1.52

nmol/l

7.36

169

1148

Malignant neoplasm of bladder

279

0.97

0.02

1.3

1.2

1.25

1.49

nmol/l

0.64

251

Bacterial meningitis

132

1.06

0.02

1.4

1.25

1.47

nmol/l

0.36

120

Injury of muscle and tendon at wrist and hand level

661

0.98

0.02

1.3

1.39

1.50

nmol/l

0.37

588

Injury of other and unspecified intrathoracic organs

281

1.03

0.02

1.2

1.3

1.31

1.46

nmol/l

0.25

255

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

470

1.02

0.02

1.4

1.2

1.92

1.48

nmol/l

0.90

421

Vestibular neuronitis

399

0.98

0.02

1.2

1.4

1.39

1.50

nmol/l

0.24

364

Carcinoma in situ of skin of scalp and neck

1.08

0.02

1.0

1.1

1.10

1.58

nmol/l

—

Liquid cancers, including Hilmo

178

1579

0.99

0.02

1.4

1.3

1.35

1.45

nmol/l

0.70

160

1434

Fall involving bed

107

0.93

0.02

1.0

1.1

2.21

1.54

nmol/l

—

Liquid cancers

141

1344

0.99

0.01

1.4

1.3

1.34

1.45

nmol/l

0.66

124

1225

Varicose veins

298

2259

1.00

0.01

1.3

1.55

1.45

nmol/l

0.87

266

2045

Aortic valve malfunction, age under 60 years

448

0.98

0.01

1.4

1.3

1.44

1.49

nmol/l

0.10

408

Alzheimer disease, including avohilmo

155

1066

1.01

0.01

1.2

1.16

1.49

nmol/l

5.43

138

961

Acute posthaemorrhagic anaemia

124

1.05

0.00

1.2

2.23

1.47

nmol/l

0.66

107

416

0.99

0.00

1.3

1.34

1.54

nmol/l

0.30

374

Outcome of delivery

329

0.99

0.00

1.4

1.27

1.51

nmol/l

0.92

294

Injuries to the elbow and forearm

370

3174

1.00

0.00

1.4

1.3

1.41

1.46

nmol/l

0.30

334

2866

Coxarthrosis, primary, with hip surgery

231

2141

1.00

0.00

1.4

1.3

1.59

1.43

nmol/l

1.38

202

1946

Other and unspecified iridocyclitis

185

0.97

0.00

1.6

1.4

1.44

1.45

nmol/l

0.02

167

Scar conditions and fibrosis of skin

129

1.01

0.00

2.0

1.3

1.13

1.46

nmol/l

—

114

MS-disease / Multiple Sclerosis

255

0.98

0.00

1.3

1.5

1.09

1.39

nmol/l

0.96

236

Atypical facial pain

181

0.99

0.00

1.4

1.3

1.23

1.45

nmol/l

0.64

162

Congenital malformations of eye, ear, face and neck

216

1.02

0.00

1.2

1.4

1.48

1.47

nmol/l

0.01

196

Hypoparathyroidism

136

1.03

0.00

1.2

1.3

1.84

1.38

nmol/l

0.90

117

Vasomotor rhinitis (mode)

284

0.99

0.00

1.5

1.4

1.91

1.42

nmol/l

0.58

255

Other congenital malformations of face and neck

102

0.98

0.00

1.1

1.5

1.37

1.43

nmol/l

—

Personal history of malignant neoplasm

269

1.00

0.00

1.7

1.3

1.11

1.51

nmol/l

1.15

242

Alzheimer disease

132

947

1.00

0.00

1.2

1.12

1.49

nmol/l

5.91

118

853

Melanocytic naevi of trunk

531

1.00

0.00

1.3

1.23

1.48

nmol/l

1.02

479

Contact with heat and hot substances

197

1.02

0.00

1.6

1.4

1.14

1.46

nmol/l

1.31

178

Meningitis

195

1.03

0.00

1.3

1.4

1.26

1.49

nmol/l

0.59

175

Melanoma in situ of eyelid, including canthus

0.00

0.0

1.0

—

1.87

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.2

—

2.06

—

Nightmares

0.00

0.0

1.3

—

1.78

—

Constitutional tall stature

0.00

0.0

1.3

—

2.42

—

Generalized epilepsy, strict definition

0.92

0.00

1.1

1.3

1.36

1.42

nmol/l

—

Early syphilis

0.98

0.00

1.2

1.33

1.61

nmol/l

—

Tuberculosis of other organs, strict

1.01

0.00

1.1

1.2

1.38

1.59

nmol/l

—

Coccidioidomycosis, including avohilmo

0.00

0.0

1.2

—

1.81

—

Macrocephaly

0.00

0.0

1.0

—

2.45

—

Leishmaniasis, including avohilmo

0.00

0.0

1.0

—

1.18

—

Other congenital malformations of integument

0.00

0.0

1.0

—

2.26

—

Inflammation of lacrimal passages (acute and unspecified)

0.98

0.00

1.0

1.1

1.55

1.37

nmol/l

—

Diphtheria, including avohilmo

0.00

0.0

1.2

—

1.33

—

Relapsing fevers, including avohilmo

0.00

0.0

1.0

—

1.22

—

Benign neoplasm: Short bones of upper limb

0.86

0.00

1.2

1.1

1.59

1.41

nmol/l

—

Central retinal artery occlusion

0.88

0.00

1.3

1.2

1.20

1.69

nmol/l

—

Erythrasma

0.00

-0.00

0.0

1.2

—

1.61

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.0

—

1.87

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.0

—

1.84

—

Tuberculosis of other organs

0.97

-0.00

1.0

1.2

1.51

1.67

nmol/l

—

Alpha thalassaemia

0.00

-0.00

0.0

1.2

—

1.72

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

1.0

—

1.01

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.3

—

2.60

—

Certolizumab pegol

0.94

-0.00

1.3

1.25

1.52

nmol/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.98

-0.00

2.0

1.1

0.87

1.37

nmol/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

1.50

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

1.59

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.2

—

2.11

—

Kissing spine

0.00

-0.00

0.0

1.0

—

1.23

—

Reduction defects of upper limb

0.00

-0.00

0.0

1.2

—

1.47

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

1.41

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

1.1

—

2.12

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.02

-0.00

1.7

1.2

1.64

1.29

nmol/l

—

Relapsing fevers

0.00

-0.00

0.0

1.0

—

1.22

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

-0.00

0.0

1.3

—

1.84

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.2

—

1.61

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

0.98

-0.00

1.5

1.1

1.37

1.33

nmol/l

—

Eclampsia

0.00

-0.00

0.0

1.0

—

1.07

—

Tuberculosis of other organs, strict, including avohilmo

1.00

-0.00

1.1

1.2

1.38

1.60

nmol/l

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

1.0

—

0.97

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.3

—

2.50

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.3

—

2.09

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.3

—

2.55

—

Nystagmus and other irregular eye movements

0.86

-0.00

1.0

1.1

2.53

1.45

nmol/l

—

Other meningitis

0.85

-0.00

1.4

1.2

1.29

1.68

nmol/l

—

Lichen striatus

0.00

-0.00

0.0

1.0

—

1.31

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.0

—

2.35

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.1

—

2.38

—

Anomalies of pupillary function

0.99

-0.00

1.6

1.3

1.79

1.39

nmol/l

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.0

—

2.32

—

Dengue, including avohilmo

0.00

-0.00

0.0

1.0

—

1.63

—

Early syphilis, including avohilmo

0.88

-0.00

1.2

1.33

1.57

nmol/l

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

1.2

—

1.64

—

Noonan syndrome

0.00

-0.00

0.0

1.2

—

1.76

—

Crushing injury of lower leg

0.00

-0.00

0.0

1.2

—

1.79

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.0

—

1.84

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.2

—

1.30

—

Benign neoplasm of male genital organs

0.93

-0.00

1.0

1.2

1.44

1.60

nmol/l

—

Shoulder region

0.91

-0.00

1.4

1.1

0.96

1.59

nmol/l

—

Other disorders of binocular movement

0.91

-0.00

1.1

1.3

1.18

1.50

nmol/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

-0.00

0.0

1.2

—

0.97

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.96

-0.00

1.2

1.00

1.68

nmol/l

—

Other specified and unspecified disorders of eyelid

1.00

-0.00

1.6

1.1

1.76

1.80

nmol/l

—

Sleep terrors [night terrors]

0.00

-0.00

0.0

1.0

—

2.12

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

1.01

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.00

-0.00

1.0

1.3

1.10

1.31

nmol/l

—

Ankylosis of teeth

0.00

-0.00

0.0

1.4

—

1.61

—

Suppurative otitis media, unspecified

0.92

-0.00

1.0

1.2

1.99

1.64

nmol/l

—

Moyamoya

0.00

-0.00

0.0

1.2

—

1.88

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.88

-0.00

1.0

1.2

1.43

1.42

nmol/l

—

Enterohaemorrhagic Escherichia coli infection

0.00

-0.00

0.0

1.1

—

0.84

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C peptide [Moles/volume] in Serum or Plasma --post meal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS